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ABSTRACT 
Investigations into the use of long-wavelength fluorigenic substrates, which are 
non- or weakly fluorescent but are converted by an appropriate enzyme to a 
highly fluorescent product, have been carried out in order to determine several 
different enzymes and their inhibitors. 
Certain nonfluorescent compounds based on long-wavelength Xanthenes and 
oxazines dyes were synthesised. Amongst these, naphthofluorescein di-
phosphate and naphthofluorescein mono-phosphate has been demonstrated 
to be new fluorigenic substrates for alkaline phosphatase. The hydrolysis 
product of these substrates can be used for trace analyses using diode laser 
based fluorescence detection. Its application to the determination of 
theophylline, an inhibitor of this enzyme, has also been demonstrated. The 
novel use of CHAPS has been used to shift the fluorescence, and especially 
the excitation wavelength of naphthofluorescein to match the output of a 635 
nm diode laser in a simple and sensitive fluorescence detector. 
Naphthofluorescence di-acetate has also been synthesised and successfully 
applied to the determination of acetylcholineterase and one of its potent 
inhibitors, metrifonate. 
The potential of naphthofluorescein ~-D-galactopyranoside as a substrate for 
~-galactosidase and its use for enzyme inhibition by PHMB and PETG has 
also been an important investigation of this project. 
For the assay of proteases, the fluorigenic substrate NF-albumin has proved to 
be a highly sensitive substrate using NF-succinimidyl ester, which has also 
been synthesised. Proteases and protease-inhibition based assays have 
been carried out. A dual-enzyme assay and selective inhibition-based assay 
has also been demonstrated. 
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Chapter 1 
Introduction 
1.1 Fluorescence 
Fluorescence is the emission of longer wavelength radiation by a substance 
as a consequence of absorption of energy of a shorter wavelength. This 
occurs by a series of steps from a higher energy level running to the ground 
level. 
1.1.1 Absorption and emission of radiation 
The absorption of radiation by an atom or molecule can lead to the production 
of an electronically excited species that can exhibit different chemistry than 
that of the ground state species. The method by which the excited species 
assimilates that energy, in rotational, vibrational or electronic modes, depends 
on the wavelength of the incident radiation [1]. Species can exist only in 
certain defined, discrete energy states and a transition between two such 
states has defined energy. As a result, the quantisation of energy levels for 
such individual species exhibits specific absorbed and emitted energies, and 
frequencies of radiation. 
The distribution of electrons amongst the molecular orbitals gives the 
electronic configuration of a molecule. Each electronic configuration has 
orbital angular momentum and spin angular momentum, which determines the 
electronic state of the molecule [2]. Most molecules that exist naturally are 
stable and not very reactive because their electrons have paired spins and 
closed shell molecules [3]. 
Absorption of a photon by a molecule excites the electrons from the ground 
state, SQ, to a higher vibrational energy level in the upper singlet state, S1, S2, 
S3 (Figure 1.1). The electrons remain paired and may be in a vibrationally 
excited state where V > O. In this excited state the molecule is subjected to 
collisions with its environment, its thermal energy is discarded by non-radiative 
means such as release of heat. This vibrational cascade succeeds in lowering 
2 
the molecule's vibrational energy, relaxing to the lowest vibrational level of the 
first excited singlet state, S, [4]. From this state most molecules will return to 
the ground level without emitting light, the excess energy being lost by internal 
conversions or various quenching processes. Alternatively, as the electrons 
move from S, to So. a photon of defined energy can be emitted, fluorescence. 
Figure 1.1 
Singlet state Triplet state 
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Jablonski diagram showing absorption, and emission processes of 
fluorescence and phosphorescence. So (ground sing let state) refers to the 
electronic and vibrational transitions found when the electrons are in cr and " 
bonding orbitals. S" S2 (first and singlet levels) and T" T2 (first and second 
triplet levels) refer to electronic and vibrational transitions in the cr' and ,,' 
anti bonding orbitals. 
Like all radiation processes (with the exception of phosphorescence), 
fluorescence is very rapid having a first order decay with a lifetime of 
nanoseconds. It has a longer wavelength and lower energy than the absorbed 
3 
photon. The difference between these excitation and emission wavelengths is 
the Stokes' shift. The Stokes' shift for a molecule can be changed when 
necessary as a molecule can be excited away from its maxima. This is 
possible because fluorescence always occurs from the lowest vibrational level 
of S, to So. Thus, the shape and maxima of the emission spectrum will be 
independent of the excitation wavelength, only the fluorescence intensity of 
the emission spectra will be affected. 
Electrons in the S, state may also undergo intersystem crossing to the first 
excited triplet state T,. The subsequent radiative transition from T, to So is 
phosphorescence. The S to T transition is forbidden [5). However, 
phosphorescence is made possible as a result of spin-orbit coupling and the 
triplet level lying below S, [3]. Due to the relatively long lifetime of the triplet 
state, molecules in this state are much more susceptible to radiationless, 
deactivation processes. For these reasons phosphorescence at room 
temperature is rare, but by dispersion of the sample in a rigid matrix or 
freezing the solution to low temperature enables phosphorescence to be 
observed from many compounds. The decay times for the processes 
mentioned associated with fluorescence are shown in Figure 1.2. 
So ~ So ABSORBANCE 
Sn 
10-12 • la'" sec 
• S, INTERNAL CONVERSION 
10·e _ 10'v sec 
Sn + hv FLUORESCENCE 
S, 10" sec To INTERSYSTEM CROSSING 
10':' - 10" sec 
So INTERNAL CONVERSION 
10'z - 10"· sec ~ Sn+ hv PHOSPHORESCENCE 
T1---l 10 -10·3 sec 
... So INTERNAL CONVERSION 
Figure 1.2 Decay times for processes associated with fluorescence . 
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1.1.2 Fluorescence intensity 
Fluorescence arises in most cases from the lowest excited singlet state S, (v=O), 
even though, through absorption the electrons may initially populate a higher 
singlet state. For many organic molecules the S,(v=o) to SO(v=O) transition is the 
most intense and the maximum intensity in both absorption and emission 
spectra corresponds to the same transition (Frank-Condon Principle). The 
upper and lower electronic states of such organic molecules are a similar size 
and shape, the vibrational spacing will be the same and the absorption and 
emission spectra will be mirror images (Figure 1.3). 
ABSORPTION EMISSION 
Figure 1.3 Representation of absorption and emission spectra. 
Fluorescence intensity (I F) in dilute solutions is directly proportional to the 
intensity of the excitation light source and solution concentration and is given 
by equation 1.1 : 
1.1 
5 
q> is the quantum efficiency, 10 is the incident radiant power at the wavelength 
of interest, E is the molar absorptivity at that wavelength, b is the cell path 
length and c is the molar concentration [6] . 
For a very dilute solution where A<O.05 absorbance units, equation 1.1 
approximates to equation 1.2: 
1.2 
K is an instrumental factor, it is a proportionality constant due to the fact that 
although fluorescence is emitted in all directions, only that of a limited aperture 
is measured. 
In order to emit radiation as fluorescence, a molecule must first absorb 
radiation. The higher the molar absorptivity (E), the more intensely fluorescent 
a compound will be. Because fluorescent emission in organic compounds 
comes predominately from the S,(v=O), it is often found that the quantum 
efficiency (q» is independent of the excitation wavelength [6]. For highly 
fluorescent molecules, such as fluorescein, under some conditions q> 
approaches one. 
In theory, the observed fluorescence intensity, which is only a fraction of IF 
because of instrumental factors, is proportional to both the solute 
concentration and to the intensity of the exciting light source at the absorption 
wavelength , suggesting the more intense the light source the greater the 
fluorescence. However, in practice a highly intensive radiation source can 
cause photodecomposition of the sample, therefore a moderate intensity is 
used. 
1.1.3 Structure-Fluorescence relationship 
In most organ ic molecules of spectroscopic interest the It-electrons and n-
electrons are considered when determining the likelihood of fluorescence. 
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The types of molecules that are most likely to fluoresce are those with 
delocalised It-orbital systems. Compounds containing isolated It-bonds exhibit 
It-electron transitions in the vacuum ultraviolet spectral region , and super-
delocalised systems have the It-electron spectra within the near ultraviolet to 
near infrared range. 
The most intense and useful fluorescence is found in compounds containing 
aromatic functional groups with low energy It-lt' transition levels and most un-
substituted aromatic hydrocarbons fluoresce in solution. However, the simple 
heterocycles such as pyridine (1) , furan (2) , thiophene (3) and pyrrole (4) , do 
not show fluorescence. 
o N 
o o 
(1 ) (2) 
s o 
(3) 
H 
I 
N o 
(4) 
This is due to the presence of the heterocyclic atom. In pyridine and pyrrole, 
the lowest energy electron transition is thought to involve an n-lt' system, 
which rapidly converts to a triplet state and prevents fluorescence. 
In a It-bond the distribution of electronic charge is concentrated above and 
below the plane of the a-axis. These It-bonding electrons are free to move 
within the molecule and can be delocalised between several atoms. The 
number of rings and their degree of conjugation affects the quantum efficiency 
(<p) , which usually increases with increased It-electron conjugation. 
1.1.4 The effect of structural rigidity [7] 
It is found that fluorescence is favoured in molecules that possess rigid 
structures, for example, when measured under similar conditions the quantum 
efficiency (<p ) for fluorene (5) and biphenyl (6) are 0.99 and 0.23 respectively. 
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The difference in behaviour appears to be mainly as a result of the increased 
rigidity caused by the bridging methylene group in the fluorene In addition, 
enhanced intensity results when fluorene is adsorbed on a solid surface. In 
these circumstances the added rigidity provided by the solid surface may 
account for the absorbed effect. 
o-o~ - ~ /; 
(5) (6) 
Lack of rigidity in a molecule causes an enhanced internal conversion rate and 
consequently an increase in the likelihood for radiationless decay. 
1.1.5 Effect of substituted groups 
In a number of molecules the absorption of a photon can be traced to the 
excitation of the electrons of a small group of atoms. For example, when a 
carbonyl group is present in a molecule, absorption at 290 nm is normally 
observed, although the precise absorption depends on the nature of the rest of 
the molecule. Groups of this kind are called chromophores, from the Greek for 
colour bringer, and their presence often accounts for the colour of materials 
[4] . 
These types of substituted group plays an important role in the nature and 
extent of fluorescence. Fluorescence yields of aromatic and heterocyclic 
hydrocarbons are usually altered by ring substitutions [8]. The fusion of 
benzene rings to heterocyclic nuclei results in an increase in the molar 
absorptivity (E) and substitution of benzene ring causes a shift in the 
absorbance wavelength (Amax.) and a corresponding change in fluorescence 
[7]. Groups that generally increase fluorescence are electron donating groups 
such as -OH , -OCH3, -NH2, -NHCH3, and -N(CH3)2. It follows that those that 
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diminish fluorescence are electron withdrawing. These include -CHO, NH3', -
NHCOCH3, -N02, and -COOH groups [9]. 
Halogen substitution causes a decrease in fluorescence, a greater decrease is 
seen with increasing atomic number. This is thought to be due to the heavy 
atom effect, which increases the probability of intersystem crossing to the 
triplet state. 
Intramolecular hydrogen bonds may affect the fluorescence, but this is often 
unpredictable. In salicylic acid (7), for example, hydrogen bonding between 
carbonyl groups and the phenolic groups results in an enhanced fluorescence, 
whereas this type of bonding in proteins may quench the fluorescence [10] . 
(7) 
1.1 .6 Temperature, Solvent and pH effects [1 1-13] 
The quantum efficiency (<p) for most molecules decreases with increasing 
temperature. This is due to an increase in the frequency of molecular 
collisions at elevated temperatures, thereby increasing the probability for 
deactivation by external conversions. 
A decrease in the solvent viscosity increases the probability of external 
conversions that lead to decreases in quantum efficiency. The polarity of the 
solvent exerts an important influence. The energy of n-lt' transitions is often 
increased in polar solvents, while that for It-lt' transitions decreases. These 
shifts may occasionally be large enough to lower the energy of the It-lt' to 
below the n-lt' and thereby enhance the fluorescence. Fluorescence is 
decreased in solvents containing heavy atoms, for example, carbon 
9 
tetrachloride and ethyl iodide. The effect is similar to that which occurs when 
heavy atoms are substituted into fluorescent compounds, giving an increase in 
intersystem crossing . 
A large number of fluorescent compounds contain ionisable groups. In these 
compounds it is common to find that only one ionic form is fluorescent and that 
pH control is important, for example, in compounds such as oxybarbiturates 
(8) and fluorescein (9) where the fluorescence increases with increasing pH. 
yy yy o 0 o 0 
pH 7-8 :::" 
HNyNH 
'" 
NyNH 
0 0-
(8) 
Unionised Mono-anion 
Non -fluorescent 
HO 
pH 7 :::" 
Non-fluorescent 
1.1.7 Advantages of fluorescence 
o 0-yy 
pH 13-14:::" I 
NyN 
'" 
HO 
0-
Di-anion 
Fluorescent 
o 
eOOH 
(9) 
Fluorescent 
When compared with conventional absorbance-based techniques, 
fluorescence is several orders of magnitude more sensitive and more 
selective. The main reason for this is that in fluorescence the emitted radiation 
is measured directly and can be changed by altering the intensity of the 
incident radiation. So, an increase in signal over a zero background is 
10 
measured in fluorescence. In other spectrophotometric methods, like 
absorbance, the measured quantity absorption is measured indirectly as the 
difference between the incident and transmitted beam. Therefore, a small 
decrease in intensity of a very large signal is measured with corresponding 
large loss in sensitivity. 
The specificity of fluorescence is due to two main factors. The first is that 
there are fewer fluorescent compounds than absorbing ones. This is because 
all fluorescent compounds must absorb radiation, but not all the compounds 
that absorb radiation fluoresce. In consequence there are much fewer 
interferences when a fluorescence rather than an absorptiometric method is 
employed. Secondly, there are two wavelengths in fluorescence to 
characterise the sample, unlike spectrophotometry where there is only one. 
For example, two compounds that absorb radiation at the same wavelength 
will probably not emit at the same wavelength and so the compounds will have 
a different Stokes' shift. Other factors that increase selectivity are the lifetime 
and polarity of fluorescence which help in the discrimination of compounds [5). 
Fluorescence is also generally more sensitive to the environment of the 
chromophore or molecule that is absorbing and emitting photons than is light 
absorption. This is a consequence of the relatively long time the molecule 
stays in the exited state before de-excitation. Absorption is a process that is 
over in 10-15 seconds and the solvent is the only thing really close enough to 
affect the solute. In contrast, during the 10-9_10-7 seconds that a singlet state 
remains excited , all kinds of physical and chemical processes can occur like 
protonation, solvent reorientation, and changes in optical rotation. These 
processes can even involve other molecules which are over 10 nm away from 
the fluorophore at the moments of excitation . It is therefore possible for 
fluorescence to provide dynamic information on its environment within 
nanoseconds. 
Another fairly unique feature of fluorescence is resonance energy transfer 
(RET) [14). RET is a distance dependent interaction between the electronic 
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excited states of two dye molecules in which excitation is transferred from a 
donor molecule to an acceptor molecule without the appearance of a photon. 
It is primarily a result of non-radiative dipole-dipole interactions between the 
donor and the acceptor. The requirements for the resonance interaction 
producing energy transfer are that: 
• Donor and acceptor molecules must be in close proximity 
(typically 10-100 °A). 
• Absorption spectrum of the acceptor must overlap fluorescence 
emission of the donor. 
• Donor and acceptor transition dipole orientation must be 
approximately parallel. 
Ra (the distance of 50% energy transfer) defines energy transfer, which 
depends on the inverse sixth power of the distance between the probes. 
Depending on the molecules chosen , this distance varies, but is always 
shorter than 10 nm. 
FRET has found extensive applications in a number of research areas, such 
as structure and conformation of proteins [15] , receptor-ligand based assays 
[16], immunoassays [17]. DNA sequencing [18-19] and fluorigenic protease 
assays [20] . 
In the area of protease assays, FRET has been applied to the assay of 
specific proteases. An assay for probably the most looked at protease in 
recent times, human immunodeficiency virus 1 protease (HIV-1 PR), has been 
developed [21]. This assay has important applications in the identification of 
inhibitors for this protease as therapeutics. The quenched fluorigenic 
substrate was an octapeptide containing the cleavage site for HIV-1 protease 
with a fluorescent donor, 5-[(2-aminoethyl) amino] naphthalene-1-sulfonic acid 
(EDANS), and a quenching acceptor, 4-(4-dimethlaminophenylazo) benzoic 
acid (DABCYL) , attached at the COOH- and NH2-termini, respectively. The 
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intrinsic fluorescence of EDANS is dramatically reduced in this substrate 
because of intramolecular resonance energy transfer to the DABCYL group. 
Since resonance energy becomes insignificant beyond a distance of 10 nm, 
the full fluorescence quantum yield of EDANS is restored after cleavage of the 
peptide and concomitant liberation of the DABCYL-linked peptide fragment. 
Hence, proteolytic activity can be continuously monitored by simply recording 
the increase in fluorescence intensity with time. The assay was shown to 
effectively determine HIV-1 protease activity as well as detect the potent 
aspartic protease inhibitor. This method may also be used to study substrate 
requirements, since an efficient donor-acceptor pair can be used with virtually 
any peptide sequence. 
FRET protease assays have also been applied to the analysis of renin [22], 
Escherichia coli leader peptidase [23] and tail specific protease (which 
represents a new class of proteases that have no seqence homology to any 
well characterised proteases) [24] . 
1.1.8 Fluorigenic substrates 
Fluorescence spectroscopy has been widely used for many years in enzyme 
assays [25-30] and immunoassays [31] . The principal features of these 
assays are their spectral selectivity and sensitivity, due to the detection of a 
small emission signal against a zero background. 
A significant number of compounds are commercially available for use as 
fluorigenic substrates for detection of activities of specific enzymes [32-34]; 
however, the absorption maxima for most of these are below 600 nm. These 
compounds, themselves nonfluorescent, are converted by an appropriate 
enzyme to a highly fluorescent product. The most commonly used fluorigenic 
substrates are those based on a number of coumarin , fluorescein, and 
resorufin derivatives. Unfortunately, these substrates are far from the ideal as 
their fluorescent products suffer from reduced sensitivity because of high 
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background fluorescence [35]. These background interferences originate from 
endogenous fluorescence species and from Raman and Rayleigh scattering, 
which are most significant in UV/visible region of the spectrum [36] . 
Fluorescence interference from an endogenous fluorophore, contained in a 
complex matrix, generate the most substantial background effect. Substances 
found in blood plasma for example, proteins and amino acids, have 
fluorescence emissions at 350 nm, and protein-bound bilirubin gives an 
emission peak at 520 nm. 
Most fluorescence experiments that involve biological samples are performed 
in aqueous conditions, which give rise to the problem of Raman scattering. 
When an excitation wavelength of 350 nm is used a Raman signal appears at 
397.5 nm, which can interfere with signals from other fluorophores. Rayleigh 
scattering is present in all solution based fluorescence experiments and is due 
to the solvent. Its effect can be minimised by the use of filters and 
monochromators and by the right-angled optical arrangement used in most 
fluorimeters. 
Autofluorescence of glass, solvents or impurities can greatly reduce the 
potential sensitivity of the analysis. Yet fluorescence detection in long 
wavelength spectral region has proved to reduce these problems [37] . Long 
wavelength substrates possess spectral properties which are observed 
between 600-1000 nm, a region characterised by little interference from 
biomolecules. The fluorescence of impurities is diminished, since the number 
of compounds absorbing light and fluorescing is very small , and Raman 
scattering is reduced because the intensity is proportion to 1..-4 [38]. Thus the 
major interference in the long wavelength region is noise generated from the 
detector. The sensitivities of long wavelength assays are usually detector 
limited as opposed to background limited. This situation has improved 
significantly with the development of semiconductor-based detectors, 
photodiodes and recently available long wavelength laser diodes. 
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The spectral range makes the products of long wavelength fluorigen ic 
substrates suitable for excitation with inexpensive laser diodes, which enhance 
the observed fluorescence signal. Consequently, long wavelength fluorigenic 
substrates are being increasingly used in bio-analytical applications [39-43). 
1.1.9 Long wavelength fluorophores 
One of the major advantages of long wavelength region (600-1000 nm) is that 
it does not include a large number of intrinsic fluorophores. Theory predicts 
that quantum yield decreases as the energy difference between ground and 
excited states decreases [44) . In practice what seems to happen is that there 
is a relatively small number of really bright fluorophores in this region and 
compared with the UV/vis region, a much larger number of nonfluorescent or 
poorly fluorescent molecules. Since, most fluorimetric assays are based on 
label or probe molecules, this is a very favourable situation to develop a range 
of assays it is only necessary to synthesise or modify fluorophores to provide 
suitable reactive groups. Fluorophores with moderate molar absorptivities and 
quantum yield may give excellent limits of detection because of the low 
backgrounds. The dye families with long wavelength spectral properties are 
xanthene, oxazine, phthalocyanine and polymethine cyanine. 
Phthalocyanine dyes (11) have a structure analogous to natural porphyrins 
(11 ) 
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and have become important colorants as dyes and pigments. In search for 
long wavelength absorbing dyes for optical recording media, phthalocyanines 
(Amax = 690 nm) were the first candidates to be considered and attracted 
attention as functional dyes in various fields, such as laser disc memory and 
photodiodes [45). 
Phthalocyanine dyes serve as precursors for naphthalocyanine isomers with 
absorbance maxima ranging from 720 to 800 nm. These are produced by 
annelation of a phenyl ring and give a bathochromic shift in wavelength. The 
naphthalocyanine dyes are planer, rigid molecules, which undergo an 
excitation process resulting in the population of the first singlet state S,. The 
absorption spectra of 2,3-naphthalocyanine (12) are consistent with • 7t-7t 
transitions in the energy region above 769 nm. They are very stable, resist 
(12) 
degradation by light, heat and oxidation, but have limited solubility in protic 
solvents and relatively small Stokes' shifts. However, the series of 2,3-
naphthocyanine derivatives is potentially very important with electro-optical 
applications in areas such as optical recording media, organic 
photoconductors, colour filter dyes and photosensors. 
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Polymethine cyanine dyes (13) are smaller molecules, generally have higher 
aqueous solubility. They are particularly interesting because they can be 
tailored for different applications due to the ability to predict their spectral 
properties. They can be turned to the desired wavelengths by altering the 
heterocyclic nucleus and the number of double bonds in the methine chain . 
(13) 
By changing the functional groups, several multi-colour derivatives of these 
have been made, and used for different tasks including pH determination, 
DNA labeling, and in laser sensitive lithograph printing plates [46] . 
Phthalocyanine, polymethine cyanine and naphthalocyanines have been 
widely applied long wavelength dyes [47]. They possess large molar 
absorptivities, acceptable quantum efficiencies and strongly fluorescent. 
A disadvantage of cyanines is that their fluorescence intensity decreases in 
aqueous solutions, presumably due to the formation of nonfluorescent dimers 
[48]. 
Oxazines such as Nile Blue (14) have been used as covalent and non-
covalent labels for proteins [41]. Their absorption and emission maxima shift 
to longer wavelengths with an increasing number of alkyl and aryl substituents 
on the two amine functionalities. Another oxazine dye of interest is oxazine 
+ 
~ ~ CIO. 
(C2Hsl2NyyO~NH2 _ 
N ~ I 
::::,... 
(14) 
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750 (15), available as a laser dye and with an excitation wavelength well 
matched to 660-670 nm diode lasers [49]. The main advantages of the 
oxazines are their excellent photostability, which far exceeds that of other 
groups of dyes, and their frequently fairly high Stokes' shifts. 
Xanthenes are among the most commonly used class of fluorescent dyes. 
The classical xanthene fluorophore, fluorescein, still finds much appl ications, 
but its excitation and emission wavelengths especially unsuitable for work in 
biological samples such as blood plasma, its emission wavelength 
corresponding closely to that of protein-bound bilirubin. Longer wavelength 
xanthene derivatives such as Texas red (sulphorhodamine 101 chloride), [50], 
have also been used , but still longer excitation and emission wavelengths are 
desired. 
Rhodamine 800 (16) [51], seems to be a good candidate: its major long-
wavelength excitation bands are at ca. 635 and 690 nm, but it can be 
efficiently excited by diode lasers operating at 650-670 nm, and with an 
emission wavelength in aqueous solution of ca. 720 nm Rayleigh scattering 
interference is very small. Like other xanthene dyes rhodamine 800 does not 
have particularly environment sensitive fluorescence properties, though its 
(16) 
~I 
~ 
(17) 
° 
S03H 
fluorescence is enhanced ca. 3-fold in acetonitrile solution compared with 
aqueous solution. Its interaction with serum albumin and a-1 acid glycoprotein 
produce fluorescence enhancement ( ca 1.3 and 2.5 times respectively) . This 
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dye is thus not suitable as a fluorescence probe, but it has potential as an ion-
pairing reagent and any derivatives with active functional groups may be 
extremely useful long wavelength labels. 
Perhaps the most promising long wavelength xanthene dyes, particularly for 
use in enzyme assays are naphthofluorescein and its sulphone- analogue. 
Vita blue (17) absorbs at 633 nm, which is an attractive feature as this makes 
it excitable by 635 nm diode laser. However, a disadvantage associated with 
this compound is that it is very difficult to synthesise. This is probably due to 
the deactivating character of sulphonic acid groups in Friedel-Crafts 
acylations. However, there is great potential for use of naphthofluorescein and 
its modified forms as long wavelength fluorophores. 
1.1.10 Fluorescent labeling 
In the past the majori ty of fluorescent labeling was the non-covalent labeling of 
proteins through electrostatic adsorption using hydrophobic, non-
functionalised dyes. Successful labeling and good assay detection 
sensitivities were accomplished with these non-covalent labeled proteins, but 
problems occurred because of damage to size exclusion columns used to 
purify these labeled reagents [52]. To overcome this damaging problem 
covalent labeling with functionalised dyes was developed. 
Waggoner et al. developed a new class of biological labeling reagents based 
on symmetrical dyes with iodoacetamide (18), isothiocyanate (19), N-
succinimidyl (20) and hydrazide (21) groups for thiol , primary amines and 
aldehyde labeling, respectively [53]. 
Gooijer et al. successfully used dyes containing the iodoacetamide group for 
the determination of the non-steroidal anti-inflammatory drug naproxen in 
saliva [54]. 
19 
The highly reactive isothiocyanate group can react with various types of 
compounds, particularly those with active hydrogen. The reaction takes place 
above pH 9.0, is spontaneous, and the isothiocyanate group reacts selectively 
with amines or alcohols to form stable thioureas or thiourethanes. 
Bhattacharyya [39] used this principle to directly label nucleic acids with 
fluorescein isothiocyanate. 
o 
R/'-..N~I 
I 
H 
(18) (19) (20) 
(21) 
The succinimidyl ester group is well known for its acylating properties and can 
be used for labeling primary and secondary amines at slightly alkaline pH [34]. 
Nuijens et al. have extensively used dyes that contain hydrazide to label 
aldehydes in pre-column HPLC procedures [38]. They proposed that when 
labeling small antigens, mono-functionalised dyes should be used in 
preference to bifunctional dyes as complications from cross-linking of proteins 
does not occur to a significant extent when using bi-functionalised dyes [55]. 
1.2 Enzymes 
In a biochemical system thousands of complex organic reactions occur. Each 
step of these reactions is under the control of a very efficient and specific 
organic catalyst. These catalysts are known as enzymes. Enzymes have high 
molecular weights ranging from 5,000 to 500,000 Da. They occur in cells of 
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plants, animals and micro-organisms. Enzymes can be isolated from their 
native media and be used to function under laboratory conditions. The 
number of known enzymes is several thousands . 
1.2.1 Enzyme structure and function 
All enzymes are proteins, but not all proteins enzymes, the difference being 
that enzymes possess catalytic activity. The part of enzyme tertiary structure 
that is responsible for the catalytic activity is called the 'active site' of the 
enzyme, and often makes up only 10-20 % of the total volume of the enzyme. 
This is where the enzyme chemistry takes place 
The active site is usually a hydrophilic cleft or cavity containing an array of 
amino acid side chains which bind the substrate and carry out the enzymatic 
reactions. In some cases the enzyme active site also binds one or more 
cofactors which assist in the catalysis of particular types of enzymatic 
reactions. 
One of the distinguishing features of enzyme catalysis is its high substrate 
selectivity, which is due to a series of highly specific non-covalent enzyme-
substrate binding interactions. Since the active site is chiral , it is naturally able 
to bind one enantiomer of the substrate over the other. There are four types of 
enzyme-substrate interactions used by enzymes, as follows: 
1. Electrostatic interactions : Substances containing ionisable functional 
groups which are charged in aqueous solution at or near pH 7 are often 
bound via electrostatic interactions to oppositely charged amino acid 
side chains at the enzyme active site. Thus, for example, carboxylic 
acids (pKa 4-5) are found as the negatively charged carboxylate anion 
at pH 7, and are often bound to positively charged side chains such as 
the protonated E-amino side chain of lysine or protonated side chain of 
arginine. Similarly, positively charged substrate groups can be bound 
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electrostatically to negatively charged amino acid side chains of 
aspartate and glutamate. 
2. Hydrogen-bonding : These interactions are widely used for binding 
polar substrate functional groups. The strength of hydrogen bonds 
depends upon the chemical nature and the geometrical alignment of the 
interacting groups. Studies of enzymes in which hydrogen-bonding 
groups have been specifically mutated have revealed that hydrogen 
bond between uncharged donors/acceptors are of energy 2.0-7 .5 KJ 
mor' , whilst hydrogen bonds between charged donors/acceptors are 
much stronger, in the range 12.5-25 KJ mor' . 
3. Non-po/ar (Van der Waa/s interactions) : Van der Waals interactions 
arise from interatomic contacts between the substrate and the active 
site. Since the shape of the active site is usually highly complementary 
to the shape of the substrate, the sum of enzyme-substrate Van der 
Waal interactions can be quite substantial (50-100 KJ mol-') , even 
though each individual interaction is quite weak (6-8 KJ mor' ). Since 
the strength of these interactions varies, they are only significant at 
short range (2-4 N), so a very good 'fit' of the substrate into the active 
site is required in order to realise binding energy in this way. 
4. Hydrophobic interactions : If the substrate contains a hydrophobic 
group or surface , then favourable binding interactions can be realised if 
this is bound in a hydrophobic part of the enzyme active site. These 
hydrophobic interactions can be visualised in terms of the tendency for 
hydrophobic organic molecules to aggregate and extract into a non-
polar solvent rather than remain in aqueous solution. These processes 
of aggregation and extraction are energetically favourable due to the 
maximisation of inter-water hydrogen-bonding networks which are 
otherwise disrupted by the hydrophobic molecules. These hydrophobic 
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interactions are very important for maintaining protein tertiary structure 
and are centra l to the behaviour of biological membranes. 
1.2.2 Enzyme Kinetics 
The effect of enzyme and substrate concentration in a catalysed reaction is 
often explained by theory which postulates that enzyme and substrate react 
through an intermediate (ES) to give product and enzyme back again : 
k, k, 
E + S ( ) ES ) E + P 1.3 
k, 
It can be shown from steady state assumption that: 
k, [E][S] 
[ES] = 1.4 
(k, + k,1 k,) + [S] 
kcat [Eo][S] 
[ES] = 1.5 
Km + [S] 
Vmax [S] 
V= 1.6 
Km + [S] 
where v is the velocity of the reaction , Vmax = kcat [Eo] is the maximum 
velocity, [S] is the substrate concentration and Km = is the Michaelis constant, 
which is defined as the concentration of substrate where the rate of reaction 
reaches half of its maximal velocity. 
Equation 1.5 shows that the rate of reaction increases with increase in the 
substrate concentration and reaches a maximum when all the enzyme is 
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saturated with the substrate . The graph V versus [S) (Figure 1.4) shows three 
distinct regions: 
1 . At low substrate concentration the velocity of the reaction is directly 
related to the substrate concentration; this is the region of first order 
kinetics. 
2. At intermediate substrate concentration there is a significant curve, 
where the velocity of the reaction increases more slowly with increase 
in the substrate concentration. 
3. At high substrate concentration Vmax is attained and the observed 
velocity is independent of further addition of substrate; this is the region 
of zero order kinetics. 
Figure 1.4 
Analytical useful region 
for enzyme detenmination 
Analytical useful region 
for substrate determination 
[S] 
Graph of v against [S] for single-substrate enzyme-catalysed reaction, from 
Michae lis-Menten equation. 
The graph of Michaelis-Menten equation , v against [S) (Figure 1.4), is not 
entirely satisfactory for the determination of V max and Km. Unless, after a 
series of experiments, there are at least three consistent points on the plateau 
of the curve at different [S) values, then an accurate value of Vmax, and hence 
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of Km, cannot be obtained: the graph being a curve, cannot be accurately 
extrapolated upward from non-saturating values of [S]. 
Lineweaver and Burk overcame this problem without making any fresh 
assumptions. They simply inverted the Michaelis-Menten equation: 
1 1 1 
= + 1.7 
V Vmax [S] Vmax 
This is of the form y = mx + c, which is the equation of a straight line graph; a 
plot of y against x has a slope m and intercept c on the y-axis. As can be seen 
from Figure 1.5, Km and Vmax may be read directly from this plot. 
Figure 1.5 
Intercept 
= -1 / 1<", 
1 
1 1 V 
./"I--<:>Iope = I<", 1 V m., 
/1+--lntercept = 1 1 Vm., 
1 1 [S] 
The Lineweaver-Burk plot. 
Multiplying both sides of equation 1.7, equation 1.8 in obtained. This equation , 
[S] 
v 
1 Km 
[S] + - -
Vmax Vmax 
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1.8 
first described by Hanes, is illustrated in Figure 1.6 a, where a graph of [S]/v 
against [S] is plotted, yielding a straight line with slope 1/v and intercept 
KmN max on the y-axis and -Km on the x-axis. 
A third linear transformation of Michaelis-Menten equation is obtained by 
multiplying both sides of equation 1.7 by vVmax and rearranging to give: 
v 
v = Km-- + Vmax 1.9 
[S] 
On plotting v against v/[S] , a straight line is obtained with slope -Km, which 
intercepts on the y-axis at Vmax and x-axis at Vmax/Km. This plot is known as 
Eadie-Hofstee plot (Figure 1.6 b) . 
IS] / v (a) (b) 
... --,Slope = 
1 I vmax 
" .. --,Slope = 
-Km 
IS] v I IS] 
Figure 1.6 (a) The Hanes plot ; (b) the Eadie-Hofstee plot 
An alternate direct linear plot was described by Eisenthal and Cornish-
Bowden in 1974. The Michaelis-Menten equation was rearranged to show 
the dependence of Vmax on Km through: 
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v 
Vmax = v + --- 1.10 
Km [S] 
and the resulting plot is illustrated in Figure 1.7. The substrate concentration 
is plotted as a negative value on the x-axis and is joined to its experimentally 
obtained velocity value on the y-axis by a straight line. This line describes all 
possible sets of values for Km and Vmax. 
Figure 1.7 The Eisenthal-Cornish-Bowden plot for an enzyme-catalysed reaction . (V' max 
is the best estimate of Vmax• K'm the best estimate of Km) . 
1.2.3 Factors affecting enzyme activity 
1.2.3.1 Temperature 
The rate of enzyme-catalysed reactions, like that of the other chemical 
reactions, increases with increase in temperature. The temperature , at which 
the enzyme shows maximum activity is called the optimum temperature above 
which enzyme activity decreases. This decrease in activity may not be due to 
the denaturation of the enzyme but may be due to changes in the velocity of 
27 
breakdown of the enzyme-substrate complex, change in affinity of the enzyme 
for substrate, stability or ionisation of substrate or pH of the buffer. 
1.2.3.2 pH 
Enzymes are amphoteric molecules containing a large number of acidic and 
basic groups at the surface. The charges on these groups vary with pH 
changes in their environment. Any change in pH results in a change of 
ionisation state of the enzyme especially at the active site and neighbourhood 
of the active centre, which in turn affects the binding on the substrate with the 
enzyme. Different enzymes have different pH optimum ranges for their 
activity. The optimum pH often lies between 5-7 , but extreme values of 1.5 
and 10.5 have been found for pepsin and alkaline phosphatase, respecti vely. 
Reactions catalysed by enzymes are usually carried out at their optimum pH. 
At the extremes of pH an enzyme may undergo irreversible denaturation, 
where activity may not be restored even after re-adjustment of the pH . 
1.2.3.3 Activators 
Substances which increase the catalytic activity of an enzyme, are used in a 
very small amount and which , unlike coenzymes, do not participate in the 
reaction, are called activators. For example the catalytic activity of isocitrate 
dehydrogenase is increased by Mg2+, Zn2+, and Mn2+. These metal ions 
stabilise a particular conformation of the enzyme for maximum activity. There 
are activators which do not have a direct effect on the enzyme activity but they 
only interact with the substrate prior to its interaction with the enzyme. 
1.2.4 Enzymes as analytical reagents 
The selectivity of enzyme action have made them valuable analytical reagents. 
The history of enzymatic analysis started in 1845, when Osann [56] detected 
hydrogen peroxide with peroxidase. 
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Enzymatic analysis became the subject of serious scientific studies in the mid 
1930's when Warburg and Christian [57] reported the discovery of hydrogen 
transferring enzymes and corresponding co-enzymes. A few years later 
spectrophotometric methods for enzymatic determination were established, 
followed by more sensitive spectrofluorimetric methods. Because of their high 
degree of selectivity and sensitivity, enzymatic methods of analysis are finding 
uses in food, agriculture, forensic and clinical fields. 
Despite all these novel characteristics, there are still certain disadvantages 
associated with the use of soluble enzymes, such as high cost, which is an 
appreciable factor when continuous flow, automated systems are employed. 
Instability, even at room temperature for certain enzymes has restricted their 
analytical involvement. 
These general limitations on enzymes as catalysts have been minimised to a 
greater extent by the technique of enzyme immobilisation. 
1.3 Immobilised enzymes 
The term immobil isation implies the artificial confinement of enzymes to water 
insoluble supports by physical or chemical means or both with retention of 
their catalytic activities, and which can be used repeatedly and continuously 
[58] . The major breakthrough in enzyme technology occurred in 1916 when 
Nelson and Griffin [59] first immobilised invertase on charcoal and observed 
that the enzyme retained most of its activity over a long period of time. Their 
work was almost ignored until the 1950s. Since then much attention has been 
paid to the preparation and utilisation of these enzyme derivatives; their 
science and technology have recently experienced a phenomenal growth. 
Many books and reviews have been published on the subject during the last 
two decades [60-66]. 
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1.3.1 Why immobilise enzymes? 
Immobilised enzymes offer many advantages over their soluble analogues 
[67], some of which are listed below: 
I. Low cost, they are economical as they can be used repeatedly and 
continuously. 
11. Increased stability in storage and use against denaturing conditions 
such as high temperature, extreme pH, and extreme salt 
concentrations. 
Ill. They are easy to use, need no solution preparation. 
IV. They do not contaminate the sample. Insoluble enzymes can be 
easily recovered from the reaction medium in case of batch 
analysis, while in the case of continuous flow system, samples are 
made to pass through immobilised enzyme reactors, resulting in 
controlled product formation. 
v. Rapid termination of reactions, especially in flow systems 
vi. Less susceptibility to the normal activators and inhibitors of the 
enzyme, therefore much more useful for complex analytical samples 
such as blood. 
VII. The possibility of simultaneous determinations, due to the greater 
variety of designs available for the use of immobilised enzymes in 
flow systems. 
1.3.2 Methods of immobilisation 
Immobilised enzymes are classified on the basis of the methods adopted for 
their immobilisation [66]. An outline of these methods is given in Figure 1.8. 
The schematic of possible modes of enzyme immobilisation is shown in Figure 
1.9. More technical details and information about individual enzymes may be 
found in recently published reviews [61-B6,68-B9] . 
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Immobilised enzymes 
Attachment to 
(prefabricated) 
carrier 
Crosslinking 
Adsorption 
Ionic binding 
Covalent binding 
I 
Entrapment Membrane 
confinement 
Microcapsule type 
Lattice type 
Figure 1.8 Classification of the methods employed for enzyme immobi lisation . 
1.3.2.1 Carrier-binding method 
This method involves the binding of the enzyme to water insoluble carriers. As 
the carrier is directly involved in binding to the enzyme, its chemical 
composition, particle size and surface area plays an important role. The 
carrier binding method can be classified into three major categories. 
a. Adsorption 
This is the easiest method to perform, based on physical adsorption of 
enzyme protein on the surface of water insoluble carrier. Protein molecules 
may interact with the carrier by ionic, hydrophobic, hydrogen bonding and Van 
der Waals interactions but only the first two of these are likely to lead to a 
greater attraction of the enzyme for the carrier than for water and so to its 
binding. Practically such enzyme derivatives can be obtained just by stirring 
the enzyme with the matrix for some time. A wide variety of solids have been 
used to adsorb the enzymes [70]. Although the method is cheap, easily 
carried out, gives a high initial yield and there are less chances of disruption of 
enzyme protein, a significant problem is the leakage of the enzyme from the 
31 
carrier during use as the binding force between the carrier and the enzyme is 
weak [66]. 
Covalent binding 
Carrier binding 
Cross-linking 
Lattice type 
Entrapment 
Ionic binding 
Micro-capsulc type 
C Enzyme molecule 
((.. H20 insoluble matrix 
Figure 1.9 Schematic representation of various modes of enzyme immobilisation. 
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b. Covalent binding 
This method, which involves the formation of bonds between the enzyme and 
its support, has been the most widely used technique for immobilisation of 
enzymes. The advantages include flexibility of the method and the ability of 
the immobilised enzyme to achieve good flow properties, especially if 
inorganic material (e.g. glass, silica gel, alumina, etc.) or organic polymers 
(e.g. cross-linked ion exchange resins) [66,70-73] are used as the support 
matrix. During the operation the bound enzyme does not leak from the 
support even if factors such as pH, solvent, substrate and temperature are 
changed. The only drawback of covalent coupling in certain cases is the low 
initial yield of the active enzyme, probably due to the blockage of some of the 
active sites by involvement of its groups in covalent bond formation . The 
functional groups in enzyme protein which are normally involved in covalent 
bond formation include the 0.- and E-amino groups, [3- and y-carboxyl groups, 
the phenolic group of tyrosine, the sulfhydryl group of cysteine, the hydroxyl 
group of serine and imidazole group of histidine [65] 
1.3.2.2 Cross-linking method 
Immobilisation of enzymes to supports in cross-linking agents has rapidly 
emerged within the last couple of decades and is one of the most popular 
methods nowadays [74-75]. Bi-functional reagents have been used as cross-
linking agents, among which glutaraldehyde is most frequently used. Among 
the carriers controlled pore glass (ePG) has gained much acceptance. The 
reaction sequence of the coupling of an enzyme to glass by cross-linking 
method is described in 4.2.2. 
1.3.2.3 Entrapment methods 
Enzymes have been immobilised in water insoluble polymers of synthetic and 
natural origin either by physical entrapment within the carrier (i.e. a sort of gel 
33 
entrapment) or by encapsulation in semipermeable membranes [72] . The 
most popular matrices for gel entrapment include polyacrylamide, polvinyl 
alcohol , and silica. Bhatia et al. have reported an aqoeous sol-gel process to 
encapsulate enzymes [76]. The process uses sodium silicate as a precursor 
and is carried out in two steps: preparation of a Iow-pH silicate sol followed by 
gelation at neutral pH with a suitable buffer containing the enzyme This 
method has the advantage of being chemically simple, having a high initial 
yield , but the drawbacks are the loss in enzyme activity due to slow leaching 
during operation [66,68] , poor flow properties and low reactivity for higher 
molecular weight substrates. 
1.3.2.4 Membrane confinement method [62] 
Compared to all methods mentioned above, membrane confinement is the 
simplest. This method depends on the use of a semipermeable membrane; 
the enzyme is placed on one side of the membrane while the substrate and 
the product pass freely through the membrane. 
1.3.3 Changes in enzyme properties after immobilisation 
Immobilisation of an enzyme results in a change in many of the physical and 
kinetic properties of the corresponding soluble counterparts. This may be due 
to a considerable change in the microenvironment of the enzyme. Among the 
changes in physical properties, the storage and temperature stabilities are 
prominent. Numerous enzymes have been reported with an increase in long-
term storage and thermal stability. Sulphite oxidase, which in the soluble form 
loses its activity rapidly (20 % after six hours) at room temperature, when 
immobilised on controlled pore glass showed no loss in activity for months in 
spite of continuous use at 25 °C [77] . This increase in stability may be due to 
the stabilisation of the native structure of enzyme. Immobilisation also has 
profound effect on the optimal pH. Depending on the nature of the carrier, the 
pH may shift towards a higher to lower value. Goldstein et al. [78] studied this 
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phenomenon in detail. If the carrier used for immobilisation is negatively 
charged, then more positively charged ions, mainly H+, will accumulate at the 
boundary layer between the carrier and surrounding solution. To compensate 
for that, the pH of the bulk solution has to be displaced towards more alkaline 
pH. If the carrier is positively charged the opposite may occur. 
Enzyme kinetics and therefore reactivity are changed after immobilisation, 
possibly due to the placement of the enzyme in a new environment. The 
charge on the carrier may also contribute to change in the rate constants. 
Excellent discussions on this aspect are available [79-80] . 
1.3.4 Analytical applications of immobilised enzymes 
Immobilised enzymes have been used for a long time in industry for 
biotechnological purposes, and in clinical , food and environmental analysis. 
Many reviews [63-64,66,68-70] and monographs [61-62,72] exist on their 
analytical applications and have demonstrated that immobilised enzymes can 
be used in electrodes or in the form of enzyme reactors. A brief description of 
them is given below: 
1.3.4.1 Immobilised enzyme electrodes 
An immobilised enzyme electrode is an electrochemical sensor on whose 
surface is attached a thin layer of enzyme. The outer surface of the enzyme 
exposed to the analyte is covered with a semipermeable membrane to protect 
the enzyme and allow the passage of substrate and product. The electrode is 
dipped into the analyte solution, which is stirred continuously to speed up 
mass transfer and provide fast response. When the enzyme electrode is 
immersed in a sample solution, the substrate diffuses into the enzyme layer, 
where it is converted into a product, which then diffuses out of the enzyme 
layer to the electrode. Since the conversion of substrate to product depletes 
the available concentration of substrate to product a concentration gradient of 
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both substrate and product is formed. After some time (0.5-10 min) a steady 
state is reached where the rate of supply and rate of consumption of substrate 
and rate of transfer to the electrode becomes constant. Quantitative 
measurements either at steady state or during the initial stages of the reaction 
can be made. 
Enzyme electrodes have been used for analysis of an analyte alone [81-82] or 
in a mixture [83]. These electrodes are very handy, easy to use and are 
cheap, but the disadvantages associated with their use are their long response 
and recovery times and their poor reproducibil ity. 
1.3.4.2 Immobilised enzyme reactors 
The reactors are columns holding immobilised enzymes on appropriate 
supports. Solutions carrying analyte can be made to pass through and react 
with enzyme, the enzyme being retained, while the product is carried to the 
detector. The advantage of these reactors is that almost any detector system 
can be used which can record the concentration of substrate, a product or 
coenzyme. Principally there are two types of reactors, packed-bed and open-
tubular, both of which have been used successfully in flow systems. 
a. Packed-bed reactors 
Packed-bed reactors are receiving much attention. Their use was previously 
avoided because of the pressure drop across the column, but nowadays with 
the introduction of inorganic supports like glass beads (controlled pore glass, 
ePG, etc.), that problem has disappeared [84]. These supports do not swell 
on packing, so that the pressure drop is minimised. Such reactors are easily 
prepared by packing a column of fixed volume with immobilised enzyme 
(Figure 1.10 a). The unique advantage of a packed-bed reactor is its large 
surface area, thus it has the potential of providing a relatively larger number of 
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immobilised enzyme molecules, therefore making possible the almost 
complete conversion of substrate into product. 
b. Open-tubular reactors 
Such reactors are comparatively difficult to construct. They are prepared by 
covalently immobilising enzymes onto the inner wall of a tubing made of nylon 
[84] or polyacrylamide (Figure 1.10 b). The advantages of open-tubular 
reactors are: 
I. Low pressure drop. 
ii. They are well suited for air-segmented analysers (auto-
analysers ). 
Ill. Blood samples do not block the reactors. 
IV. Their commercial availability. 
The problem associated with these reactors is the small amount of enzyme 
that can be attached to the inner wall of the tube owing to the small surface 
(a) 
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(b) 
Figure 1.10 Immobilised enzyme reactors (a) packed-bed (b) open-tubu lar. 
area. Thus to achieve reasonable conversion of the substrate to product, a 
very long reactor would be required , which in turn would increase the 
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dispersion [85]. Also radial mass transfer to the walls in an open tube with a 
flowing liquid may be prohibitively slow. Horvath et al. [86] have shown that 
segmentation and coiling of the tubing improves radial mass transfer and thus 
the efficiency of use of the immobilised enzyme. 
1.3.5 Immobilised enzymes in FIA 
Immobilised enzymes were introduced in a continuous flow system around 
1974 [87] . But their application in FIA started in 1982 [88]. Since that time a 
variety of FIA methods using immobilised enzymes appeared, which shows 
their usefulness in many areas of application especially for the determination 
of enzyme substrates [89-97] . 
Up until 1988, only 30% of publications which , appeared for the determination 
of substrates dealt with glucose determination [88]. This may be due to its 
clinical importance, as it is most frequently determined in clinical laboratories, 
or it may be due to the availability and cost of glucose oxidase, and perhaps 
also due to the high stability of this enzyme after immobilisation. 
There has also been an increasing interest in food analysis by using 
immobilised enzymes in FIA [98]. Both areas (clinical and food) take 
advantage of high enzyme selectivity, so that enzymatic reactions can be 
applied to complex matrices like whole blood, serum, urine and all types of 
food and drinks. 
As the knowledge of FIA is developing more interesting applications of 
immobilised enzymes appear. Starting from the determination of a single 
analyte by using a single immobilised column and progressing towards the 
determination of five or six analytes [99] is an example of advances in 
enzymatic methods in FIA. Analysis of more than one analyte is made 
possible by placing more than one reactors in series or parallel like 
determination of inosine monophosphate and glutamate by immobilised 
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inosine monophosphate dehydrogenase and glutamate oxidase, placed 
parallel to each other [100] and determination of glucose and total malto 
sugars by immobilised glucoamylase, glucose oxidase and mutarotase placed 
in series [101). A plug of analyte mixture is split into sub-plugs before transfer 
to enzyme reactors. 
In spite of the high selectivity of enzymes for their substrates, sometimes 
interferences appear from the real samples e.g. blood and urine, in which 
ascorbic acid, uric acid and NH3 may reduce the system applicability. 
However, a system's selectivity can be increased in several ways: 
1 By the application of dialyser units or liquid chromatographic columns 
[102] . 
2 By using appropriate reactors which can eliminate the interfering 
species [103]. 
3 By measuring the response between the signal of the sample in the 
presence and in the absence of enzyme. 
After the exploitation of the advantages of immobilised enzymes in conjunction 
with FIA for chemical analysis, the technique has also emerged to process 
analysis [104]. Conventionally, most industrial analyses are carried out off-line 
and face problems like limited reliability, time consumption and extra labour to 
deal with large number of samples for analysis. FIA with immobilised enzyme 
reactors can give reliable determination of analytes in media originating from 
food and fermentation. 
The use of immobilised enzymes in FIA is not limited to the determination of 
enzyme substrates, but is also gaining attention for the determination of many 
enzyme inhibitors. The analytical applications of inhibition of a large number 
of immobilised enzymes have been reviewed [105]. 
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1.4 Enzyme inhibition 
There is a variety of natural and synthetic compounds which have the ability to 
inhibit specific enzymes and reduce or eliminate their catalytic activity. Drugs, 
metal ions and many other substances are among such inhibitors. 
Two types of enzyme inhibition that are commonly observed are: reversible 
and irreversible inhibition. 
1.4.1 Reversible inhibition 
Reversible inhibition occurs if an inhibitor is bound non-covalently at the active 
site of the enzyme. Three distinct mechanisms of reversible inhibition are 
known and are recognised by the effect of substrate concentration on 
inhibition. 
i. Competitive inhibition 
In competitive inhibition , the inhibitor (I) mayor may not be similar to the 
substrate, and attacks at the active site or close to the active site of the 
enzyme in a reversible fashion: 
ES E + P 1.11 
El 
As shown in equation 1.11 , El and ES complexes are formed and no ESI 
complex appears in this type of inhibition. A high concentration of substrate 
can overcome this inhibition by making the reaction proceed towards ES and 
then product formation . 
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The physical interpretation of competitive inhibition is that the inhibitor can 
reversibly bind with enzyme and compete with substrate for the binding site. 
Inhibitor can only bind with the free enzyme and not with the ES complex. By 
increasing the substrate concentration , inhibition decreases. From the kinetic 
expression it can be seen in Figure 1.8 a that in the presence of a competitive 
inhibitor the reaction reaches half of its maximum velocity at high substrate 
concentration (Km) i.e. the y-intercept of the Lineweaver-Burk plot remains the 
same and the value of Km is increased, which is the characteristic of 
competitive inhibition. 
ii. Uncompetitive inhibition 
E + S E + P 1.12 
El 
In uncompetitive inhibition inhibitors only bind with the ES complex and not 
with the free enzyme. In this case a high concentration of substrate can not 
reverse the inhibition, but increased substrate concentration increases the 
inhibition. In this case the rate of reaction can not reach half of its maximum 
velocity i.e. the intercept and the value of Km are decreased (Figure 1.8 b) . 
iii. Noncompetitive inhibition 
Noncompetitive inhibitors decrease the catalytic activity of an enzyme without 
influencing the binding relationship between the substrate and enzyme. It 
means that inhibitor and substrate can bind at the same site to an enzyme to 
form ES, El and ESI complexes. Noncompetitive inhibition completely 
depends on the inhibitor concentration and is unaffected by the substrate 
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concentration . Lineweaver-Burk plots of these modes of reversible inhibition 
are shown in Figures 1.11 a,b and c. 
-1 /Km 
1N 
v~ 
-1 /Km 
Figure 1.11 
---+. E + P 1.13 
El ESI 
a 
No inhibitor 
Inhibitor 
More inhibitor 
t lS 
b c 
1N 
(1 +1IKi) 
v~. 
1- 1Nmax 
1/S -1 /Km 1/S 
Lineweaver-Burk plot for different modes of reversible inhibition: where a, 
b,and c show competitive, uncompetitive and noncompetitive inhibition 
respectively. 
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1.4.2 Irreversible inhibition 
Irreversible inhibition occurs when an inhibitor binds to the active site of the 
enzyme by an irreversible reaction and can not subsequently dissociate from 
it. A covalent bond is usually formed and the inhibitor may act by preventing 
substrate-binding or it may destroy some component of the catalytic site. In 
such type of inhibition the enzymatic activity can not be reversed by dilution of 
dialysis. 
1.5 Flow injection analysis 
1.5.1 Introduction 
The term flow injection analysis (FIA) was first used by Ruzicka and Hansen 
[106] in 1975 to describe the use of injection into an unsegmented flowing 
stream for continuous-flow analysis. FIA is now widely used and well 
established and has the following advantages; its simple basis, relatively 
inexpensive equipment, ease of operation and great capacity for achieving 
results that are excellent in view of the rapidity, accuracy and precision with 
which they are obtained. FIA is based on four main principles: 
a. un segmented flow 
b. direct injection 
c. reproducible operational timing 
d. controlled partial dispersion 
The basic scheme of an FIA system is shown in Figure 1.12. An FIA system 
usually consists of the following components: 
a. A propelling unit which should produce a steady pulse-less flow of one 
or more solutions. The solutions may be of dissolved reagents or 
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merely a carrier for the sample plug. The most common method of 
propulsion is a peristaltic pump, other methods include gas pressure 
systems and gravity feed reservoirs. 
b. An injection system which allows the reproducible introduction of a 
volume of sample solution into the flow without stopping it. 
c. A length of tubing along which the transport operation takes place, this 
is referred to as the reactor. Dispersion of the sample plug into the 
carrier or reagent takes place as the plug passes along the tube, also 
there may be chemical reactions occurring 
d. A flow cell, accommodated in a detector (e.g. photometer) which 
transduces some property of the analyte into a continuous signal to a 
recorder or microcomputer. 
Carrier 
Peristaltic 
pump 
I njection Reaction Detector 
valve coil 
Figure 1.12 Schematic diagram of a single-line FIA manifold . 
Waste 
The flow emerging from the sensing system usually goes to waste, although it 
is sometimes re-circulated through the peristaltic pump to achieve greater 
constancy of flow rate. 
The signal obtained from FIA techniques is transient. Typical FIA peaks can 
be seen in Figure 4.10. The parameters affecting the peak shape are : 
a. the flow rate of the carrier; 
b. the volume injected along with the length and bore of the sample loop; 
c. the length and bore of the manifold; 
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e. the viscosity of the sample and carrier; 
f. the detector and recording system time constant. 
1.5.2 Theory of flow injection analysis 
The theory and applications of FIA are covered by review articles [107-109] 
and books [110-112]. In FIA a sample injected into a carrier stream flowing 
through a narrow bore straight section of tube initially exists as a well defined 
plug. As the plug travels downstream it disappears and mixes with the carrier 
stream. A well defined concentration gradient is formed . If the sample 
dispersion is due to convection, the flow profile is characterised by a parabolic 
head and tail. This type of flow is called laminar flow, and is characteristic of 
most flow injection systems. If this were the only mass transport process 
operating , the peak would have an infinitely long tail , as the velocity at the 
walls of the conduit is zero. Two additional mass transport processes are 
operational though; molecular diffusion in the longitudinal direction (parallel to 
the direction of flow) and molecular diffusion in the radial direction 
(perpendicular to the direction of flow). The longitudinal diffusion is small 
compared with the dispersion due to the flow velocity and can be ignored 
under the conditions of most flow injection experiments. Radial diffusion 
moves sample molecules to and from conduit walls where the flow velocity 
profile is zero towards the centre of the tube, where the flow velocity is at 
maximum . 
The net result of radial diffusion is that a peak with a finite peak width is 
obtained. Radial diffusion becomes more important as the residence time of 
the sample increases. At long residence times, the dispersion product 
process in controlled primarily by the diffusion process and the peak shape 
assumes a symmetrical Gaussian shape. 
The dispersion or dilution of a sample in FIA is given by the following equation: 
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D = CO/Cmax 
Where, D is the dispersion coefficient, Co is the concentration of sample,Cmax 
is the concentration of sample at the peak maximum calculated from the peak 
response of the detector due to the analyte. 
The degree of dispersion of the sample zone depends on the tube length and 
radius, the flow rate, the sample volume injected and the molecular diffusion 
coefficient of the species concerned. 
By changing the flow parameter, the dispersion can be easily manipulated to 
suit the requirement of a particular analytical procedure so that optimum 
response is obtained at minimum time and reagent expense. 
The dispersion types fall into three categories: limited, medium and large. The 
peak shape varies from shape and asymmetric for limited dispersion, 
Gaussian for medium dispersion and broad with exponential peak shape for 
large dispersion. 
1.5.3 Additional application modes for basic FIA 
Apart from numerous types of analysis carried out with simple FIA, a number 
of additional modes have been developed to explore the versatility of the 
technique. These are briefly described here: 
1.5.3.1 Merging zones 
A disadvantage of continuous flow injection analysis is the continuous 
consumption of the reagents. If this problem is serious it can be minimised by 
the introduction of merging zones technique, which can be achieved by 
intermittent pumping [110] or by the use of multiple injection valves [113]. In a 
multiple injection system there are two choices; in one , two injection valves 
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are placed in parallel with each other, sample and reagent are injected into the 
separate streams and then merged at the mixing point. In the other, the 
injection valves are placed in series and sample and reagent are injected into 
the same carrier stream; the two zones move downstream and merge before 
passing through the detector. The purpose of this technique is to reduce the 
consumption of expensive reagents and to create a composite zone that is 
information rich . 
1.5.3.2 Stopped flow 
The most useful manoeuvre in FIA is the stopped flow . There are two 
different purposes for operating a FIA system in stopped flow mode: 
a. to increase the sensitivity of measurement by increasing the residence 
time without any appreciable increase in dispersion and thus 
conversion of the measured species 
b. to record a reaction rate which then serves as the basis for the 
analytical results. 
The stopped flow technique is based on one of the most important 
observations in FIA postulating that to increase the residence time, one should 
keep the reaction coil short and decrease the velocity of the carrier stream 
[114). When carrier stream ceases to move, the dispersion of the sample 
zone will stop and the dispersion coefficient D will become independent of 
time. Thus, by an appropriate choice of length of the stop - go intervals, one 
can gain reaction time during the stop period. 
1.5.4 Sequential analysis 
The concept of sequential analysis was reported by Ruzicka et al. [115]. And 
has been exploited in many assays [116-118] . Sequential analysis is simpler 
than the other techniques; precisely measured volumes of carrier, sample and 
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reagent solutions are separately aspirated into a holding coil by means of a 
pump, which could be a syringe pump or peristaltic pump. Due to its simplicity 
this technique seems to find wide application in process control and in the 
laboratory. Although the technique is simpler than conventional FIA, the 
complexity of gradients formed by the zone penetration with reverse flow is still 
an unsolved problem [115]. 
1.5.5 Multicomponent determination in FIA 
A typical sample sometimes needs to be analysed for more than one species, 
which is important, for example, in food processing, in clinical and industrial 
analysis and in process control. In order to eliminate the limitation of FIA for 
the determination of only one species at a time many attempts to achieve 
multi component analysis have been made with a variety of procedures and 
manifolds, for example by using a single injection with several detectors in 
series or parallel [119]. Enzymatic assays have particular importance in food 
and clinical analysis. A number of enzyme reactors have been reported to be 
used for simultaneous determination of more than one component in a mixture 
[120-122]. By the implementation of the pH gradient technique, which is 
based on the formation of complexes of various cations in different parts of the 
sample zones according to the pH, more than one component can be 
determined in an assay mixture. Marcos et al. reported the simultaneous 
determination of metal ions in this way [1 23]. More recently an automated flow 
injection method was developed for the determination of six different analytes 
simu ltaneously, by using six enzyme reactors in parallel , with a single detector 
and a single injection valve [124]. 
1.5.6 Applications of FIA 
As FIA is compatible with a variety of chemical processes and detection 
systems and offers ease of automation [1 25], it has numerous areas of 
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applications such as biotechnology, agriculture, environmental pollution , 
pharmaceutical and clinical analysis [98]. 
FIA techniques have the advantage of being fast, sensitive, stable, accurate 
and have a small volume sample requirement compared with many other 
techniques. With suitable arrangement, the technique can be used at- or on-
line, allowing real time measurements. The growing importance of these 
techniques is reflected in a substantial amount of application information [115]. 
Different features of FIA have been exploited from time to time in clinical 
analysis. A list of clinically relevant species has been compiled by Ruzicka 
and Hansen [111], and Rocks and Riley [125]. Valcarcel and Luque de Castro 
have also provided a review on applications of FIA [110] which includes 
sections on the enzymatic and non-enzymatic methods in clinical analysis. 
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Chapter 2 
Materials, Instruments and General Procedures 
50 
MATERIALS 
SUBSTANCE 
2.1 .1 Enzymes 
Alkaline phosphatase: from bovine (calf) intestine 
EC 3.1.3.1 
Acetylcholinesterase Type Ill : from Electric Eel 
EC 3.1.1.7 
p-galactosidase Grade VI : from Escherichia coli 
EC 3.2.1.23 
a-chymotrypsin Type 11: from bovine pancreas 
EC 3.4.21 .1 
Protease Type XXI: from Streptomyces griseus 
EC 3.4.21.81 
Proteinase K: from Tritirachium album 
EC 3.4.21 .64 
2.1.2 Proteins 
Alpha-casein from bovine milk, MW 24,000 
Albumin , bovine, MW 67,000 
Ovalbumin, Grade VI: from chicken egg 
2.1.3 Inhibitors 
Theophylline 
Metrifonate 
Phenylethyl thiogalactoside 
p-hydroxymercuribenzoic acid 
Ethylenediaminetetraacetic acid (EDTA) 
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SUPPLIER 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
3-aminophenylboronic acid 
t-epoxysuccinyl-L-Ieucylamido (4-guanidine) butane 
Protease inhi bit~r cocktail 
2.1.4 Fluorophores and fluorigenic substrates 
Naphthofluorescein 
Nile Blue 
4-methylumbelliferyl phosphate 
Naphthofluorescein ~-D-galactopyranoside 
5-(and-6)-carboxypahthofluorescein 
succinimidyl ester 
2.1.5 Buffer reagents (All Analytical Grade) 
Glycine 
Sod ium phosphate 
Sodium dihydrogen orthophosphate 
Sodium carbonate 
Sodium hydrogen carbonate 
Cyclohexylaminopropane sulfonic acid 
[Tris (hydroxymethyl) aminomethane hydrochloride] 
(Tris-HCI) 
Sodium chloride 
Sodium azide 
Magnesium chloride 
2.1.6 Other reagents 
1,6-dihydroxynaphthalene 
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Sigma 
Sigma 
Sigma 
Molecular probes 
Sigma 
Sigma 
Sigma 
Molecular probes 
Fisons 
Sigma 
Fisher Scientific 
Sigma 
Fisher Scientific 
Sigma 
Sigma 
Fisons 
Sigma 
Sigma 
Sigma 
4-nitro-1 ,6- dihydroxynaphthalene 
Phosphorus oxychloride 
Phthalic anhydride 
Anhydrous pyridine 
Anhydrous magnesium sulphate 
N, N'-dicyclohexyl-carbodiimide 
D-Serine 
Thiophosgene 
Pd-Charcoal 
N, N-dimethylformamide 
Potassium bromide 
Acetic anhydride 
Sodium hydroxide 
Hydrochloric acid 
Chloroform 
Dichloromethane 
Toluene 
Ethyl acetate 
Ethanol 
Methanol 
Deuterium oxide 99.9 % 
Acetic acid 
Glutaraldehyde 
Caffeine 
Theobromine 
Arginine 
Cysteine 
Glucose 
Ascorbic acid 
Tryptophan 
Glutamine 
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Aldrich 
Aldrich 
Sigma 
Aldrich 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Fisher Scientific 
Fisher Scientific 
Fisher Scientific 
Fisher Scientific 
Sigma 
Sigma 
Sigma 
Sigma 
Fisher Scientific 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
2.1.7 Chromatographic columns 
Glass column 2.5 x 30 cm 
Glass column 3.0 x 25 mm (170 mm bed volume) 
Glass column 3.0 x 50 mm (350 mm bed volume) 
2.1.8 Column matrix 
Sephadex G-25 (PD-10 column) 
Sephadex gel G10 
Silica gel (230-240 mesh) 
Glass, aminopropyl , average pore size 75 °A 
200-400 mesh 
2.1 .9 Cells 
3 ml quartz fluorescence cell 
1 ml quartz fluorescence cell 
3 ml quartz UV cell 
25 III quartz flow cell (Fluorescence) 
25 III quartz flow cell (UV) 
2.1 .10 Pipettes 
Automatic pipettes: 
Volume 100 111, 200 III and 1000 III 
Volume 0.1 )11 -10111 
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Pharmacia 
Omnifit 
Omnifit 
Pharmacia 
Sigma 
Sigma 
Sigma 
Hellma 
Hellma 
Hellma 
Hellma 
Hellma 
Gilson 
Eppendorf 
2.1.11 Flow injection equipment 
Gilson Minipulse 3 peristaltic pump 
Teflon capillary tubing 0.8 mm 1.0. 
Manual sample injection valve fitted with 
25111 or 50 III Teflon sample loop 0.8 mm 1.0. 
Switch valve 
2.2 General procedures 
2.2.1 Buffer preparation 
Gilson 
Omnifit 
Omnifit 
Omnifit 
Amount of buffer reagent to be weighed was calculated using the following 
equation: 
MW x molarity x volume 
Amount (g) = 
1000 
Triply deionised water was used to make up the required volume. pH 
adjustment was achieved by adding the required amount of acid or base. Tris-
Hel , phosphate, glycine, carbonate and cyclohexylaminopropane sufonic acid 
buffers have been used during the experimental work. 
2.2.2 pH measurements 
pH measurements were carried out using a Whattman PHA 230 bench pH 
meter. A pH range of 0.00 to 14.00 can be made with an accuracy of ± 0.01 
pH. The instrument was calibrated with high resolution buffer solutions at pH 
4.000, 7.000 and 10.000, ± 0.005, before use. 
55 
2.2.3 Water purification 
Solutions were prepared using triply deionised water purified by a Maxima 
ultra pure water system (USF Elga Ltd .). 
2.2.4 Mass determinations 
Weighing operations were made using Precisa 40SM-200A four decimal place 
electronic balance. 
2.2.5 Pipetting 
Pipetting was carried out using Gilson and Eppendorf variable volume 
automatic pipettes. 
2.2.6 Fluorescence measurements 
Fluorescence spectra were obtained using a Hitachi F-4500 spectrofluorimeter 
fitted with a R298 photomultiplier tube to enable spectra to be taken at the 
high wavelengths involved in this project. The block diagram (taken from 
[126]) of the signal processing and control systems of the F-4500 are shown in 
Figure 2.1. The spectrofluorimeter mainframe has a xenon lamplight source, 
the beam of which is incident on the excitation monochromator. The beam 
after wavelength selection with the excitation monochromator (Am.x) is 
irradiated onto the sample cell. Light emitted from the sample in the form of 
fluorescence (A.em) then passes through the emission monochromator (which is 
at right angles to the incident light) to remove any light that is not at the 
emission wavelength. The intensity of fluorescence is detected via a red-
sensitive photomultiplier tube. Instrument parameters are shown in Table 2.1. 
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Figure 2.1 Block diagram of the signal processing and control system of the model F-
4500 spectrofluorimeter (Hitachi) 
Table 2.1 
Instrumental parameters for the Hitachi F-4500 fluorescence spectrometer. 
Parameter 
Wavelength range 
I Excitation slit width 
Emission slit width 
Scanning speed 
Wavelength accuracy 
Response 
I PMT Voltage 
200-900 nm 
1.0, 2.5, 5.0, 10.0 nm 
1.0, 2.5, 5.0, 10.0, 20.0 
15, 60, 240, 1200, 2400, 12000, 30000 nm/min 
± 2.0 nm 
0.004, 0.01 , 0.05, 0.1, 0.5, 2.0, 8.0 seconds 
400. 700, 950 V 
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2.2.7 Absorption measurements 
Absorption measurements were carried out on an Unicom PU8700 series 
UV/vis spectrophotometer. The diluent buffers were used as the reference. 
2.2.8 Infra red measurements 
Infra red spectra of sample KBr disk were recorded on a Perkin Elmer 1600 
series FTIR spectrometer. 
2.2.9 NMR spectra 
1H and 31 p NMR spectra were recorded on a Bruker AC 200 (200 MHz) 
spectrometer. Multiplicities are recorded as broad peaks (br), singlets (s) , 
doublets (d), triplets (t) , quartets (q) and multiplets (m). 
2.2.10 Mass spectra 
Electron impact mass spectra were recorded on a VG micromass 7070E. 
2.2.11 Thin layer chromatography (TLC) measurements 
TLC analyses were carried out on silica TLC plates. The solvents systems 
used for each compound are specified in the corresponding experiments. 
2.2.12 Gel filtration chromatography 
Purification of some of the compounds was performed by gel filtration 
chromatography using Sephadex G-10. The anhydrous Sephadex powder 
was mixed with the eluent (water) and allowed to swell for 4 hours. The 
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swollen gel was allowed to settle and excess solution removed, forming a 
slurry. The column was mounted vertically and the dead space in the bed 
support and tubing were filled with elution solution in order to remove all the air 
bubbles. The gel slurry was poured carefully into the column and the solvent 
was added until the column was full . An eluent reservoir was connected to the 
column and the flow started. 
After use, the column was eluted for 45 minutes with eluent to clean the gel. 
The column was further eluted with phosphate azide saline buffer (pH B.O) in 
order to prevent any microbial growth. The connection tubing was sealed, 
ensuring that the reservoir of eluent above the gel prevented the column 
drying out, and the column stored at room temperature. 
Size exclusion for protein conjugates was performed by using Sephadex G-25 
pre-packed columns previously equilibrated, by passing through it three 
column volumes of the appropriate buffer. 
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Chapter 3 
The synthesis and properties of long wavelength fluorigenic 
substrates. 
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3.1 Introduction 
Amongst the recent developments in fluorescence spectrometry, the increased 
use of long wavelength probes and labels is one of the most important [127-
128]. The major benefits include the much reduced 'autofluorescence' 
background obtained from many biological samples if the excitation 
wavelength exceeds ca. 550 nm and emission wavelength ca. 600 nm, and 
the ease with which long wavelength fluorescence is detected by using diode 
laser sources, simple fibre optics and solid state detectors in small, low-cost 
and robust instruments. 
The applications of fluorigenic substrates, which are non- or weakly 
fluorescent but are converted by an appropriate enzyme to a highly fluorescent 
product, is widespread in biochemical analysis [1 29]. Such methods combine 
the amplification effects of the catalytic enzyme action with the high sensitivity 
of fluorescence spectrometry. Some applications are straightforward enzyme 
assays, while in others the enzyme is a label through which other reactions 
such as immunoassays are monitored [130]. The most commonly used 
fluorigenic substrates are those based on a number of umbelliferyl (7-
hydroxycoumarin) derivatives [131], but the reaction products fluoresce at ca 
460 nm, a wavelength at which there is much background fluorescence from 
biosamples. Assays based on fluorescein (emission at ca. 520 nm [132]) and 
resorufin (emission at ca. 590 nm) [133] conjugates have also been described. 
In the present work the synthesis and properties of naphthofluorescein 
diphosphate and naphthofluorescein monophosphate as new long wavelength 
substrates for alkaline phosphatase and naphthofluorescein diacetate for 
acetycholinesterase is described. Attempts to synthesise long wavelength 
substrates for proteases such as naphthofluorescein isothiocyanate and nile 
blue-peptides are also demonstrated. 
Previous studies have 
carboxynaphthofluorescein as 
demonstrated the applicability of 
a solution pH probe [1 34], and a 
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naphthofluorescein calcein derivative as an intracellular pH probe [135] . 
Naphthofluorescein has also been investigated as a possible acceptor for use 
in fluorescence energy transfer assays [136]. 
Naphthofluorescein is a commercially available dye. Preliminary studies were 
carried out with NF purchased from Molecular Probes, Inc. However, further 
samples from the same source were found to be unsuitable for modification to 
the phosphate form of NF. It was therefore decided to synthesise NF in our 
laboratory. 
3.2 Synthesis of naphthofluorescein 
OH 
Figure 3.1 The structure of naphthofluorescein 
Naphthofluorescein (NF) was prepared according to the procedure described 
by Lee et al. [137]. In a 250 ml round bottom flask, 1,6-dihydroxynaphthalene 
(10.0 g, 63 mmol) , phthalic anhydride (4.6 g, 31 mmol), and zinc chloride (4.2 
g) were mixed and heated in an oil bath at 170 QC for 120 min. A 200 ml 
solution of sodium hydroxide (5M was added to the mixture. The blue solution 
was filtered through celite, acidified with concentrated HCI, and filtered. This 
solid was dried in a vacuum oven at 35 °C. Yield: 12.8 g (95 %). The crude 
dye was purified by converting it into the diacetate followed by hydrolysis in 
basic ethanol [138]. The solid was refluxed with five parts by weight of acetic 
anhydride for 90 min. The solution was allowed to cool overnight at 4 °C. The 
diacetate was filtered and collected as light pink shiny crystals (Yield: 30 %). 
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Sodium hydroxide (2.0 g) and ethanol (40 ml) were added to the diacetate in a 
100 ml round bottom flask and the mixture was concentrated to dryness under 
reduced pressure. The solid was dissolved in 200 ml distilled water and 
acidified with concentrated HCI. The purple crystals of NF were filtered, dried 
as before, and recrystallised with ethanol. The solvent was removed in vacuo. 
(Yield : 71 %).TLC (ethyl acetate, 79 %, methanol, 20 %, acetic acid, 
1%) : Rf = 0.88 Mass spec. : M+ = 432, l H NMR (200 MHz, DMSO-d6) : 
/) 8,67 (d, 2H, J = Hz), 8.08 (m, 1 H), 7.75 (m, 2 H), 7.44 (d, 2 H, J = 
9Hz) , 7.36 (dd, 2 H, J = 9 Hz, 2 Hz, 2 H) , 7.29 (m, 1 H), 7.20 (d, 2 H, J 
= 2Hz), 6.68 (d = 2 H, J = 9Hz) . 
3.2.1 Effect of cyclodextrins and surfactants on the fluorescence 
enhancement and absorbance wavelength shift of 
naphthofluorescein 
The use of aqueous cyclodextrins (CD) solutions to enhance the fluorescence 
properties of various compounds has been widely reported [139-140] . The 
maximum fluorescence intensity is obtained from a molecule which is totally 
encapsulated inside the CD cavity, and the more a molecule is subjected to 
the aqueous environment surrounding the cyclodextrin, the lower the 
fluorescence intensity. The inclusion of COs is influenced mainly by the 
hydrophobicity and shape of the guest molecule. The diameter of the cavity 
varies from 5.7 AO to ca 10 AO for a-CD to y-CD. 
Detergents and surfactants have also been shown to enhance the intensity of 
some fluorescent compounds [141 -144]. The effect of a range of COs (a-CD, 
P-CD, methyl p-CD, 2-hydroxypropyl p-CD, and y-CD), and a surfactant (3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate, CHAPS) on the 
spectroscopic properties of naphthofluorescein were studied (Table 3.1). 
Addition of a-, P- and y-CDs (5% w/v) had relatively little effect on the 
absorption wavelength, while methyl j3-CD and 2-hydroxypropyl p-CD at the 
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same concentration produced excitation wavelength shifts to 609 and 616 nm 
respectively but the emission wavelengths were same in each case. The most 
dramatic wavelength shifts were obtained with CHAPS (Table 3.2 and Figure 
3.2) which produced shifts to ca. 635 nm (excitation) and 680 nm 
(fluorescence) when present at 2.5% level. The lower levels of this reagent 
produced only slightly less significant shifts while 3.0% CHAPS produced a 
small further shift in the excitation wavelength, but had little effect on the 
fluorescence emission wavelength . 
Table 3.1 
Effect of additives on the fluorescence properties of naphthofluorescein. 
Additive (% w/v) Excitation Emission Intensity 
Maximum (nm) Maximum (nm) Enhancement 
0.05 M phosphate buffer 595 660 
a.-cyclodextrin (5.0) 597 660 
p-cyclodextrin (5.0) 603 660 
y-cyclodextrin (5.0) 599 660 
2-hydroxypropyl p-cyclodextrin (5 .0) 616 660 
Methyl p-cyclodextrin (5 .0) 609 660 
CHAPS (2.5) 635 680 
Table 3.2 
Absorbance and emission wavelength shift of naphthofluorescein. 
CHAPS (% w/v) 
0.0 
1.0 
1.5 
2.0 
2.5 
3.0 
Excitation 
Maximum (nm) 
595 
610 
619 
625 
635 
637 
Emission 
maximum (nm) 
660 
665 
670 
675 
680 
680 
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factor (%) 
11 
43 
37 
47 
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Figure 3.2 
500 540 580 
Wavelength (nm) 
CHAPS (% WN) 
3.0 
2.5 
2.0 
1.5 
1.0 
0.5 
0.0 
620 660 
Excitation spectra for naphthofluorescein (1 .25 x 10.0 9 I ml) with various 
concentrations (0 .5-3 .0 % w/v) of CHAPS in tris-HCI buffer pH.9.O. 
3.3 Preparation of naphthofluorescein phosphate 
Figure 3.3. 
R 
o 
C02H 
NFMP (R = 0 , RI = po, -3) 
NFDP (R, RI = P04~ 
Structure of naphthofluorescein phosphate. 
Naphthofluorescein phosphate was prepared by treating naphthofluorescein 
(NF) with phosphorus oxychloride [145] . To a solution of NF (0 .246 g, 5.68 
mmol) dry pyridine (2.0 ml) under nitrogen was added at 0 cC. To this solution 
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was added phosphorus oxychloride (0.107 g, 11.40 mmol) in pyridine under 
nitrogen was added at 0 QC. The mixture was allowed to react for 30 min. The 
reaction was quenched by pouring the mixture over ice water (50 ml) and 
neutralising with ammonium hydroxide to pH 7.0. Pyridine was extracted with 
chloroform (3 x 50 ml) . 
TLC (ethyl acetate, 70 %, methanol , 10 %, water, 10 %, acetic acid, 10 
%) Rr = 0.2 for naphthofluorescein di-phosphate (NPDF) , 0.5 for 
naphthofluorescein mono-phosphate (NFMP) and 0.8 for NF. 
The aqueous phase was lyophilised. The crude material (305.20 mg) was 
purified on sephadex G-10 (2.5 x 30 cm) with elution of 600 ml disti lled water 
(Figure 3.4). Fractions for NFDP and NFMP were collected and lyophilised. 
172.0 mg NFDP (dark pink solid) and 33.0 mg NFMP (light pink solid) were 
obtained. 
IR (KBr) Vmax (cm-I) 1402 (P-O-Ar); Mass spec. : M+ = 593; 31 p NMR 
(202.4 MHz, D20) ii 20.171 . 
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Figure 3_4 Purification profile of NFDP (A) and NFMP (6) . 
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3.3.1 Enzymatic and spectroscopic 
naphthofluorescein phosphate 
characterisation of 
The enzymatic reactions and spectroscopic measurements were performed by 
adding 0.1 Ilg/ml alkaline phosphatase (ALP) into 5.0 Ilg/ml in 0.05 M tris-HCI 
buffer, pH 9.0 at 22 DC (room temperature). The mixture was left to incubate 
for 5 minutes and was monitored by absorption or fluorescence enhancement 
which proportionally corresponds to the formation of the enzymatic product. 
The fluorescence measurements were made by using 1.0 Ilg/ml of NFMP and 
NFDP respectively. 
3.3.1.1 UV -VIS absorption spectra 
As can be seen in Figure 3.5 NFMP has a very weak absorbance at 
approximately 500 nm and no other absorbance at wavelengths longer than 
430 nm as a result of phosphorylation of NF. The action of ALP resulted in 
NFMP hydrolysis and formation of NF as a final product which absorbs 
maximally near 600 nm. 
0.20 
0.15 
Q) 
" c:
co 
.0 0.10 ~ 
0 
V) 
.0 
<{ 
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000 
300 400 500 600 700 
Wavelength (nm) 
Figure 3.5 Absorbance spectra of NFMP CA) and NF (8). 
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3.3.1.2 Fluorescence Spectra 
NFMP and NFDP are non-fluorescent substrates. On hydrolysis with ALP they 
exhibit fluorescence at 660 nm (when excited at 595 nm). As previously 
described an inclusion of 2.5 % CHAPS shifts the excitation and emission 
wavelengths of NF to 635 nm and 680 nm respectively. Therefore 
fluorescence measurements were carried out in the presence of 2.5 % 
CHAPS. NFMP was found to be a more efficient substrate for ALP than NFDP 
(Figure 3.6) . A possible reason for this finding is that NFDP hydrolysis occurs 
via NFMP (as shown below), therefore a longer period of time is required to 
completely hydrolyse all the NFDP to NF. 
j;: 
Figure 3.6 
800 
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(8) 
o~~~~~~==~~~~~ 
650 670 690 71 0 730 750 770 790 81 0 830 850 
Wave length (nm ) 
Fluorescence emission spectra of NF produced from 1.0 !,g/ml of NFMP (A) 
and NFDP (8) by alkaline phosphatase after a 5 min incubation at 22 °C in 
tris-HCI containing 2.5 % CHAPS. 
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3.3.1.3 Dependence of rate of hydrolysis of NFMP on APase 
concentration 
The influence of enzyme concentration on the fluorescence development was 
studied under conditions where the NFMP concentration was fixed at 1.0 ~gl 
ml and ALP concentration was changed. As shown in Figure 3.7 the 
fluorescence intensity increased linearly with an increase in the concentration 
of ALP up to 0.3 ~g/ml for the given concentration of the substrate. 
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Figure 3.7 
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Dependence of the rate of hydrolysis of ALP concentration . NFMP (1 fig/m I) 
was incubated at 22 DC in 0.05 M tris-HCI pH 9.0. 
3.3.1.4 Comparative kinetic fluorescence measurement of 4-
methylumbelliferyl phosphate (4-MUP) and NFMP hydrolysis by 
ALP. 
Preliminary studies showed that the rate of hydrolysis of NFMP by ALP was 
dependent on the enzyme concentration (Figure 3.7). The kinetic parameters 
of NFMP were assessed and compared with equivalent characteristics of 4-
MUP, a conventional substrate for ALP. The enzyme reaction was initiated by 
adding constant amounts of ALP (1.0 ~lg/ml) to different concentrations of 
substrates. The reaction mixtures were incubated at 40 QC for 10 min in 0.05 
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M tris-Hel pH 9.0. The results are given in Table 3.3 A and B, which show 
that the hydrolysis reactions obeyed the classical Michaelis-Menten kinetics 
(Figure 3.8) , yielding Km values of 0.53 and 1.05 ~M for 4-MUP and NFMP 
respectively. The Km (Michaelis-Menten constant) is an indication of the 
efficiency of a substrate for an enzyme. The smaller the Km value of a 
substrate the more efficient it is as a substrate. Despite the fact that the 
enzyme kinetics of 4-MUP appears to be superior to those of NFMP, there is a 
great potential for the use of NFMP as a long wavelength substrate in enzyme 
assays. 
Table 3.3 
Kinetic parameters of 4-MUP (A) and NFMP (B) hydrolysis by APase. 
(A) 
[4-MUP] (~M) V (FU/min) liS (1/~M) IN (1/FU/m in) 
0.1 70.1 10.00 0.014 
0.2 132.3 5.00 0.0076 
0.4 221 .1 2.50 0.0045 
0.6 339.6 1.67 0.0029 
0.8 445.2 1.25 0.0022 
1.0 543.0 1.00 0.0018 
Table 3.3 
(8) 
[NFMP] ( ~M) V (FUlmin) liS (1I~M) IN (1IFU/m in) 
0.1 23.7 10.00 0.042 
0.2 40.8 5.00 0.024 
0.4 71 .1 2.50 0.0141 
0.6 87.2 1.67 0.0115 
0.8 114.3 1.25 0.0086 
1.0 156.1 1.00 0.0064 
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Figure 3.8 Lineweaver-Burk plot for the hydrolysis of NFMP and 4-MUP by ALP. 
3_3_1_5 Determination of theophylline by its inhibitory effect on alkaline 
phosphatase using a solid state detector 
The combined effects of wavelength shift and intensity enhancement 
faci litated the use of phosphate derivatives of naphthofluorescein as 
fluorigenic substrates. This was demonstrated by the determination of the 
Figure 3.9 
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Inhibition of immobilised alkaline phosphatase by theophylline, detenmined 
using the solid state fluorescence detector. 
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anti-asthmatic drug theophylline by using its inhibitory effect (Figure 3.9) on 
APase immobilised in a flow injection microreactor system. The solid state 
fluorescence instrument (chapter 4) could detect NF at levels of ca. 10-9 M. 
Although the inhibition of the enzyme by theophylline using NFDP in the flow 
injection system was modest, it sufficed to determine this drug at therapeutic 
(l-1g mrl) level. 
All the conditions used in this method were same as described in chapter 4. 
3.4 Preparation of naphthofluorescein di-acetate 
Naphthofluorescein (0.32 g, 0.74 mmol) was refluxed with acetic anhydride (10 
ml) for 6 h. The solution was allowed to cool overnight (4 °C). The next day 
light pink shiny crystals were filtered and dried. Yield: 0.23 g (60.5%). 
TLC (toluene, 70%, acetic acid , 30%) [146] Rr = 0.3 for 
naphthofluorescein di-acetate (NFDA) and 0.7 for naphthofluorescein 
mono-acetate (NFMA). 
The NFDA was purified by medium pressure chromatography on silica gel. A 
solution of the sample (20 mg) in dichloromethane was loaded onto silica gel 
(0.3 g, 230-400 mesh) and rapidly eluted with additional dichloromethane. 
The NFMA appeared to hydrolyse under these conditions; a layer of dark red 
solid remained at the top of the column. The filtrate was concentrated in 
vacuo to a pale orange solid (5 mg). 
TLC (toluene, 70%, acetic acid, 30%) Rr = 0.3 for NFDA. 
The IR spectrum of NFDA is given in Figure 3.10 
lH NMR (CDCb) 0 8.19 (d, J. 8 Hz, 1 H), 7.92 (m, 2 H), 7.55 (m, 4 H), 
7.3 (m, 6 H), 7.21 (d ,J = 7Hz, 1 H), 2.50 (s, 6 H). 
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Figure 3.10 IR spectrum (KBr) of NFDA. Vm.x (cm" ) 2500-3400 (COO-H band) 1770 and 
1701 (C=O stretch) 11 10 (C-O stretch) 893 (CH3C=O stretch). 
3.4.1 Absorbance spectra 
Figure 3.11 shows the absorption spectra of naphthofluorescein di-acetate (A) 
and the acetylcholinesterase-hydrolysed product (8 ). NFDA exbibits a week 
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Figure 3.11 Absorption spectrum of 3 flg/ml solution of NFDA before (A) and after (B) 
treatment with 1.2 U of acetylcholinesterase for 2 min at room temperature. 
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absorbance at approximately 650 nm. Upon treatment of NFDA with 
acetylcholinesterase the absorbance increased with a wavelength shift to 595 
nm, which indicates the formation of NF. 
The fluorescence characteristics of NFDA are described in chapter 5. 
3.5 Synthesis of a fluorigenic substrate for proteolytic enzymes 
3.5.1 Synthesis of serine-nile blue 
Van Noorden et a/. (147) recently reported a new type of fluorigenic substrate 
for proteases based on the leaving group cresyl violet. They found that cresyl 
violet is not fluorescent when amino acids or peptide groups are attached but 
becomes highly fluorescent after proteolytic cleavage of the amide bonds. 
The same procedure was used to prepare peptide-nile blue conjugate. 
Figure 3.12 The proposed structure of serine-nile blue. 
D-serine (1 .05 g, 10 mmol) was suspended in 20 ml dry 
dimethylformamide/pyridine (1 : 1, v/v) and cooled to 0 QC. 
Dicyclohexylcarbodiimide (2.06 g, 10 mmol) was then added. After 30 min at 
o QC, nile blue hydrochloride (0.35 g, 1 mmol) was added. The reaction 
mixture was allowed to stir overnight at room temperature. The solvents were 
removed at 50 °C and the residue was dissolved in 150 ml ethyl acetate. The 
solution was then successively washed with hydrochloric acid (2 M, 100 ml), 
saturated aqueous brine (100 ml) and saturated sodium bicarbonate (100 ml ). 
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The ethyl acetate solution was dried over anhydrous magnesium sulphate and 
filtered . Removal of solvent in vacuo yielded a dark blue solid , which was 
dried under high vacuum. The crude product (0.5 g) was chromatographed on 
silica gel using 5% v/v methanol in dichloromethane. 
TLC (methanol : acetic acid : water, 4 : 1 : 1) Rr = 0.08 for ser-nile blue 
IR (KBr) : Vmax (cm·1) 3361 (N-H stretch) , 1170 (C=O stretch) 
The product was tested by fluorescence measurements and was found to be 
highly fluorescent. On addition of appropriate amounts of various proteases 
(a-chymotrypsin, pepsin , proteinase-K, alkaline protease) separately, no 
change in the fluorescence intensity was observed. This suggests that the 
serine-dye conjugation has not taken place. The method was repeated by 
changing the conditions but the title product could not be prepared 
successfully. With the failure of this procedure it was decided to attempt a 
method for naphthofluorescein isothiocyanate. 
3.5.2 Synthesis of an isothiocyanate analogue of naphthofluorescein 
The synthesis of isothiocyanate derivatives of xanthene dyes was reported in 
the late 1950s. Silverstein [148] synthesised Rhodamine B isothiocyante and 
conjugated it to a protein. He found that satisfactory labelling was difficult to 
produce. Riggs et a/. in 1958 [149] successfully prepared fluorescein 
isothiocyanate (FITC) by treating aminofluorescein with thiophosgene. This 
compound is highly stable. Despite the growing number of choices in amine-
reactive fluorophores, xanthine based dye (FITC and tetramethylrhodamine 
isothiocyanate TRITC) still remain the most widely used reactive fluorescent 
dyes for preparing fluorescent antibody conjugates. In the present work the 
same procedure as for the preparation of FITC was used in order to 
synthesise naphthofluorescein isothiocyanate. The reaction scheme is given 
in Figure 3.13. 
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Figure 3.13 The reaction scheme for preparation of nitronaphthofluorescein , 
aminonaphthofl uorescein and naphthofluorescein isothiocyanate. 
3.5.2.1 Nitronaphthofluorescein (NNF) 
Using the same procedure as for naphthofluorescein, but a nitro derivative of 
one of the starting materials (phthalic anhydride) was used. The NNF was 
isolated as a dark green solid. 
TLC (ethyl acetate, 70%, methanol , 10%, acetic acid, 10%, water 10%), 
Rr = 0.32 
IR (KBr) Vmax (cm-1) 3396 (OH), 1701 (C=O), 1602 (N02) 
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3.5.2.2 Aminonaphthofluorescein (ANF) 
A solution of 0.25 g 10% palladium-on-charcoal and nitronaphthofluorescein 
(0.13 g, 0.25 mmol) was stirred under nitrogen in anhydrous methanol (25 ml) 
for 120 min. Hydrogen was then applied to the flask via a hydrogen balloon 
and the reaction mixture was stirred overnight at room temperature. After 
hydrogen uptake was completed by TLC the solution was passed through a 
short pad of silica to remove the catalyst and then evaporated to dryness 
yielding the title compound (0.092 g, 70.7%) as a dark green solid . 
TLC (ethyl acetate, 70%, methanol , 10%, acetic acid, 10%, water, 
10%), Rr = 0.25. 
IR (KBr) Vmax (cm'1) 3190 (O-H and N-H stretch) 1702 (C=O stretch) 
1577 (N-H stretch) 
3.5.2.3 Naphthofluorescein isothiocyanate (NFITC) 
To a solution of aminonaphthofluorescein (11 .0 mg, 0.02 mmol in anhydrous 
pyridine 0.4 ml) thiophosgene (22 Ill , 0.3 mmol) was added under nitrogen at 0 
QC. The mixture was allowed to react for 60 min at room temperature. The 
solvent was evaporated to dryness. The residue (black) was re-crystallised 
from ethyl alcohol to yield 7.0 mg of the title compound. The fluorescence 
properties of this compound were studied. Unfortunately this compound did 
not exhibit any fluorescence when examined in absence and presence of a 
number of proteases. Attention was then turned to naphthofluorescein 
succinimidyl ester, which is a commercially available compound. Conjugation 
of this dye to 3 different proteins (bovine serum albumin, ovalbumin, a-casein ) 
and its assays with serine proteases are described in chapter 7. 
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3.6 Discussion 
Fluorigenic substrates usually offer practical convenience and higher 
sensitivity in enzymatic assays than their chromogenic counterparts [150]. As 
an essential requirement, however, a useful fluorigenic substrate should have 
no or little absorbance at the wavelength where its enzymatic product can be 
efficiently excited and measured, since the substrate absorbance always 
diminishes the detectable fluorescence signals in a fluorescence detector 
[151]. Naphthofluorescein mono and di-phosphate and naphthofluorescein di-
acetate in this work were synthesised in good yields from the parent 
compound , naphthofluorescein which was also prepared in our laboratory. 
The purification of these analogues was accomplished by simple 
chromatographic techniques. These compounds were found to be reasonably 
stable and optically clean at wavelengths around 595 nm (Figures 3.5 and 
3.12) where their final hydrolytic product, NF, can be easily and sensitively 
detected. The phosphate derivatives of NF are particularly suitable for alkaline 
phosphatase assays since NF, as an enzymatic product absorbs and 
fluoresces maximally at alkaline pH at which the enzyme assays are 
performed [152]. NFMP appeared to be a more efficient substrate for APase 
than NFDP (Figure 3.6). The possible reason for this finding is that NFDP 
hydrolysis occurs via NFMP, therefore a longer period of time is required to 
completely hydrolyse all the NFDP to NF (i.e. hydrolysis is a two stage 
process). 
Acetycholinesterase also has been found to exhibit maximum activity at 
alkaline pH. Therefore NFDA could be an ideal long wavelength substrate for 
this enzyme. The enzyme assays using this substrate are described in 
chapter 5. 
Attempts to synthesise oxazine-protein conjugates using a variety of 
conditions were unsuccessful. Also unsuccessful were many attempts to 
prepare naphthofluorescein isothiocyanate using the Riggs reaction scheme. 
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However, protein conjugates with naphthofluorescein succinimidyl ester were 
successfully prepared and assayed with 3 different proteases (chapter 7). The 
results presented in this chapter also demonstrate an enzyme inhibition assay 
for alkaline phosphatase by theophylline using NFDA as a substrate and show 
that the hydrolysis product of this and other NF based substrates can be used 
for trace analyses using diode laser based fluorescence detection. It has been 
shown that polar fluorophores in micelles of different charges and organisation 
exhibit wavelength-selective fluorescence (red edge fluorescence) [143]. This 
implies that NF molecules when bound to micelles, are in motion ally restricted 
environment. Furthermore, NF is likely to be localised in the miceller 
interfacial region. This region of the micelle offers considerable restriction to 
the orientational motion of the solvent dipole around the excited state 
fluorophores. The novel use of CHAPS to shift the fluorescence, and 
especially the excitation wavelength of NF is crucial in matching the 
characteristics of this fluorophore to those of the lowest wavelength diode 
lasers available at low cost. 
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Chapter 4 
Naphthofluorescein mono-phosphate, a new long wavelength 
fluorigenic substrate for alkaline phosphatase 
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4.1 Introduction 
Alkaline phosphatase (ALP, EC.3.1.3.1) is a non-specific enzyme, which 
hydrolyses phosphate esters, at alkaline pH. It is a dimeric allosteric enzyme 
[153] with four zinc ions, although only two of them are necessary for the 
activity [154]. The catalytic mechanism of ALP is illustrated in scheme 4.1. 
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Scheme 4.1 Mechanisn of ALP catalysed hydrolysis of a phosphate ester. 
In the first step, the enzyme binds noncovalently to the substrate forming an 
enzyme-substrate complex. The complex breaks down to give the product, 
and a phosphoprotein intermediate is formed, where the enzyme is covalently 
bound to the phosphate. The phosphoprotein intermediate is then converted 
to a noncovalent complex, with the equlibrium depending on the pH of the 
reaction medium. Under normal conditions, the pH is around 9.0. At this pH 
the reaction continues to the right where it is terminated by the release of the 
enzyme and phosphate. 
Alkaline phosphatase is found in a variety of tissues and is particularly 
associated with bone mineralisation, but its function and natural substrate are 
sti ll unknown [155]. The increase in activity of ALP can result in painful 
changes in the bones, hepatitis and tumerigenesis. Alternatively, it can be 
used as an indicator of normal physiological processes such as pregnancy 
and bone growth. The enzyme is widely used in test systems used to 
diagnose various diseases (Paget's disease, hyperparathyroidism, etc), 
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modification of DNA and RNA, and production of various therapeutic 
preparations [156]. 
Various substrates are available for the determination of alkaline phosphatase. 
Some are shown in Table 4.1. 
Table 4.1 
Methods and substrates for detennination of alkaline phosphatase activity . 
Method 
Spectrophotometry 
Spectrofluorimetry 
Chemiluminescence 
Electrochemical 
Substrate 
p-Nitrophenyl phosphate (pNPP) 
4-methylumbelliferyl phosphate 
3-o-methyl-fluoresce in mono-phosphate 
Cortisol-21-phosphate 
Phenacyl phosphate 
Flavin adenine dinucleotide-3-phosphate 
Adamantyl1 ,2-d ioxetane aryl phosphate 
pNPP 
5-bromo-4-choloro-3-indolyl phosphate 
Reference 
[157] 
[158] 
[159] 
[160] 
[161] 
[162] 
[163] 
[164] 
[165] 
Alkaline phosphatase can also be used to determine substances that are its 
inhibitors. Methods for pesticides and metals have been reported for the 
determination of these analytes [163,166]. Species of pharmaceutical and 
clinical interest have also been determined by their inhibitory effect on the 
enzyme activity [167-168] . 
Theophylline is a member of the xanthine family of drugs, which are central 
nervous system stimulants. Theophylline is a bronchodialator and respiratory 
stimulant, its most important use being as a prophylactic agent for controlling 
the symptoms of chronic asthma. Adequate control of asthma is generally 
achieved with 1 0-20 ~g mr' (55-11 0 ~M) , but in cases of toxicity, levels as 
high as 60 ~g ml-' can be encountered. Owing to the toxicity of theophylline 
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and the variations in metabolism between individuals, the use of drug as a 
therapeutic agent necessitates close monitoring. 
Several methods have been reported for the analysis of theophylline in 
biological fluids, based mainly on high-performance liquid chromatography 
[169], electrochromatography [170], and immunoassays [1 71-174]. Luque de 
Castro et a/. [175] have recently described a fluorimetric method for 
theophylline that is based on its ability to inhibit alkaline phosphatase. 
The aim of this study was to: 
I. develop a simple and reliable spectrofluorimetric-flow injection method 
making use of naphthofluorescein mono-phosphate, a long wavelength 
substrate for alkaline phosphatase. The biochemical reaction scheme 
is given below (Figure 4.1). 
11. determine theophylline based on its inhibitory effect on immobilised 
alkaline phosphatase by using naphthofluorescein mono-phosphates in 
a flow system. 
The hydrolysis product of naphthofluorescein mono-phosphate, 
naphthofluorescein (Figure 4.1) has been found to have an optimum excitation 
wavelength that is dependent upon the presence of additives such as 
0 
II 
0 o- p- o 0 OH ?' 1- ?' 
0 
'-":: 
0 :::,... 0 :::,... 
:::,... :::,... // 
Alkaline 
:::,... :::,... // 
eOOH phosphatase eOOH • ?' ?' 
:::,... :::,... 
Naphthofluorescein Naphthofluorescein 
mono-phosphate (fluorescent) 
(nonfluorescent ) 
Figure 4.1 Reaction for the alkaline phosphatase catalysed hydrolysis of 
naphthofluorescein mono-phosphate. 
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cyclodextrins and CHAPS described in (3.2.1). Such an effect can therefore 
be used to ra ise the excitation of naphthofluorescein in order to match the 
output of a 635 nm diode laser in a simple and sensitive fluorescence detector. 
Diode laser instrument 
The laboratory constructed detection system is shown in Figure 4.2 . A laser 
diode (various long wavelength options) provides the excitation source, which 
is modulated and requires 5 volt DC power supply. A laser pulse generator 
which has 5 pulse speed option drives the laser i.e. CW-2MHz. Many short-
wavelength cut-off filters have been selected to minimise fluorescent signal 
loss. The output beam of the laser at a selected wavelength excites the 
fluorophores of the sample in a rectangular flow cell. The emission beam from 
Laser diode 
and optics 
Cuvette 
=:::Jo}-----------. ----------. 
Filter 
Laser driver pes I I I 
• • • 
Lens 
Photodiode 
Detector PCS 
Data handling 
Amplifier 
PCS 
Figure 4.2 Diagram of the portable solid state long wavelength fluorescence detector. 
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the sample, passes through a biconvex lens onto the surface of photod iode. 
The lens focuses the emission beam onto a photodiode through the short 
wavelength cut-off filter for detection. The applications of this instruments are 
given in detail in [176]. 
4.2 Experimental 
4.2.1 Effect of inclusion of CHAPS on the wavelength excitation shift of 
naphthofluorescein 
The effect of a range of cyclodextrins and CHAPS on the fluorescence and 
excitation shift of naphthofluorescein have previouly been discussed (3.2.1). 
An inclusion of 2.5% CHAPS remarkably shifts the excitation wavelength of 
naphthofluorescein (ca. 597 nm to 635 nm), which is crucial in matching the 
characteristics of this fluorophore to those of 635 nm diode lasers currently 
Figure 4.3 
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Fluorescence excitation spectra of NF, the hydrolysis product of NFMP [2.2 x 
10,9 M] with ALP [1.2 x 10'" mg/ml] at 40°C, (a) without, and (b) with 2.5 % 
CHAPS, 
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available at low cost. Figure 4.3 shows the fluorescence excitation spectra of 
the hydrolysis product of naphthofluorescein mono-phosphate with alkaline 
phosphatase, (a) in the absence, and (b) in the presence of 2.5% CHAPS. In 
subsequent experiments 2.5% CHAPS has been included. 
4.2.2 Immobilisation of alkaline phosphatase 
Alkaline phosphatase was immobilised as described in [177]. Alkylamino 
glass (1 g) was treated with 12 % (v/v) glutaraldehyde solution at room 
temperature for 1 h. The activated glass was washed with distilled water and 
left to dry at room temperature. 
0.5 g of activated glass was added to a cold solution of 10 mg of alkaline 
phosphatase in 2.5 ml of phosphate buffer (0.1 M, pH 6.0). Nitrogen was 
bubbled through the solution after every 10 min. over the first 30 min. to 
remove oxygen. The solution was kept at 4°C for 2.5 h. Finally CPG-
immobilised enzyme was washed with cold distilled water and stored in 
Tris.HCI buffer (0.1 M, pH 6.0). The overall reaction is as follows, (Figure 4.4) 
OEt 
I 
CPG- O- Si-(CH )-NH + I 23' 
o 0 
II II 
H- C- (CH,),C- H .. 
OEt H 0 I I II 
CPG- O- Si - (CH )- N= C- (CH )- C- H I 23 23 
OEt OEt 
Silanised CPG Glutaraldehyde Activated CPG (A) 
A + Enz- NH, .. 
OEt H H I I I 
CPG- O-r-(CH, ), N= C-(CH,),C= N- Enz 
OEt 
Immobilised enzyme 
Figure 4.4 Reaction scheme for enzyme immobilisation. 
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4.2.3 Establishment of a flow injection system for the determination of 
activity of immobilised alkaline phosphatase on 
naphthofluorescein mono-phosphate 
The activity of alkaline phosphatase on naphthofluorescein mono-phosphate 
was determined by incorporating an immobilised enzyme column into the flow 
injection system shown in Figure 4.5. The system was optimised for various 
variables to obtain the best measurement conditions and maximum 
fluorescence intensity. 
Tris·HCI 
pH 9.0 
Peristaltic 
pump 
Injection 
valve 
ALP 
Thermostated 
water bath 
Detector 
Data 
handling 
Figure 4.5 Flow injection manifold for naphthofluorescein determination . 
4.3 Results 
4.3.1 Selection of buffer system for ALP 
Waste 
Several buffers have been used with this enzymatic system [170]. Tris-HCI, 
glycine, and carbonate buffers with a working range of pH 7-9, 8-10 and 8.5-
10.5, respectively, were investigated in this study. As can be seen in Figure 
4.6, all the buffers have an optimum of pH 9.0 for the activity of ALP, however 
in Tris buffer the response was higher, therefore tris buffer was selected for 
further studies. Soluble ALP shows pH optimum at 9.5, which is shifted to 9.0 
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when the enzyme is immobilised. This may be attributed to the new 
environment for the enzyme and changes in its kinetic properties after it is 
immobilised. 
The effect of buffer concentration between 10-90 mM was studied (Figure 4.7) . 
In order to have sufficient buffer capacity a concentration of 50 mM was 
selected. 
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Figure 4.6 Influence of pH on the activity of ALP. 
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Figure 4.7 Effect of concentration of Tris-HCI on the response of ALP. 
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10.5 
90 
4.3.2 Effect of temperature 
It was observed that a slight variation in room temperature affected the 
response from the column. Therefore the effect of temperature on the activity 
of immobilised ALP was investigated, shown in Figure 4.8. The activity of 
immobilised enzyme increased as the temperature was increased up to 50°C. 
Further increase in temperature produced denaturation of the immobilised 
enzyme. All the subsequent experiments were therefore carried out at a 
constant temperature of 40 °C. 
250 
S' 225 ~ 
~ 200 
"' c: Q) 
"E 175 Q) 
u 
c: 
Q) 150 u 
"' Q) 
0 125 ::> 
u: 
100 
20 30 40 50 60 
Temperature C 
Figure 4.8 Effect of temperature on the activity of ALP. 
4.3.3 Effect of flow rate: 
Flow rate effect was also examined for the optimum response from 0.5-3.0 
ml/min. It was observed that increasing the flow rate from 0.5-1 .5 ml/min 
slightly increases the fluorescence signal peak height. Flow rate above 1.5 
ml/min resulted in a gradual fall in the enzymatic activity because of the 
decreased residence time of the sample injected in the system (Figure 4.9) . 
Therefore, the flow rate of 1.5 ml/min is recommended for achieving suitable 
sensitivity. 
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Figure 4.9 Effect of flow rate on the response of ALP. 
4.3.4 Calibration for naphthofluorescein mono-phosphate 
A series of standard solutions of naphthofluorescein mono-phosphate were 
injected into the flow system (Figure 4.5) under the selected conditions in 
order to establish a calibration graph for naphthofluorescein mono-phosphate. 
350 f 
NFMP Ig/ml] 
300 6.25x 10-
8 
1.25x 10-7 
S 2.50x10-7 ~ 250 
1'; 3.75x 1O-7 
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QJ 150 u 
c: 
Q) 
u 
V> 
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Time (seconds) 
Figure 4.10 Typical FIA responses for NFMP hydrolysis by ALP. 
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A linear relationship between the naphthofluorescein mono-phosphate 
concentration and fluorescence intensity was obtained over the range 1.25 x 
10-8 - 6.25 X 10-7 moles/ml (Figure 4.11). Each standard was injected in 
triplicate. The peaks (Figure 4.10) show an excellent linearity in the range 
investigated. Actually this linearity extended up to 7.5 x 10-7 moles/ml. The 
limit of detection of the systemwas investigated and it was found that the 
system could detect easily down to 9.0 x 10-9 g/ml (1 .8 x 10-9 moles/ml) . 
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Figure 4.1 1 Calibration graph of naphthofiuorescein mono-phosphate . 
4.4 Determination of theophylline based on its inhibitory effect on 
immobilised alkaline phosphatase using a solid state fluorescence 
spectrometer in the flow system 
By using the optimum values of the variables previously found, a series of 5 
standard solutions of theophylline with concentrations between 55-110 J.!M 
were injected in triplicate. Figures 4.13 and 4.14 show some typical responses 
and a graph of theophylline respectively, based on inactivation of alkaline 
phosphatase. A flow injection merging zone approach was used for this study 
(Figure 4.12). Theophylline and the substrate solutions were simultaneously 
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injected via a dual injection valve into two buffer streams which merge at a 
point. When the buffer solution was injected instead of the sample 
(theophylline) solution, the peak obtained was proportional to 
naphthofluorescein mono-phosphate concentration and corresponded to the 
blank enzymatic reaction i.e, non-inhibited reaction. The reaction was slow in 
the prescence of the inhibitor and the difference between the signal thus 
provided was proportional to the concentration of the inhibitor (theophylline) . 
Peristaltic Theophylline 
pump (50 pi) 
NFMP 
Tris-HCI pH 9.0 (25 ~d) 
Thennostated 
water bath 
Solid state 
detector 
Data 
handling 
Figure 4.12 Schematic of the now injection system for detection of theophylline. 
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Figure 4.13 Typical recorder peaks for alka line phosphatase inhibition. 
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Figure 4.14 Inhibition of alkaline phosphatase by th eophylline, determin ed with the use of 
naphthofluorescein mono-phosphate [6 .25 x 10.7 flg/ml] using the solid state 
fluorescence spectrometer. 
4.6 Discussion 
Detection of enzyme activity is an important tool for the analysis of biological 
and chemical samples ranging from cell extracts, biological fluids, or chemical 
mixtures. Fluorimetric methods have proven to be safe, rapid and sensitive 
techniques to determine enzyme activity. The availability of a suitable 
fluorigenic substrate is critical to the success of fluorimetric determination of 
enzyme activities. Although fluorigenic substrates are generally preferred due 
to their sensitivity, the currently existing substrates still have certain 
deficiencies. 
The known fluorigenic substrates of alkaline phosphatase (ALP) are 4-
methylumbelliferyl phosphate and fluorescein di-phosphate [32-34] . These 
substrates are hydrolysed to 4-methylumbelliferone and fluorescein, which 
fluoresce at 450 nm and 525 nm respecti vely. Unfortunately these 
compounds suffer from reduced sensitivity because of high background 
fluorescence, which originates from endogenous fluorescent species [36]. 
Naphthofluorescein mono-phosphate (NFMP) is an alternative to the above 
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mentioned ALP substrates and has numerous benefits. The absorption and 
emission spectra of its hydrolysis product, naphthofluorescein, are ca. 597 nm 
and 660 nm respectively. The spectral properties especially excitation 
wavelength of naphthofluorescein can be shifted further to the longer 
wavelengths with the inclusion of an appropriate amount of surfactants (Figure 
3.2), which is crucial in matching the characteristics of this fluorophore to 
those of longer wavelength diode lasers. 
The most important feature of fluorescence detection using long wavelength 
(600-1000 nm) laser source is the reduction of the background fluorescence. 
However, only a limited number of compounds fluoresce in this region. 
Furthermore, the sample photodecomposition is reduced when longer 
wavelengths are used. 
ALP in this work was immobilised on controlled pore glass (CPG). The 
enzyme reactor was placed on a flow injection system. In order that an assay 
with optimum sensitivity could be constructed, the experimental conditions 
such as buffer (type, pH and concentration), temperature and flow rate , under 
which enzyme activity could be achieved were investigated. The results 
obtained show identical trends for all buffers examined; a summery of the 
results for carbonate, glycine and tris-HCI buffers is shown in Figure 4.6. The 
enzyme exhibited a maximum response at pH 9.0 in all buffers, however tris-
HCI was the most appropriate for the operation of the system. The exhibition 
of optimum response of ALP at pH 9.0 appears to be ideal for the enzymatic 
product NF, which absorbs and fluoresces ideally at alkaline pH . The activity 
of the enzyme also increased with increasing buffer concentration (probably 
due to an increase in ionic strength) up to an optimum between 15 and 50 mM 
and thereafter decreased markedly. Increasing temperature had a positive 
influence on the enzymatic reaction ; however, temperatures over 45 QC 
produced denaturation of the biocatalyst. The flow rate finally selected (1 .5 ml 
min-) was appropriate for the reaction. Higher flow rates decreased the 
analytical signal due to a shorter on-line NFMP-ALP contact time. 
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Under these optimum conditions it was possible to obtain good calibration 
linearity over the range 6.25 x 10-8 - 6.25 x 10-7 M for NFMP (y = 564.21 x + 
4.64, r = 0.9949, n = 6) (Figure 4.11). The relative standard deviation for 10 
successive injections was 1.07% at 2.50 x 10-7 M NFMP level. 
The combined effect of wavelength shift of NF (Figure 43) and fluorigenic 
properties of NFMP (Figure 4.10) led to the idea to measure NF with the 
fluorescence detection system (constructed in our laboratory) using a 635 nm 
laser diode. This was demonstrated by the determination of the anti-asthmatic 
drug theophylline at therapeutic ( ~g mr) levels using its inhibitory effect (Figure 
4.13) on alkaline phosphatase immobilised in the flow injection microreactor 
system. 
Several other compounds were examined for their ability to inhibit ALP, which 
were either structurally similar to theophylline e.g. caffeine and theobromine 
(and hence often interfere in enzyme assays) , or reported as inhibitors of ALP 
and likely to be encountered in blood. 
No inhibition was noted for caffeine or theobromine (0-1 mM) or for arginine 
(0-500 ~M) ; these two amino acids are found in blood at ca. 90 ~M . Cysteine 
also showed no inhibition of the enzyme when tested between 0-200 ~M 
(serum level 33 ~M) . 
In conclusion the results presented here demonstrate the use of a new 
fluorigenic substrate for alkaline phosphatase, and show that the hydrolysis 
product of this substrate, NF, can be used for trace analyses using diode laser 
based fluorescence detection. NFMF along with the long wavelength 
substrates for the determination of other enzyme is expected to of importance 
in high throughput screen applications. 
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Chapter 5 
Investigation of the potential of naphthofluorescein di-acetate 
as a long wavelength substrate for acetylcholinesterase 
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5.1 Introduction 
Acetylcholinesterase (AChE, EC. 3.1.1.7) is a general ester hydrolysing 
enzyme that is highly effective against acetylcholine (ACh) . It is found in high 
concentration in nerve tissue. An active enzyme is crucial for normal 
neuromuscular function, and its inhibition produces tetanic shock with eventual 
muscle paralysis. AChE is a target for nerve agents and insecticides. It has a 
molecular weight of approximately 260,000 (source: elctric eel) and is a 
functional tetramer of four subunits with an active site. AChE is remarkably 
efficient with a turnover number (kcat) of 25,000 S·l ; it cleaves a substrate 
molecule every 40 ~s . In fact this high turnover is necessary for post-synaptic 
membranes to return rapidly to a resting polarised state. 
It has been revealed that the active site of AChE consists of three major 
domains: (1) an esteratic locus, comprised of active site serine, (2) an anionic 
locus, that is ~ 4.7 A" from esteratic serine, where the quarternary 
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ammonium pole of ACh and of various active site ligands binds, (3) a 
hydrophobic region, that is contiguous or near the esteratic and anionic loci 
and that is important in binding aryl substrates and active site ligands. The 
diagram of the domains of the active site of AChE is given in Figure 5.1. 
The mechanism of AChE with its substrates bears resemblance to the serine 
protease mechanism, described in (7.1). In the first step the substrate is 
bound to the active site of the enzyme, which rapidly hydrolyses it in a second 
step. Esters such as organophosphorus compounds or derivatives of the 
carbamic acid are converted in an identical way, whereas phosphorylated or 
carbamylated AChE hydrolyses very slowly. Thus, the decrease of the 
enzyme activity allows the application of these compounds in agriculture 
(insecticides) or even warfare (nerve gases) [178-179]. 
Due to the biochemical importance of these reactions several methods have 
been used for the determination of the activity of acetylcholinesterases and as 
a consequence, for quantitation of enzyme inhibitors. Gunther et al. described 
a potentiometric detection of AChE using acetylthiocholine (ATCh) and 5, 5'-
dithiobis-2-nitrobenzoate (DNS) [180]. Sipponen reported a reaction method 
for the postcolumn detection of organophosphorus nerve agents separated by 
high performance liquid chromatography [181]. The work of Lui et al. involved 
microassays for the determination of pesticides in vegetable and fruit samples. 
This method utilises AChE immobilised onto the microtiter wells [182]. Other 
methods for assaying AChE include spectrophotometric detection [183], which 
involves the measurement of coloured species formed by the hydrolysis of 0.-
naphthyl acetate with fast Red G G salt (p-nitrobenzenediazonium 
fluoroborate) , chemiluminescence [184-185] and fluorimetric detection [186] . 
Diaz, et al. [187] have described a sensitive method for the determination of 
fenitrothion using indoxy acetate and 2-naphthyl acetate as f1uorigenic 
substrates. Hadd et al. [188] recently reported an AChE-catalysed hydrolysis 
of acetylthiocholine with coumarinylphenylmaleimide (CPM). The resulting 
thioether, CPM-thiocholine was detected by laser induced fluorescence. 
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5.2 Inhibitors of AChE 
5.2.1 Types of AChE inhibitors 
Agents which inhibit AChE must be numbered in thousands. They are 
relevent to biochemistry, pharmacology, physiology, toxicology and ecology. 
The inhibitors can be divided into three groups on the basis of their binding 
with different subsites of the enzyme. 
1. Compounds which bind to the anionic site, e.g. galanthamine, 
tetraalkylammonium etc. 
2. Compounds which bind to the esteric site, e.g. a majority of 
organophosphorus compounds. 
3. Compounds which bind to the esteric and anionic sites, e.g. 
carbamylated compounds and certain organophosphorus 
compounds resembling neostigmine. 
5.2.2 AchE inhibitors as drugs 
In addition to the carbamates and organophosphorus compounds there are 
many clin ical agents which decrease the AchE activity. Among these tacrine 
[189], donepenzil [190], physostigmine [191], galanthamine [192], and 
metrifonate [193-194], have been investigated with potential therapeutic 
benefits in Alzheimer's disease. These agents have been reported to exert 
their beneficial effect on intellectual functioning by blocking AChE and 
enhancing cholinergic function. 
5.2.3 Reactivation of the inactivated AChE 
The reaction between organophophorus compounds (OPs) and AChE yields 
very stable complexes in place of the acetylated enzyme. The phosphorylated 
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enzyme breaks down only very slowly so that the enzyme is inactivated for a 
long period of time. The inhibition of AChE by OPs is normally considered to 
be irreversible in enzymological terms , as it involves a covalent link but that 
some reagents have been found that actually release the OP compounds. 
The most efficient reactivators are those with an ionisable oxime group 
(=NOH). 2-PAM (pyridine 2-aldoxime) and TMB-4 (1 , 1'-trimethylene-bis(4-
formylpyridinium bromide)-dioxime have been found to be the most effective 
for organophosphorus poisioning [195]. 2-PAM and TMB-4 have also been 
used in flow injection methods [196] as excellent reactivators for immobilised 
AChE inhibited by a variety of organophosphorus compounds. 
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5.2.4 Metrifonate 
Metrifonate (2 , 2, 2-trichloro-1-hydroxyethylphosphate) is a potent 
cholinesterase inhibitor and is widely used as an insecticide and for the 
treatment of scistosomiasis [197]. Becker et al. [198] have reported the use of 
metrifonate as one of the safer and effective drugs for the treatment of 
Alzheimer's disease. Dose levels as high as 10 mg/kg body weight given 
consecutively over 6 days do not show any toxic effects. However a few side 
effects have been quoted, like mild vertigo, lassitude, nausea, and colic [198] . 
Metrifonate is very stable in acidic media and in organic solvents but is highly 
unstable in alkaline media, in which it undergoes rearrangement into 0 , 0-
dichlorodimethylvinyl phosphate (dichlorovos or DOVP). Inhibition of AChE by 
metrifonate in vivo and in vitro is due to OOVP and not to metrifonate itself 
[199]. Conversion of metrifonate into dichlorovos and its inhibition reaction are 
shown in Figure 5.3. The mechanism involves an attack on phosphorus by the 
OH group of the enzyme present at the esteric site in the active centre of the 
enzyme. In the course of the attack the leaving group of ODVP is replaced by 
the enzyme. The phosphorylated enzyme undergoes hydrolysis to a 
hydrolysed phosphate group and an active enzyme. Hydrolysis of the 
phosphorylated enzyme is very slow compared to the hydrolysis of the 
acetylated enzyme. If the enzyme is incubated for a long time with DOVP it 
undergoes aging. 
The widespread use of metrifonate clinically and in agriculture calls for the 
need of sensitive methods for its determination. Metrifonate determination 
relies almost completely on gas chromatographic methods with different 
detection systems: flame ionisation, flame photometry and mass spectrometry 
[200-201]. Gas chromatography-mass spectrometry is preceded by liquid-
liquid extraction followed by evaporation to dryness in order to isolate 
metrifonate and DOVP. The latter is a liquid at room temperature so any 
evaporation procedure may result in loss of ODVP. Uni et al. [202] proposed a 
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liquid chromatographic method for the quantitation of metrifonate in blood 
samples, which they claim is very simple and economical as compared to gas 
chromatographic methods. However, the stability of metrifonate during 
sample preparation was a major problem. 
The toxicity or activity of a drug is often the result of enzyme inhibition in vivo, 
thus the test involving enzyme inhibition could be more reliable than the 
chromatographic methods given above. Enzymatic methods for drug 
determination may prove themselves to be more effective clinically because 
sample preparation for such methods is often simple and analysis time is 
short. 
Figure 5.3 
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Conversion of metrlfonate into dichlorovos, and its reaction mechanism with 
AChE. 
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The present work describes the fluorimetric determination of AChE 
immobilised on CPG in a flow injection configuration using naphthofluorescein 
di-acetate (NFDA) as a substrate. NFDA was prepared in our laboratory The 
synthetic procedure is described in 3.4. NFDA is hydrolysed by AChE to 
naphthofluorescein (Figure 5.4). This substrate is an alternative to the 
previously used fluorigenic substrates for AChE with numerous benefits. 
Naphthofluorescein has spectroscopic characteristics of excitation 597 nm and 
emission 660 nm which clearly fall in the long wavelength region of the 
electromagnetic spectrum. The benefits of long wavelength region have been 
recently reviewed [36]. 
o 
CO, H 
Naphthofluorescein di-acetate 
(nonfluorescent) 
AChE 
• 
o 
CO, H 
Naphthoftuoresce in 
(highly fluorescent) 
OH 
Figure 5.4 Reaction for the acetylcholinesterase catalysed hydro lysis of 
naphthoftuorescein di-acetate . 
NFDA has also been utilised for the analysis of metrifonate based on the 
inhibition of the enzymatic activity of AChE. 
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5.3 Experimental 
5.3.1 Enzyme immobilisation 
Acetylcholinesterase (12.45 mg, 1000 U) was immobilised on controlled pore 
glass (CPG, 0.56 g) by the method described by Masoom and Townshend 
[172] . The immobilised enzyme was stored in phosphate buffer (0.1 M, pH 
7.0) at 4 °C when not in use. When being used, it was packed into glass mini-
columns (170 or 350 III bed volume). 
5.3.2 Flow injection manifold and procedure 
The flow injection manifold used for the determination of the activity of AChE 
on NFDA is shown in Figure 5.5. The NFDA solution (25 Ill) was injected into 
a carrier stream of 0.05 M phosphate buffer (pH 9.0). The substrate solution 
was captured in an enzyme column and allowed to react with the immobilised 
enzyme for a certain period of time. The hydrolysis product of NFDA reacted 
with AChE was monitored fluorimetrically at 660 nm using a Hitachi F4500. 
Carrier 
buffer 
Figure 5.5 
Peristaltic 
pump 
Injection valve 
-
+ I·········································· AChE 
:!! ... »:+ .... +!+:~ ".:.' 
i .......... ............................. - Thennostated 
Incubation water bath 
loop 
Detector 
Data handling 
Flow injection manifold for naphthofluorescein detennination. 
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5.4 Results and discussion 
5.4.1 Influence of pH and ionic strength 
The influence of pH on the activity of immobilised AChE was examined by 
using sodium phosphate and sodium carbonate buffers over the range 7.0-9.2 
and 8.5-10.5 respectively. The results are given in Figure 5.6. The sensitivity 
of AChE for the substrate increases as the pH increases and remains almost 
constant from 8.5-9.0 in each buffer; however in phosphate buffer the 
response was higher. Therefore phosphate buffer was selected for further 
studies. It should be noted that as NF is a pH dependent compound, these 
effects are due to the influence of pH on both the fluorophore and enzyme. 
The effect of ionic strength was studied using different concentrations of 
phosphate buffer (0.01-0.07 M). It was found that the fluorescence intensity 
decreases with higher concentration of the buffer solution (Table 5.1). A 0.05 
M phosphate buffer concentration was chosen as a compromise between 
sensitivity and maximum buffering capacity. 
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Figure 5.6 Effect of pH on the activity of AChE. 
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Table 5.1 
Effect of concentration of phosphate buffer on the response of AChE. 
[Phosphate buffer] ! M 0.010 0.025 0.050 0.075 0.100 
Relative Intensity (a.u) 190.2 189.7 188.7 181 .1 164.3 
5.4.2 Influence of temperature on the activity of AChE 
The influence of temperature on the activity of AChE was studied over the 
range 25-50 °C by connecting the immobi lised enzyme column to a 
thermostated water bath. The results are shown in Figure 5.7, which indicate 
that an increase in temperature has no effect on the enzyme activity up to 35 
QC. There was however, a small increase in the enzyme activity around 40 °C. 
Above 40 °C an irreversible fall in the acti vity due to the denaturation of the 
immobilised enzyme was observed. As a result, subsequent investigations 
were carried out at 37 °C in order to ensure a long lifetime for the enzyme 
column. 
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Figure 5.7 Influence of temperature on the enzymatic reaction . 
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5.4.3 Influence of incubation time 
In many flow injection methods the stopped-flow technique is used in order to 
increase the yield of the reaction product i.e. to increase the system's 
sensitivity. This technique was also exploited in this work to give better 
sensitivity. Incubation times of 0.5-3.0 minute were examined by stopping the 
flow as the substrate (25 III of 17.0 ~lM solution) reached the enzyme column. 
As shown in Figure 5.8, an incubation time of 2.0 minute gave the maximum 
response. This response was constant with further increase in time. 2.0 
minute incubation time was therefore selected for subsequent experiments. 
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~ 
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Figure 5.8 Influence of incubation time on the hydrolysis of NFDA by AChE. 
5.4.4 Influence of the enzyme reactor volume 
T h 
, ensi 'vi y f t e enzyme for FDA was investigated by using a set of two 
columns (170 and 350 III bed volume). As can be seen in Table 5.2 the 170 
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,tI volume reactor can efficiently hydrolyse up to 20 >lM of the substrate. 
Therefore it was decided to chose 170 >11 volume reactor for further studies. 
Table 5.2 
Effect of volume of the enzyme reactor. 
Volume of AChE reactor bd) [NFDA) I (ftl) Relative intensity (a.u) 
170 5.0 59.1 
10.0 128.6 
20.0 231 .0 
350 5.0 54.7 
10.0 121 .0 
20.0 245.9 
5.4.5 Calibration graph for naphthofluorescein di-acetate 
NFDA standards (2.5 x 10.6-12.5 x 10.6 M) were treated with AChE under the 
selected conditions in a flow injection system. Each standard was injected in 
tipl icate. The calibration graph obtained for NFDA shows good linearity in the 
range investigated as shown in Figures 5.9 and 5.10. 
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Figure 5 9 Peaks for NFDA hydrolysis by AChE. 
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Figure 5.10 Calibration graph for NFDA using AChE. 
5.5 Enzyme inhibition 
The inhibition of immobilised AChE by an organophosphorus compound, 
metrifonate was investigated. It has previously been reported [183] that 
inhibition of immobilised AChE in a flow injection system could be monitored if 
the substrate and the inhibitor are present together in the enzyme column 
otherwise inhibitor will inhibit part of the enzyme and other parts of the enzyme 
column will remain active for the substrate. The same approach was adopted 
in this work. The activity of immobilised enzyme before and after the injection 
of a sample containing inhibitor was monitored by injecting 10 ~lM solution of 
NFDA in the flow system. The inhibitor and the substrate were held in the 
enzyme column for a brief period of time. The decrease in response was 
taken as a measure of the enzyme inhibition. The percent inhibition was 
calculated as follows 
% 1 = 
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where A:J and AI are the responses in the presence and absence of the 
inhibitor respectively. 
The previously optimised conditions were checked in order to investigate the 
influence of metrifonate on the activity of immobilised AChE. No significant 
change in the level of inhibition was observed by varying the conditions, 
however the inhibition decreased after 2 min of incubation. Therefore, all the 
conditions with exception of incubation time used for the inhibition of AChE 
were as previously described. 
5.5.1 Influence of incubation time of inhibitor 
The influence of incubation time was investigated over a range of 1.0-3.0 min. 
25 ~I of a sample containing 4~d/ml of metrifonate and 1 O~l/ml of NFDA were 
injected into the carrier buffer. The mixture was captured in the AChE column 
and allowed to react for a certain period of time. Table 5.3 shows that the % 
inhibition increased with an increase in incubation time, but after 2 min 
inhibition decreased because the enzyme-inhibitor complex is not stable and 
starts to hydrolyse. 2 min incubation time therefore was selected for further 
studies. 
Table 5.3 
Influence of incubation time of metrifonate on % inhibition . 
Incubation time (min) 
% inhibition 
1.0 
68.0 
5.5.2 Enzyme reactivation 
1.5 
76.0 
2.0 
84.0 
2.5 
79.0 
3.0 
710 
Along with the above optimisation to obtain a sensitive method for metrifonate 
determination, attention must also be given to the rapid recovery of the 
enzyme activity so that it can be reused. As a first step, the possibility of 
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continuously passing buffer solution through the column to displace the 
inhibitor was studied. Then the activity of the column was checked by injecting 
the substrate . It was found that metrifonate can be displaced by the buffer 
and enzyme activity regenerated, but the procedure is too slow; ca 15-18 min 
was required for 100 % reactivation. 
Different oximes have been used successfully [180] in the flow injection 
system for the reactivation of immobilised AChE inhibited by 
organophosphorus and carbamate compounds. Pyridine-2-aldoxime 
methiodide (2-PAM), at 4 x 10-5 M, a previously optimised concentration for 
pesticides, was injected through an injection valve (100 >d). This gave 100 % 
recovery of the enzyme with only one injection of oxime. The rate of 
reactivation by 2-PAM actually depends on the degree of inhibition. 93 % 
inhibited enzyme was fully reactivated in 3 min, which was checked by 
consecutive injections of the substrate (5 x 10-6 M) after treatment with 2 PAM. 
The results are given in Figure 5.11 . 
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80 
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Figure 5_11 Reactivation of immobilised AChE with 2-PAM after inhibition by metrifonate. 
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Table 5.4 
Recommended experimental conditions for the determination of metrifonate 
pH 
Buffer system 
Buffer concentration (M) 
Enzyme reactor volume ( ~.tI) 
Loop size (Ill) 
Temperature QC 
Incubation time for sustrate (min) 
Incubation time for inhibitor (min) 
Reactivation time (min) 
5.5.3 Assay procedure for metrifonate 
9.0 
Sodium phosphate 
0.05 
170 
25 
37 
2.0 
2.0 
3.0 
Based on the previous investigations a procedure involving the inhibition and 
subsequent reactivation of immobilised AChE was established for the 
determination of metrifonate. Under the optimised conditions 25 III of 10 IlM 
NFDA solution was first injected into the system in order to set the reference 
response corresponding to the fully active enzyme reactor. A mixture 
containing metrifonate and the same amount of substrate was then injected 
and the response was recorded. The enzyme reactor was then reactivated by 
injecting 100 III of 4.0 x 10-5 M 4-PAM solution for 3 min. The same protocol 
was employed for a series of standards of metrifonate. A typical set of flow 
injection peaks from this study are shown in (Figures 5.12). Peak heights 
were measured and a calibration curve was established by plotting % 
inhibition against standard [mtrifonatej as shown in Figure 5.13. The linear 
range for metrifonate was between 0.5-6.0 IlM. The limit of detection, defined 
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as the analyte concentration giving a signal , y , equal to the blank signal, ya, 
plus three standard deviations of the blank, sa, (y-ya) = 3sB [203] was 0.15 IlM. 
The method for the detection of the activity of acetylcholinesterase and its 
inhibition by metrifonate using naphthofluorescein is sensitive, rapid and 
economical. The sensitivity of the system can be further improved by the 
inclusion of a suitable amount of CHAPS (as previously described) in order to 
use diode laser as an excitation source in a simple and sensitive fluorescence 
detector. This will make the system attractive for clinical studies. 
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Figure 5.1 2 Flow injection peaks for inhibition of AChE by metrifomate. (a) shows the 
peaks for the substrate. 
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Figure 5.13 Calibration curve for the determination of metrifonate. 
5.5.3.1 Effect of interierences 
The effect of potential interferences by some compounds which are present in 
blood i.e. glucose, ascorbic acid, tryptophan and glutamine were studied. 
These compounds were mixed individually with inhibitor (metrifonate) at 
dilutions equivalent to their concentration in blood as given in Table 5.5. None 
was found to interfere in the metrifonate determination. 
Table 5.5 
Effect of different blood components on % inhibition. 
Interference none Glucose 
Concentration. (flgmr ' ) 0 65 
I Inhib ition (%) 86 85 
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Ascorbic 
acid 
14 
83 
Tryptophan Glutamine 
10 50 
85 84 
5.4 Discussion 
Spectrofluorimetric methods for assay of acetylcholinesterase (AChE) 
commonly util ise fluorescein diacetate (FOA) as a substrate. Because 
cholinesterase enzymes have pH optima in the range of pH 9.0-10.5, there is 
no need for further basification of the solution to detect the FOA product, 
fluorescein, which has a pl<.= 7.9. A problem with fluorescein-based enzyme 
substrate, however is that they are seriously deficient in their ability for work in 
biological samples such as blood plasma. The emission wavelength ({Aem 525 
nm) of fluorescein corresponds closely to that of protein-bound bil irubin (Aem 
520 nm). 
Other substrates which have been used for spectrofluorimetric analysis of 
AChE include indoxy acetate, 2-naphthyl acetate, and acetylthiocholine with 
coumarinylphenylmaleimide. The excitation maximum for these are below 600 
nm where most biological molecules absorb which lead to errors in 
measurements. 
Naphthofluorescein diacetate (NFOA) in this work was evaluated as a new 
substrate for determination of the activity of AChE in a flow injection system. 
AChE was immobilised on controlled pore glass. The enzyme-generated 
product, naphthofluorescein (NF), gave adequate signals and appeared to be 
more promising than the previously reported compounds for fluorimetric 
detection, particularly the longer wavelengths necessary to avoid 
interferences. 
The pH range of NF detection coincided with the optimum for AChE. Under 
the conditions utilised the optimum pH for enzymatic assay was found to be 
9.0. Temperature had no significant affect on the activity of immobilised 
enzyme. However, at temperatures higher than 40 °C the enzyme activity 
gradually decreased. A decrease in the activity is probably due to the thermal 
denaturation of the enzyme. The incubation time exhibited a significant effect 
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on the product formation . Which increased linearly from 0.5-2.0 minutes and 
remained constant on further increase. A possible reason for this finding is 
that NFDA hydrolysis occurs via naphthofluorescein mono acetate, therefore 
longer period of time is required to completely hydrolyse all NFDA to NF. 
The inhibition of AChE is of great interest to the clinical point of view. A large 
number of carbamate and organophosphorus (OP) compounds have been 
used as clinical agents. These agents have been reported to exert their 
beneficial effects on intellectual functioning by blocking AChE and enhancing 
cholinergic funtion. Among them metrifonate (MF) is known to be a most 
important compound. MF is an OP compound and has been used in the 
treatment of schistosomiasis [194]. It has been shown that this drug yields the 
direct-acting cholinesterase (ChE) inhibitor dichlorovos (DDVP) in vitro [198]. 
Long acting ChE inhibitors have potential use as therapeutic agents for 
Alzheimer disease (AD) . Secker et al. [195] have reported that MF may have 
advantages over other currently available ChE inhibitors for the treatment of 
AD. 
The quantitation of MF has been achieved from human plasma only by gas 
chromatography-mass spectrometry (GC-MS) using deuterium-Iabeled MF 
and DDVP [194]. The authors used liquid-liquid extraction followed by 
evaporation to dryness, to isolate MF and DDVP. DDVP is a liquid at room 
temperature and therefore any isolation procedure which involves evaporation 
may result in lose of DDVP. Moreover, GC-MS method that require 
deuterium-Iabeled compounds will not be economical for routine monitoring of 
patient plasma. Unni et al. [199] reported a liquid chromatography method for 
the quantitation of MF in blood samples, which they claim is a simple and 
economical as compared to GC-MS methods. However, the stability of MF 
during sample preparation was a major problem. 
MF, in this work was determined by its inhibitory effect on immobilised AChE 
in a flow injection system. The previously optimised conditions were used for 
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this investigation. The effect of pH was also found useful for the inhibition 
studies. There was considerably less inhibition by metrifonate after dissolution 
in the acidic buffer i.e. under conditions of little conversion to DDVP, compared 
to the results for the alkaline buffer (Table 5.6) . This confirms that metrifonate 
itself is not a good inhibitor of AChE and alkaline medium is required for its 
efficient conversion into DDVP which is a potent inhibitor of the enzyme. 
Table 5.6 
Effect of pH on the % inhibition of AchE by metrifonate. Substrate concentration was 10 f,M 
and inhibitor concetration was 5 f!M (50 f!1) with 1 min incubation time. 
pH 7 .0 7.5 8.0 8.5 9.0 
Inhibition(%) 31 .5 37 46.2 62 78 .5 
In order to reuse the inhibited enzyme reactor, it is necessary to reactivate the 
enzyme preferably without removing it from the flow system. Pyridine-2-
aldoxime methiodide (2-PAM), which binds preferentially with the inhibitor, 
gave complete restoration of the activity of inhibited enzyme in a short period 
of time (figure.S.11). A concentration as high as 4.0 x 10-5 M 2-PAM was 
used. 
In summary, a method for detection of AChE (immobilised) activity has been 
described which employs NFDA as a substrate. It couples the sensitivity of 
fluorescence with convenience and precision of flow injection analysis. The 
method also demonstrates the detection of metrifonate based on its inhibitory 
effect on AChE inhibtiion and continuous reuse of the immobilised enzyme 
without loss in the enzyme activity. The method is rapid (allowing 15 
measurements to be made per hour) and economic. The lack of interference 
by compounds normally found in blood may make the system applicable to 
other inhibitors of AchE. 
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Chapter 6 
Evaluation of naphthofluorescein p-D-galactopyranoside as a 
substrate for p-galactosidase. 
118 
6.1 Introduction 
~-galactosidases (EC. 3.2.1.23) are found in microorganisms, animals and 
plants. These enzymes are responsible for degradation of galactosyl ~­
linkages in glycolipids, glycoproteins, polysaccharides, and disaccharides such 
as lactose. Several glycosidases have been purified and their specificities 
determined [204-208). The enzyme from Escherichia coli (E. coli) is an ideal 
model enzyme for the study of glycosidases which act on disaccharides [209]. 
E. coli ~-galactosidase (~-Gal) is a retaining glycosidase enzyme with 
tetrameric struture and one active site per mono mer, and its x-ray structure 
has been recently determined [210). The mechanism of action of ~-Gal has 
not been firmly established, but it is generally accepted that it involves a 
double displacement reaction in which the enzyme forms and hydrolyses a 
glycosyl enzyme intermediate via an oxocarbonium ion like transition state 
[209). 
Wallenfels and Weil have comprehensively reviewed the literature on the 
enzymology of ~-Gal [211], including the effect of pH , temperature, metal ion 
and inhibitors. They concluded that properties of the enzyme vary depending 
on the substrate and buffer system. 
~-Gal is the most extensively studied example of induced enzyme formation 
and has been employed for investigating the mechanism of protein synthesis 
and genetic control. 
~-Gal is often used as a reporter enzyme in enzyme immunoassays. The 
turnover is similar to that of alkaline phosphatase. Several assays have been 
developed using ~-Gal . The important advantage of the enzyme stems from 
the variety of substrates that are available for its assays. Some of them are 
outlined in Table 6.1. 
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In the present investigation efforts to describe simple, reliable and sensitive 
assays for ~-Gal , using naphthofluorescein ~-D-galactopyranoside ( NF ~G) as 
a substrate, have been made. NF~G does not fluoresce under the conditions 
of the assay unless it reacts with the enzyme ~-Gal , whereupon the 
galactoside moity is removed by hydrolysis to yield the red fluorescent 
naphthofluorescein. The enzyme catalysed reaction is given in Figure 6.1. 
Table 6.1 
Assay methods and substrates for determination of the activity of p-galactosidase. 
Assay method 
Spectrophotometry 
Spectrofluorim etry 
Luminometry 
Colorimetry 
HO~ '<:::: OH 0 ~ 
OH 
"" 
~ 
"" 
Substrate 
o-nitrophenyl-p-galactopyranoside 
4-methyl um bell iferyl-p-D-ga I actopyranosid e 
6,8-difluoro-4-methylumbelliferyl-p-D-
galactopyranoside 
Resorufin-p-D-galactopyranoside 
Fluorescein-di-p-D-galactopyranoside 
1,2-dioxetanes 
5-bromo-4-chloro-3-indolyl-P-D-
galactopyranoside 
~~" 
OH 
COOH p-galactosidase 
References 
[212-213] 
[214-215] 
[30] 
[28] 
[216-218] 
[219-221 ] 
[222] 
COOH 
Naphthofluorescein 
p-D-galactopyranoside 
(non-fluorescent) 
Naphthofluorescein 
(highly fluorescent) 
Figure 6.1 Reaction for the p-Gal catalysed catalysed hydrolysis of NFpG. 
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The absorbance maximum of naphthofluorescein is 597 nm (Figure 6.2), 
which can be shifted to the longer wavelengths by the inclusion of an 
appropriate amount of CHAPS (as previously discussed) in order to use a 
diode laser as excitation source in a simple and sensitive fluorescence 
detector. 
6.2 Experimental 
6.2.1 Spectral properties of NFI3G 
The absorption properties of a 5 mM solution of NFpG in phosphate buffer pH 
8.0 in the absence (a) and presence (b) of 0.25 units of p-Gal were examined 
over the wavelength range 350-650 nm. The reagents were incubated for 10 
minutes at 40 °C. The maximum absorbance of the reaction product of NFpG 
and p-Gal , was found to occur at a wavelength of 597 nm (Figure 6.2), and 
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Figure 6.2 
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Absorption spectra of 5 mM solution of NFBG in phosphate buffer pH 8.0 in 
the absence (a) and in the presence (b) of 0.1 units of BGal. 
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this was used as the initial excitation wavelength to determine the 
fluorescence characteristics . 
The fluorescence properties of NFI3G revealed an intensity increase after 
enzymatic digestion, simi lar to the absorbance properties as described earlier. 
The fluorescence spectra of NFI3G before (a) and after treatment with I3-Gal 
(b) is shown in Figure 6.3. The fluorescence contribution at 597 nm of 
unhydrolysed NFI3G appears almost negligible under the assay conditions. 
The fluorescence measurements were performed in 10 mM phosphate buffer 
pH 8.0 at 40 °C. The enzyme and the substrate concentrations were 0.5 units 
mr1 and 0.6 >lM respectively. 
Figure 6.3 
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Emission spectra of 0.5 mM NFIlG before (a) and after hydrolysis (b) by 0.6 
units of Il-Gal at 40 QC. 
122 
6.2.2 Immobilisation of l3-galactosidase 
I3-Gal was immobilised on controlled pore glass by cross-linking with 
glutaraldehyde. The immobilisation procedure is given in 4.2.2. 250 units of 
I3-Gal were used for the immobilisation process. The immobilised enzyme was 
packed in an enzyme column and incorporated into the flow injection system 
(Figure 6.4) . 
6.2.3 Influence of reaction variables 
Various experimental aspects were optimised for the determination of the 
activity of I3-Gal on NFI3G. The optimisation of variables was carried out by 
injecting an appropriate amount of NFI3G into the I3-Gal column through the 
carrier buffer. The NFI3G sample was captured in an incubation loop 
connected to the I3-Gal reactor and allowed to circulate at a constant rate of for 
a certain period of time in order to achieve an easily measurable response. 
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buffer 
pH 8.0 
Figure 6.4 
Peristaltic 
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Flow injection manifold for naphthofluorescein determination. 
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6.2.4 Influence of pH 
pH is known to be a critical parameter with respect to enzyme activity and 
sometimes enzyme stability. In order to investigate the effect of pH on 
immobilised ~-Gal activity towards NF~G , 50 mM Tris-HCI , phosphate and 
carbonate buffers, at varying pH values, were studied. Figure 6.5 shows the 
pH profile for the ~-Gal reactor. Phosphate buffer pH 8.0 gave the highest 
change in intensity values. It was therefore adopted as the carrier buffer in 
subsequent experiments. 
300 
--+- Tris-HCI 
S' 250 --- Phosphate 
.!!!. -4- Carbonate 
Z- 200 ·in 
c 
'" E 150 
'" u c 
'" u 100 ~ 
0 
" 50 u::: 
0 
6.5 7 7.5 8 8.5 9 9.5 
pH 
Figure 6.5 Influence of pH on the activity of p-Gal. 
6.2_5 Influence of concentration of buffer 
The effect of concentration of phosphate buffer on the extent of product 
formation was also investigated. The concentration range of 5 mM-gO mM 
was studied and as shown in Figure 6.6, buffer concentration had a marked 
effect on the activity of ~-Gal on NF~G . The greatest increase in intensity was 
observed with 10 mM phosphate buffer pH 8. O. Higher concentrations of the 
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buffer resulted in a decrease in fluorescent signal. 
concentration was selected for further studies. 
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Figure 6.6 Effect of concentration of phosphate buffer on the response of p-Gal. 
6.2.6 Influence of magnesium ions 
~-Gal from E. coli requires Mg2+ ions for full catalytic activity and binds one 
Mg2+ ion per monomer [223]. The role of Mg2+ ions may be structural [224] 
although a direct catalytic role has also been suggested [225]. In order to 
examine the effect of Mg2+ ions on immobilised ~-Gal hydrolysis of NF~G , 
various concentrations of MgCI2 were tested (Figure 6.7). The results show 
that the intensity increased by increasing the concentration of MgCI2 up to 0.1 
mM, above which it remained virtually constant. This concentration of MgCh 
gave 38% enhancement of the maximum response, therefore the subsequent 
assays were performed in the presence of 0.1 mM MgCI2. 
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Figure 6.7 Effect of magnesium ion concentration on p-Gal hydrolysis of NFpG. 
6.2.7 Influence of temperature 
Temperature is one of the key factors for most enzymatic reactions. The 
effect of temperature on the activity of j3-Gal was examined over a range of 
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Figure 6.8 Effect of temperature on the rate of fomnation of the fluorescent product . 
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20-45 °C using a thermostated water bath . The results are shown in Figure 
6.8. It can be seen that the highest response was obtained at 40 °C. For 
temperatures higher than 40 QC, the analytical sensitivity decreased. 
Therefore, 40 °C was chosen as the operational temperature for all the 
subsequent experiments. 
6.2.8 Influence of flow rate and incubation time 
The effect of flow rate on the analytical response was studied over a range of 
0.5-2 .5 ml min-1 (Figure 6.9). The intensity gradually declined with increasing 
flow rate. In view of the response a flow rate of 1 ml min-1 was subsequently 
selected. 
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Figure 6.9 Influence of flow rate on the activity of p-galactosidase. 
The dependence of incubation time on the enzymatic reaction was also 
evaluated. The incubation time was examined between 2-12 minutes. As can 
be seen from figure 6.10, an incubation time of 10 minutes gave the maximum 
response. This response was constant with further increases in time. Thus 10 
minutes incubation time was selected for subsequent assays. 
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Figure 6.10 The dependence of incubation time on the response of p-Gal and NFpG 
reaction. 
6.2.9 Calibration curve for naphthofluorescein j3-D-galactopyranoside 
To evaluate the quantitative range, various concentrations of NFj3G were 
injected into the flow injection system (Figure 6.4), under the optimal 
conditions. The response obtained is shown in Figure 6.11 . The fluorescence 
intensity of the enzymatic reaction increased with increasing the concentration 
of NFj3G indicating that the enzymatic system appeared to be working. 
A typical calibration curve for NFj3G is shown in Figure 6.12. A linear 
relationship was obtained between fluorescence intensity and NFj3G 
concentration in the range of 1 x 10-6 -10 x 10.6 M. The coefficient of 
determination was 0.9892 with this range. The limit of detection was 
investigated and it was found that the system can detect down to 5 x 10.7 M of 
NF j3 G 
128 
250 • 
[NFPG] flM 
1110 a. 02 x 10,6 S b. 04 x 10,6 
~ c. 06 x 10'6 
Z:- d. 08 x 10'6 'Vi 
c 150 e, 10 x 10" Q) 
C 
Q) 
" c Q) 100 
" <Il 
Q) 
~ 
0 
:J 
u:: 
50 
40 60 00 100 
Time (seconds) 
Figure 6,11 Typical FIA peaks for NFpG hydrolysis by p-Gal. 
250 • 
~ 200 • c: 
Q> 
S 
• Q> 150 
" c: Q> 
" V> Q> 
0 100 
:J 
'"-
50 
R' = 0.9892 
0 
0 2 4 6 8 10 
(NaphthotluOfescein Beta-D-galactopyranoside) uM 
Figure 6,12 Calibration graph for naphlhofiuorescein p-D-ga laclopyranoside. 
129 
6.3 Inhibition of p-galactosidase 
The inhibition of p-Gal by numerous compounds was detailed in 1973 [211]. 
D'Haese et al (1997) reported a method to assay p-Gal inhibition by 
tetracycline residues in milk [226]. Srivastava et al. have recently published a 
paper on E. coli p-Gal in high throughput screening of antituberculosis drugs 
[227], describing the inhibitory effect of streptomycin, ethambutol , isoniazid, 
rifampicin, ofloxacin and sparfloxacin. 
In the present work attempts were made to evaluate the inhibitory effect of 
phenylethyl thiogalactoside (PETG), and p-hydroxymercuribenzoic acid 
(PHMB) on immobilised p-Gal in a flow system (Figure 6.4). The previously 
optimised conditions were checked. In addition to that the volume of inhibitors 
was also examined. An increase in the volume of PETG increased the rate of 
inhibition of p-Gal (Table 6.2). No significant change in the level of inhibition 
was observed by varying the other conditions. Therefore, all the conditions 
used for the inhibition of the enzyme were as previously described, with the 
exception volume of PETG. The mixtures (inhibitor and substrate) were 
captured in an incubation loop connected to the p-Gal reactor and allowed to 
react for 10 minutes and the response was measured. The results are shown 
in Figure 6.13. 
Table 6.2 
Effect of the volume of PETG on % inhib~ion of p·Gal. 50 fiM solution of PETG was used 
Volume of PETG (fill 25 50 75 100 125 
% inhibition 59 67 75 79.5 79.8 
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Figure 6.13 Inhibition of B-galactosidase by PHMB and PETG determined with 
naphthofluorescein di-p-galactopyranoside (1 0 ~M) . aT 40 QC. 10-' represents 
10.3 M PHMB and 10" M PETG respectively. 
6.4 Discussion 
Resorufin ~-D-galactopyranoside ( R~G) , Methylumbelliferyl ~-D-
galactopyranoside (M~G) and Fluorescein ~-D-galactopyranoside (F~G ) have 
been most widely used fluorigenic substrates for ~-galactosidase ( ~-Ga l ) 
detection [28, 30, 33, 218). Such compounds offer significant advantages over 
radioisotope-based assays, including ease of use and safety in handling. In 
addition, the sensitivity of fluorigenic enzyme substrates is often superior to 
that of chromogenic substrates [150, 218). 
Due to the advantages of long wavelength fluorescence, naphthofluorescein 13-
D-galactopyranoside (N F~G) was used as a long wavelength substrate for 13-
Gal. The measurements were carried out in a flow injection system using 
immobilised enzyme. 
investigation. 
Various parameters were optimised for th is 
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The environmental pH is well known to affect the substrate specificity of 
enzymes. In fact a strong effect of pH on the response of ~Gal for NF~G was 
observed. The optimum pH was found to be 8.0. This indicates that NF~G is 
a suitable substrate for ~-Gal assays since NF, as an enzymatic product 
absorbs and fluoresces at alkaline pH. 
Magnesium is a common additive in ~-Gal activity assays [212] . As shown in 
Figure 6.7, the intensity increased by increasing the Mg+2 ion concentration . 
The concentration of 0.1 mM gave ca 38% enhancement of the maximum 
response, which indicates that Mg+2 ions can activate ~-Gal. 
The temperature had a significant effect on the activity of ~-Gal. The response 
of the bioreactor increased gradually with temperature and reached a 
maximum value at 40 °C. However, further increase of temperature resulted 
in a decrease of the response, which is attributed to the existence of different 
temperature dependent conformations for the immobilised enzyme and partial 
denaturation of the enzyme. 
The incubation time is an important parameter to be optimised in enzymatic 
reactions in order to obtain the complete digestion of the substrate. The 
maximum fluorescence response was achieved at an incubation period of 10 
minutes. The calibration for NF~G was linear up to 12 ~M . The detection limit 
was 5 x 10-7 M. 
The relative effect of phenylethyl thiogalactoside (PETG) and p-
hydroxymercuribenzoic acid (PHMB) was evaluated by their inhibitory effects 
on ~-Gal. Measurements were carried out by varying the inhibitor 
concentration with constant substrate concentration . As can be seen in Figure 
6.13, 80% inhibition was obtained with 50 ~M PETG. Since PHMB 
deactivates the enzyme by reacting at -SH groups, only slight inhibition over 
the range investigated was observed due to the slower rate of inhibition. 
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Finally, p-Gal -catalysed hydrolysis of NFpG was used as a model system for 
enzyme an enzyme inhibition determination. This approach to enzyme assays 
allows automated studies to be completed with significant time saving and 
reduction of reagent (enzyme and substrate) consumption. 
NFpG in the present study appeared to be an efficient long wavelength 
substrate for p-Gal. One possible application for NFpG could be the 
continuous monitoring of lysosomal p-Gal. Lysosomes contain p-Gal as well 
as a number of other enzymes [228]. The study of these enzymes is 
particularly important because several genetic diseases have been found to be 
based on lysosomal enzyme deficiencies, including diseases caused by 
deficiencies of p-Gal [228]. At present 4-methylumbelliferone-based (4-MU) 
substrates are used for detecting lysosomal p-Gal enzyme activities. NFpG 
could be used as an alternative to the 4-MU-based substrates. 
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Chapter 7 
Properties and applications of new long-wavelength 
fluorigenic substrates for proteolytic enzymes 
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7.1 Introduction 
7.1.1 Proteases 
Proteases are enzymes that catalyse the hydrolysis of amide bonds of 
proteins and peptides. They are present in many types of viruses, and in all 
prokaryotic and eukaryotic organisms. Proteolytic enzymes that originally 
served purely digestive functions have adapted to the more specific and 
complex task of physiological regulations [229-231] . These range from 
processing and molecular assembly of nascent polypeptide chains, the 
release of protein hormones from precursor molecules, the transport of 
secretory proteins across membranes. the assembly of macromolecular 
structures such as collagen fibres or certain viruses, fertilisation, and the 
control of proteolytic digestion itself. Investigations of the specificity and 
inhibition, together with detailed analysis of amino acid sequence, three 
dimensional structure and enzymatic reaction mechanisms of proteases 
indicate that there are distinct families of these proteins (Scheme 1). 
Ever since the discovery of pepsin in the late eighteenth century there has 
been continuing investigation into the chemistry and activities of the proteolytic 
enzymes. But recent years have seen a remarkable acceleration of the pace 
of this research , fuelled by numerous applications in biotechnology, and the 
realisation that the proteases are major therapeutic targets. A stri king 
example of the link between the drug design is HIV-1 retropepsin. 
Detection of protease activity is important for biochemical applications such as 
quantifying protease activity in cell or tissue extracts, during enzyme 
purification, in protease inhibition studies particularly in high throughput 
screening , and for quality control testing . Some protease assays may require 
detection of specific protease activity; for example certain pathogens use 
proteolytic activity as a virulence mechanism and differ from their non-
pathogenic counterparts in this characteristic [232-233]. Conversely, assays 
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for contamination of biological preparations by unknown proteases require a 
substrate that can detect a variety of enzymes. 
Proteases 
I 
Endopeptidases 
Family Representative protease 
Serine proteases I Chymotrypsin , Trypsin , 
Elastase, Streptomyces grise us, 
proteinase 
Serine proteases 11 Subtilisin 
Cysteine protease Papain, Actinidine , Cathepsin 
Band H 
Asparic proteases Pepsin, Penici llopepsin, 
Aspergillopeptidase, Renin , 
Trypsinogen kinase 
Metalloproteases I Carboxypeptidases A and B 
Metalloproteases 11 Thermolysin 
L Exopeptidase 
I 
Aminopeptidases 
Carboxypeptidase 
Dipeptidases 
Omegapaptidases 
Characteristic 
active site residue 
ASp'02 , Ser'95, His57 
ASp32, Se~21, HisS. 
Cys25, His159, ASp'58 
ASp" , ASp2'3 
Zn, Glu27o, Ty~48 
Zn, Glu '43, His23' 
Scheme 1 The scheme of nomenclature of proteolytic enzymes 
Protease assays using fluorescently labeled substrates have been in use for 
many years. These assays have frequently employed proteins such as 
haemoglobin [234]. and fluorescent dye-Iabeled proteins such as fluorescein 
thiocarbamoyl casein (FTC-casein) [235]. These methods include 
precipitation assays where the undigested substrate is insoluble, such as fibrin 
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[236] or is made insoluble by treatment with trichloroacetic acid or hydrochloric 
acid [234-236]. However, all of these assays require sampling at time 
intervals, careful control of sample volume, and quantitative separation of 
labeled peptides from the unhydrolysed protein to obtain useful results. 
A few homogeneous fluorimetric assays have been performed that are 
suitable for the enzymatic analysis. One of these use 8-anilinonaphthalene-1-
sulphonic acid (ANS) as a label [237]. ANS, which is only weakly fluorescent 
in an aqueous environment, becomes fluorescent upon interaction with the 
hydrophobic portion of protein . Proteolysis results in loss of ANS binding 
sites, with a decrease in sample fluorescence. However, some enzymes may 
not act on regions of the protein to which ANS is bound, and a small decrease 
in the dye's fluorescence is difficult to measure over a large background. 
Protease substrates that have been designed to assay specific proteases 
have utilised fluorophore-Iabeled synthetic peptides, wherein fluorescence of 
the fluorophore is quenched by a spectrally overlapping chromophore. These 
double-Iabeled peptides have been used to assay specific proteases [25-29]. 
Fluorescence polarisation techniques have also been employed in the 
detection of specific proteases [238-240]. 
A new type of fluorogenic substrate for proteases, based on the leaving group 
cresyl violet, has recently been synthesised [147]. Cresyl violet is not 
fluorescent when amino acids or peptides are attached, but becomes highly 
fluorescent after proteolytic liberation. The study showed that cresyl violet-
based substrates have great potential to visualise and quantify protease 
activity in living cells and tissues. 
Homogeneous assays have also been reported that use proteins labeled with 
such a number of dye molecules that their fluorescence is heavily quenched 
[241 -244]. The release of fragments by proteolytic enzyme generates an 
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increase in fluorescence that is proportional to the enzymatic activity in the 
assay (Figure 7.1). 
Intramolecularly 
Quenched substrate 
Fluorescent 
cleavage products 
Figure 7.1 Principle of the analysis of proteases using an intramolecularly quenched 
substrate. 
7.1.1.1 Serine proteases 
Serine proteases are enzymes characterised by the prescence of a common 
catalytic triad composed of aspartic acid, serine, and histinine (Scheme 1). 
Serine acts in this case as a very reactive residue which forms a covalent 
bond with the substrate. The catalytic mechanism of these proteases is 
illustrated in Figure 7.2 by using a-chymotrypsin as an example. Hydrolysis of 
the substrate occurs in two successive stages: acylation and deacylation of 
the enzyme. In the first stage the carbonyl group of the peptide bond to be 
cleaved undergoes nucleophilic attack by serine residue 195 of a-
chymotrypsin , which results in the formation of a covalent, acyl-enzyme 
intermediate. In the second stage, a water molecule enables the covalent 
acyl-enzyme intermediate to split, which releases the carboxyl end of the 
peptide. These two stages of addition then elimination are facilitated by the 
proximity, at the enzyme's active site, of two other amino acids which thus 
actively participate in the catalysis: histidine 57 and aspartate 102. 
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Enzyme 
Figure 7.2 Catalyti c mechanism of serine proteinase. 
o~ R' Ser 195 -CH2-O- C' I 0 
Asp 10~ c" 
\ N 
0,', ~ 1 H-N-1 
CH 2 , 
His 57 
Serine proteases play critical roles in numerous physiological processes 
including digestion of food proteins, activation of the complement system, 
blood coagulation, fibrinolysis , and protease hormone activation [229]. They 
are also involved in the regulation of blood pressure and reproduction both 
during ovulation and fusion of gametes. 
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7.1 .1.2 The pathological role of serine proteases and their inhibition 
Serine proteases are not only a physiological necessity, but also a potential 
hazard. If uncontrolled, they can destroy the protein components of cells and 
tissues. The importance of this hazard is indicated by the fact that 10% of the 
proteins in plasma are protease inhibitors. The major plasma inhibitors 
including a.1 -proteinase inhibitor, antithrombin Ill , C1 - inhibitor, and 0.2-
antiplasmin are specific for serine proteases [245]. Uncontrolled proteolysis 
by serine proteases can result in diseases such as pulmonary emphysema 
[246--247], adult respiratory distress syndrome [248], and pancreatitis. Serine 
proteases may also be involved in tumour invasion [249-251], allergic 
reactions [252], and certain inflammatory processes [253]. Table 7.1 lists 
some of the important physiological roles and associated disease states which 
involve serine proteases. 
The activity of serine proteases produced by viruses explains certain tissue or 
ce ll lesions which are attributed to these pathogenic agents. The cytopathic 
effects of HIV infection (human immunodeficiency virus) includes the formation 
of syncytia, cell death and inhibition of cell proliferation. Piedmonte et al [254] 
demonstrated that there was more proteolysis in HIV-infected CD4+ 
Iymphocytes than in healthy Iymphocytes. They also indicated that there was 
a potent inhibition of protein synthesis in the infected cells, which was probably 
caused by a serine protease in the CD4+ Iymphocytes activated by HIV. This 
inhibition, which was eliminated by aprotinin (a serine protease inhibitor), may 
be caused by the direct inactivation of translation factors or by the activation of 
translation inhibitors. The understanding of the importance of proteases in the 
course of HIV infection has prompted a therapeutic strategy directed at 
inhibiting these enzymes with compounds such as Ro 31-8959 [255] and XM 
323 [256] inhibitors. 
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Table 7.1 
Serine protease that might form therapeutically useful targets for inhibitors. 
Normal function 
Blood coagu lation 
Complement activation 
Digestion 
Fibrinolysis 
Hormone generation or 
degradation 
Ovulation and ferti lisation 
Phagocytosis 
Protein tumover 
(intracellular) 
Representative enzyme 
Factor IXa 
Factor Xa 
Factor Xla 
Factor Xlla 
Factor Vlla 
Thrombin 
Activated protein C 
Plasma kallikrein 
Factor crr 
Factor Cl's 
Factor D 
Factor B 
C3 convertase 
Trypsin 
Chymotrypsin 
Elastase (pancreatic) 
Enterokinase 
Plasmin 
Plasminogen activator 
Disease state or 
therapeutic use 
Vascular clotting 
Inflammation, 
rheumatoid arthritis 
Pancreatitis 
Tumour invasion 
Tissue kallikrein Inflamation 
Post proline cleaving enzyme 
Plasmin Fertility control 
Plasminogen activator 
Acrosin 
Elastase (granulocyte) 
Cathepsin G 
Chymase (mast cell) 
Tryptase (mast cell) 
ATP- dependent protease 
Inflammation, 
emphysema, 
adult respiratory distress 
syndrome, 
rheumatoid arthritis 
Muscle degradation, fever 
Proteases as a virulence factor have stimulated the search for potent disease 
curing drugs that can inhibit the activity of proteases, an example of which is 
the HIV protease inhibitor [233). During screening for promising drug 
candidates thousands of compounds need to be assayed in order to identify a 
14 1 
few biologically active lead compounds [257]. Obviously the availability of a 
simple, sensitive, and efficient method for assaying protease activity would 
facilitate the testing of a large number of samples using high-throughput 
screening (HTS). 
In the present study attempts have been made to describe the preparation and 
use of new bovine serum albumin-(BSA), ovalbumin-, and a-casein-dye 
conjugates that provide spectrally distinct substrates for continuous 
fluorescence measurements of protease activity of a variety of enzymes. The 
conjugates were prepared from naphthofluorescein succinimidyl ester (Figure 
7.3), a long wavelength dye, and were used for the assay of numerous serine 
proteases including alkaline protease, proteinase-K and a-chymotrypsin and 
their inhibitors. 
0 ~ ~ OH 
~ 0 ~ 
~ ~ ~ 
~ C- OH 11 
c:
O 0 
N-0- 11/<-' 
""0 0 
Figure 7.3 Structure of 5-(and-6)-carboxynaphthofiuorescein succinimidylester (cNFSE) 
7.2 Experimental 
7.2.1 Preparation of conjugates 
Bovine serum albumin, at 2.5 mg/ml in 0.1 M carbonate-bicarbonate buffer, pH 
9.0, was reacted at room temperature with varying concentrations of 5-(and-
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6)-carboxynaphthofluoresceinsuccinimidyl ester (cNFSE) for 2 hours. The 
stock solution of 12 mg/ml cNFSE was prepared in N,N-dimethylformamide 
(DMF). The dilutions of the dye were made in 1 ml DMF in each case, in order 
to investigate the optimum ratio of the reactants, for the preparation of cNF-
protein. The total volume of the reaction mixture was made up with 0.1 M 
carbonate buffer pH 9.0 to 2.5 ml. The excess cNFSE reagent was removed 
by passing the solution over a Sephadex G 25 column in 0.1 M phosphate-
buffered saline (PBS), pH 7.2. The conjugated cNF-protein product was 
collected in a volume of 3.5 ml. cNF conjugates of ovalbumin and CL-casein 
were prepared using a similar protocol. 
7.2.2 Determination of dye-to protein ratios 
The dye/protein ratios were estimated by the measurement of protein 
absorbance at 280 nm, and the dye absorbance at the absorption maximum. 
Specifically, the dye/protein ratios were calculated using the equation below 
with measured values of the absorbances of the labeled dye (cNF-BSA at 650 
nm, cNF-Ovalbumin at 650 nm, and cNF-u-Casein at 635 nm) and the 
absorbance of the protein at 280 nm. 
[Dye] = Amax/Edye 
[Protein] = {A280 - CF x Amax }/Eprotein 
[Dye] 
D/P = 
[Protein] 
The extinction coefficients for each concentration of dye were calculated . The 
extinction coefficient of BSA, ovalbumin and CL-casein were obtained from 
Table 7.2. The correction factor (CF), was determined by dividing the Amax by 
A280 for each conjugate. 
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Table 7.2 
Molar extinction coefficients (c) of BSA, ovalbumin and a.-casein. The absorbance of 0.1 % 
so lution of protein in 0.1 M ca rbonate buffer pH 9.0 was measured at 280 nm. 
Protein 
Bovine serum albumin 
Ova lbumin 
a.-Casein 
Relative molecular mass 
(approximately) 
6.70 x 103 
4.50 x 103 
2.40 x 103 
£ 
Umol cm 
(in carbonate buffer) 
4.15 x 103 
2.70 x 103 
2.28 x 103 
Efficient labeling was defined by conjugates with high dye/protein ratios. As 
can be seen in Table 7.3, the conjugates with highest characteristic molar 
Table 7.3 Characterisation of cNF-Protein conjugates made by initial dye/protein ratio and 
their corresponding dye/protein molar ratios. 
Conjugate 
cNF-BSA 
cNF-Ovalbumin 
cNF-a.-Casein 
Initial 
Dye/protein ratio 
12.50 
25.00 
50.00 
100.00 
25.00 
50.00 
100.00 
25.00 
50.00 
100.00 
Dye/protein 
Molar ratio 
0.56 
0.92 
1.33 
1.82 
0.81 
1.10 
1.38 
0.87 
1.22 
1.43 
ratios were obtained with conjugates that had an initial ratio of 100: 1 in each 
case. An initial dye concentration greater than this caused a precipitation of 
the conjugates. Therefore, 100: 1 dye/protein ratios were selected for 
subsequent studies. 
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7.2.3 Excitation and emission wavelength shift of cNF-Protein 
conjugates 
cNFSE normally has an excitation wavelength maximum of 600 nm and an 
emission wavelength maximum of 660 nm. Conjugation to protein resulted in 
a significant shift of the excitation and emission wavelengths further to the red 
Table 7.4 
Excitation and emission wavelength shifts of cNF·protein conjugates.[cNFSE= AEx (600nm) and 
A Em (66Onm)1 
Conjugate 
cNF-8 SA 
cNF-o.-casein 
cNF·ovalbumin 
Figure 7.4 
Fluorescence 
500 
400 
300 
""Ex (om) 
650 
650 
630 
A C B D 
I 
f 
/
1 ;': 
( \ / \ I r 
// 
! I 
200 /f 
100 / 
520 560 600 640 680 
W .. vclcnglh (nm) 
AEm (nm) 
685 
680 
675 
720 760 800 
Excitation and emission spectra of cNFSE (A, 8 ) and cNF-8 SA (C,D). 
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end of the electromagnetic spectrum (Figure 7.4). This is probably due to the 
difference in hydrophobicity of the microenvironment surrounding the cNF. 
Similar changes in spectral properties of the dye-protein complex have been 
reported previously, when protein in human serum was labeled with 
indocyanin green (ICG), to diagnose liver activity [245]. These studies in fact 
increase interest in using cNFSE, for the labeling and determination of 
biologically important molecules. Long wavelength detection can be achieved 
by using laser sources (4.1). The shifts of excitation and emission of cNF 
conjugated to three proteins are summarised in Table 7.4. 
7.2.4 Proteolytic hydrolysis of cNF-protein conjugates 
The efficiency of cNF conjugates made with BSA, ovalbumin, and a-casein 
were investigated with several proteolytic enzymes, including 
Alkaline protease (AP) 
Proteinase-K (PK) 
a-chymotrypsin (CT) 
(EC 3. 4. 21 . 81) 
(EC 3. 4. 21 . 64) 
(EC 3. 4.21 . 1) 
The fluorescence was monitored using a Perkin-Elmer LS 50 B luminescence 
spectrometer equipped with a xenon discharge lamp (9.9 W), using an 
excitation wavelength of 650 nm for cNF-BSA and cNF-ovalbumin, and 635 
nm for cNF-a-casein. The measurements were carried out in triplicate using 
10 .lg/ml of the conjugate in 50 mM carbonate buffer pH 9.5 for AP and pH 8.5 
for PK. The reaction buffer for the CT reactions contained 50 mM phosphate 
pH 8.0. 5 ~g of AP, 7 ~g PK and 20 ~g CT were added at the indicated 
concentrations of the conjugates. The reaction mixtures were incubated for 5 
minutes at 40 °C. Figure 7.5 demonstrates that the signals obtained from the 
cNF-BSA containing reactions were significantly greater than those obtained 
from cNF-ovalbumin and cNF-a-casein containing reactions. The results 
presented herein indicated that, indeed, cNF-BSA was a better substrate for a 
variety of proteases than cNF-ovalbumin and cNF-a-casein under the 
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comparable test conditions. Therefore further studies were carried out with this 
substrate. 
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Figure 7.5 Compalison of cNF-protein conjugates (cNF-BSA, cNF-a-case in, and cNF-
ovalbumin) as substrates for proteases (alkaline protease, proteinase-K and a-
chymotrypsin). 
7.2.5 Immobilisation of proteases 
Alkaline protease, proteinase-K and a-chymotrypsin were immobilised 
separately on controlled pore glass (CPG) by cross-linking with 
glutaraldehyde. The detailed immobilisation procedure is given in 4.2.2. 5 mg 
of alkaline protease, 7 mg of proteinase-K and 10 mg of a-chymotrypsin per 9 
of CPG with a corresponding ratio of 130, 91 and 410 Units respectively were 
used for the immobilisation process. 
7.2.6 Optimisation of the effect of reaction variables in a flow injection 
system 
The immobilised enzymes were packed separately in special enzyme columns 
and were incorporated into the flow system (Figure 7.6). A number of 
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variables such as volume of enzyme, concentration of substrate, buffer 
system, pH, temperature, incubation time , length of incubation loop, and flow 
rate were optimised for the determination of the activity of proteases on the 
cNF-protein conjugates. 
Figure 7.6 
Peristaltic 
pump 
-
-
Perista ltic 
t 
Incubation 
loop 
: ......................................... 1 
Thenmostated 
water bath 
Detector 
/--•• Waste 
Data 
handling 
Flow injection manifold for naphthofluorescein detenmination. 
7.2.7 Influence of pH, buffer system and concentration of buffer on the 
activity of proteases 
The effect of pH on the activity of alkaline protease, proteinase-K and 0.-
chymotrypsin reactors was studied using 0.05 M phosphate, carbonate and 
CAPS (cyclohexylaminopropane sulphonic acid) buffers of various pH values 
as a carrier stream. The alkaline protease and proteinase-K were found to be 
significantly active at higher pH values irrespective of the buffer used. 
However, the maximum response for alkaline protease and proteinase-K was 
obtained at pH 10.0 and pH 9.5 respectively (Figure 7.7) . a-chymotrypsin , on 
the other hand, gave the highest response at pH 8.0. pH values greater than 
this resulted in a decrease in the fluorescence signal , which indicates that the 
enzyme denatures at higher pH. The soluble alkaline protease and 
proteinase-K show pH optima at 10.5 and 9.5, which are shifted to pH 10.0 
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and 9.0, respectively, upon immobilisation. This may be attributed to the new 
environment for the enzyme and the changes in its kinetic properties after 
immobilisation. For this study 25 III of 10.0 Ilg/ml cNF-8SA was injected into 
the flow system through the carrier buffer. The sample was allowed to react 
with the respective protease for 7 minutes at 40 °C in an incubation loop. The 
effect of concentration of buffers between the range 10-100 mM was also 
studied. In order to have sufficient buffering capacity a concentration of 50 
mM was selected. 
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Figure 7.7 Influence of pH on the activity of alkaline protease, proteinase-K and 0.-
chymotrypsin . 
On the basis of the investigation described above, carbonate buffer pH 10.0, 
and pH 9.0 was selected for alkaline protease and proteinase-K respectively. 
a-chymotrypsin was assayed with phosphate buffer pH 8.0 in subsequent 
experiments. 
7.2.8 Dependence of the activity of immobilised proteases on temperature 
The effect of temperature on the activity of the protease reactors was 
examined over the range 25-60 °C, using a thermostated water bath. The 
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results are described in Figure 7.8. The activity of the alkaline protease 
reactor significantly increased with temperature up to 60 °C. The proteinase-K 
column showed a similar level of activity up to 50 °C. These two enzymes 
appear to be fairly stable at high temperatures. However, an optimum 
response for both the enzymes was obtained at 45 QC. An optimum response 
for a-chymotrypsin was observed at 30 °C. On further increase in temperature 
the fluorescence signal decreased. For further studies a temperature of 45 °C 
for alkaline protease and proteinase-K, and 30 °C for a-chymotrypsin was 
selected. 
250 
-<>-Alkaline protease 
S' 
2- 200 --0- Proteinas e-K 
~ -fi-Alpha-
'" c 150 Q) 
1:' 
Q) 
" c 100 Q) 
" 
'" ~
0 50 
.2 
u.. 
0 
20 30 40 50 60 
Temperature ( C) 
Figure 7.8 Effect of temperature on the activity of alkaline protease, proteinase-K and a.-
chymotrypsin. 
7.2.9 Influence of incubation time 
The influence of incubation time on the enzymatic reation was evaluated 
between 1-10 minutes. As shown in Figure 7.9, the fluorescence signal 
increases gradually with increase in the incubation time. An incubation time of 
5 minutes gave the maximum response for alkaline protease and proteinase-
K, whereas the optimum response for a-chymotrypsin was obtained at 7.5 
150 
minutes incubation. These optimum values of incubation time were therefore 
selected for further work. 
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Figure 7.9 Influence of incubation time on the activity of alkaline protease, proteinase-K 
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7.2.10 Effect of the volume of protease reactor 
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Figure 7.10 Dependence of the activity of alkaline protease, proteinase-K and et-
chymotrypsin on the volume of the enzyme reactor. 
151 
The effect of the volume of the protease reactors was studied in the range 
200-600 III in order to obtain a sufficient substrate conversion. As shown in 
Figure 7.1 0, the fluorescence intensity increased with an increase in volume of 
the protease reactors up to 400 III for alkaline protease and proteinase-K, and 
500 III for a-chymotrypsin. These optimum reactor volumes were selected for 
further investigations. 
7.2.11 Calibration graphs for cNF-BSA using proteases 
A series of standard solutions of cNF-BSA were treated under the optimised 
conditions with alkaline protease, proteinase-K and a-chymotrypsin in the flow 
injection system. Each standard was injected in triplicate. The enzyme 
reactions were carried out individually. The calibration graphs obtained for 
cNF-BSA show a good linearity in the range investigated (Figure 7.11). The 
limits of detection of cNF-BSA and correlation coefficients using the above 
mentioned enzymes are shown in Table 7.5. 
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Figure 7.11 Calibration graphs of cNF-8SA using alkaline protease, proteinase-K and (X-
chymotrypsin. 
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Table 7.S 
Limits of detection and correlation coefficients of cNF-BSA using 3 protease systems. 
Protease Limit of detection of 
cNF-BSA (flg/ml) 
alkaline protease 0.5 
proteinase-K 0.9 
a.-chymotrypsin 2.5 
Correlation 
coefficient (R) 
0.9902 
0.9891 
0.9772 
Standard solutions 
of cNF-BSA tested 
5 
5 
5 
7.2.12 Analysis of cNF-8SA using a dual enzyme system 
In order to establish a dual enzyme assay standard solutions of cNF-8SA (5-
25 Ilg/ml) were injected into a flow system shown in Figure 12. The sample 
was directed to split into two parts using a V-connector and captured into 
separate incubation loops connected to the alkaline protease and proteinase-K 
reactors. The sample was allowed to react with the enzymes for a certain 
period of time. All optimised conditions previously described were used, with 
the exception of incubation time. Alkaline protease was incubated for 5 
minutes, Proteinase-K for 7 minutes in order to achieve time dependent 
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Figure 7.12 
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separation. Typical flow injection analysis responses of the product obtained 
by the hydrolysis of cNF-8SA by the two enzyme systems (Figure 7.13) and 
calibration curves are given in Figure 7.14. These results demonstrate that 
the system can successful ly be used for mUlti-enzyme and multi-analyte 
assays. 
7.3 Protease inhibition assays 
The previously optimised conditions were checked in order to investigate the 
influence of numerous inhibitors (protease inhibitor cocktail , EDTA, and 3-
aminophenyl boronic acid) on the activity of immobilised alkaline protease 
(AP), and proteinase-K (PK). In addition to that the volume of inhibitors was 
also examined. An increase in the volume of the inhibitors remarkably 
increased the rate of inhibition of both enzymes. No significant change in the 
level of inhibition was observed by varying the other conditions. Therefore, all 
the conditions used for the inhibition of these enzymes were as previously 
described, with the exception injection loop size. The inhibition in both cases 
was found to be highly reversible. For the complete displacement of the 
inhibitors the carrier buffer was passed through the enzyme columns for 2 
minutes. The activity of the enzyme columns was checked by injecting the 
substrate solution at intervals. 
7.3.1 Inhibitors of alkaline protease 
(i) protease inhibitor cocktail and (ii) EDTA 
Protease inhibitor cocktail is composed of aprotinin, leupeptin, bestatin, 
sodium EDTA, 4-(2-aminoethyl) benzenesulfonyl fluoride, and t-epoxysuccinyl-
L-Ieucylamido (4-guanidino) butane 
Aprotinin is a trypsin-l ike serine protease inhibitor, widely used during open 
heart surgery, mainly because it helps to minimise perioperative bleeding and 
155 
blood product transfusions. It also acts by decreasing the inflammatory 
response generated during cardiopulmonary bypass [258] . Leupeptin is a 
peptide aldehyde known to be a reversible inhibitor of calpain (a cysteine 
protease [259]. Bestatin is reported as a potent aminopeptidase inhibitor 
[260]. It has also shown to exhibit antitumour, as well as antimicrobial activity 
and it is generally believed that th is behavior is associated with its ability to 
inhibit cell surface aminopeptidases [260]. 
Sodium EDTA is a chelating agent reported to inactivate Zn-dependent 
metalloproteins and some Ca-stabilised proteins from other classes [233]. 
Sulfonyl fluoride is an irreversible inhibitor of chymotrypsin-like proteases 
[259]. The peptide derivatives containing amidino or guanidino functional 
groups are shown to be quite good inhibitors of trypsin-like enzymes [259]. 
The characteristics of the constituents of the protease inhibitor cocktail show 
that AP, being a trypsin-like protease, might partly inhibited by aprotinin, 
EDTA, and t-epoxysucciny-I-Ieucyl (4-guanidino) butane. 
7.3.1.1 Effect of the volume of protease inhibitor cocktail and EDTA on 
the activity of AP 
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Figure 7.15 Effect of the volume of protease inhibitor cocktail [30 ng/ml] and EDTA [40 
~g/ml] on the activity of AP. 
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The effect of the volume of protease inhibitor cocktail and EDT A was 
investigated in the range 25-125 ~d . It was observed that the % inhibition 
increases with an increase in the volume of the inhibitors. The results are 
shown in Figure 7.15. The optimum volumes of the inhibitors were therefore 
selected in order to achieve a high sensitivity. 
7.3.1.2 Inhibition of AP by protease inhibitor cocktail and EDTA 
A series of protease inhibitor cocktail standard solutions were mixed with the 
substrate solutions and injected into the flow system under the optimised 
conditions. The % inhibition increased with increasing amount of the inhibitor 
up to 30 !-Ig/m!. Concentrations higher than this did not increase the % 
inhibition significantly. Figures 7.16 and 7.17 show typical responses, and a 
graph for the inactivation of AP, respectively. 
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Figure 7.16 Typical flow injection peaks for the inhibition of AP by protease inhibitor 
cocktail. 
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Figure 7.17 Inhibition of AP by protease inhibitor cocktail 
An assay based on the inhibition of AP by EDT A was also developed under 
the same experimental conditions. The concentration of EDTA was examined 
between the range of 10-80 >tg/ml. The results are shown in table 7.6. 
Table 7.6 
Inhibition of AP by EDTA. 
EDTA £l!g/m l] 10 20 40 60 80 
% inhibition 1.98 7.85 22.5 30.1 38.2 
7.3.2 Inhibition of Proteinase-K by 3-aminophenylboronic acid 
Trigonal boron compounds contain a vacant 2p orbital which easily reacts as a 
Lewis acid with nucleophiles such as alkoxides and imidazoles to give a 
tetrahedral adduct [259]. This adduct formation has also been shown to occur 
in the active site of serine proteases such as a.-chymotrypsin and subtilisin 
[261]. The extended boronic acids are among the most potent reversible 
158 
protease inhibitors yet developed. These compounds are similar to the 
peptide aldehydes in their apparent function as transition state analogues, but 
they appear to be much more selective for serine proteases. In the current 
study attempts to develop an inhibition based assay for proteinase-K, by 3-
aminophenylboronic acid (APBA) using cNF-BSA as a substrate were made. 
Proteinase-K is a typical member of the subti lisin family known to be the most 
active endopeptidase at present [262]. This assay was performed under the 
same conditions as described earlier except for the volume of the inhibitor, 
which was examined between the range 25-125 ~I. 1 00 ~I of the inhibitor was 
used in the subsequent experiments since a greater sensitivity was observed 
ith this volume (Figure 7.18) 
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Figure 7.18 Effect of the volume of APBA on the % inhibition of PK. 
The standard solutions of APBA were mixed with the substrate prior to 
injection into the flow system. The concentrations of the inhibitor were 
between 2.5-40 ~g/ml. As shown in Figure 7.20, APBA efficiently inactivated 
the enzyme between 2.5-40 ~g/ml .. Typical FIA responses are given in Figure 
7.19. 
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Figure 7.19 FIA responses for the inhibition of PK by APBA. 
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7.3.3 Inhibition of a-chymotrypsin by 4-(2-aminoethyl) benzenesulfonyl 
fluoride (AEBSF) 
It has previously been mentioned that sulphonyl fluorides irreversibly inactivate 
the serine proteases. To avoid tedious procedures for the reactivation of the 
enzyme, a-chymotrypsin was used in a soluble form in these assays. Various 
parameters, such as concentration of the enzyme, incubation time, size of the 
incubation loop and volume of the inhibitor were examined in order to obtain a 
maximum response. The results are given in Table 7.7. The pH, and 
temperature were the same as previously described. 
The standard solutions of AEBSF (5-40 Ilg/ml) were incubated with a-
chymotrypsin for 10 minutes prior to injection into the flow system. A flow 
injection merging zone approach was adopted for this study. Inhibitor-enzyme 
mixtures, and the substrate solution were simultaneously injected via a dual 
injection valve into the buffer streams. This mixture was captured into a loop 
and allowed to incubate for 7 minutes at 30 °C. The results (Figures 7.21 and 
7.22) obtained show that AEBSF efficiently inhibits a-chymotrypsin. 
Table 7.7 
Oplimisalion of variables for a.-chymotrypsin inhibition. 
Variable 
a.-chymotrypsin concentrarion 
AEBSF volume 
Incubation time of enzyme and 
inhibitor before injection 
Size of the incubation loop 
Studied range 
25-100 fi9/ml 
25-100 fil 
2-10 minutes 
300-700 fil 
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Optimum value 
50 fi9/ml 
5 minutes 
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Figure 7.21 FIA responses for the inhibition of a.-chymotrypsin by AEBSF. 
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Figure 7.22 Inhibition of a.-chymotrypsin by AEBSF. 
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7.3.4 Selective protease inhibiton 
Based on preliminary investigations, a model assay for measuring the 
inhibitory effect of APBA on alkal ine protease and proteinase-K columns was 
studied. The standard solutions of APBA (2.5-40 ~g/ml ) , mixed with the 
substrate solution were injected into the flow system (Figure 7.12). This 
mixture was split in two parts via a V-connector and captured in separate 
loops containing alkaline protease and proteinase-K reactors. The sample 
was allowed to react wi th the enzymes for a certain period of time. All the 
experimental conditions used were as described previously. The results 
(Figures 7.23 and 7.24) show that APBA selectively inactivates proteinase-Ko 
This simultaneous enzyme-based assay offers the potential to determine the 
concentration of two analytes occurring in a single sample which could be 
used for the simultaneous detection of drugs using anti-drug antibodies. In 
addition, it may be possible to extend this concept to development of more 
rapid simultaneous homogeneous-enzyme-l inked assays. 
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Figure 7.23 FIA peaks for selective inhibition of proteases by APBA. 
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7.3 Discussion 
Proteolytic enzymes have been recognised as playing crucial role in many 
biological processes. Although the natural substrates for proteases are 
proteins, many studies on these enzymes have been based on their action on 
synthetic substrates [242]. Assays designed to test a broad spectrum of 
proteolytic activity generally (I) require multiple steps including fractionation 
procedures (e.g. trichloroacetic acid precipitation, electrophoretic gel (SDS-
PAGE), or chromatographic separation (HPLC) of the peptides or (ii) 
necessitate generation of radioactive substrates with varying specific activities 
due to differential decay time. Such procedures are time consuming and when 
performed quantitatively generally possess intrinsically high standard 
deviations. 
Protein (bovine serum albumin (BSA) , a-casein and ovalbumin) conjugates of 
5-(and-6)-carboxynaphthofluorescein succinimidylester (cNFSE) for use as 
fluorigenic substrates were prepared. The conjugates were labelled to such 
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an extent that the dye was efficiently quenched in the protein, yielding a 
virtually nonfluorescent substrate molecules. NF-BSA was found to be more 
sensitive to quenching effects than NF-a-casein and NF-ovalbumin and 
resulted in greatest increase in relative fluorescence on proteolytic hydrolysis 
with the enzymes including alkaline protease (AP), proteinase-K (PK) and a-
chymotrypsin (CT) (Figure 7.5). The degree of quenching of NF-BSA may be 
attributed to the hyperconjugation of cNFSE with a large protein (BSA) having 
many lysine residues per molecule [242] . 
Using the method of calculation (7.2.2.), it was found that D:P ratio 1.82 
cNFSE molecules to 1 BSA was optimal for use in these type of assays. It 
seems possible that under optimised conditions, even fewer dye molecules 
would produce maximum quenching effects. At higher reaction mixture ratios, 
even though a larger D:P ratio was achieved, an increase in background 
fluorescence accompanied the increase in D:P ratio which limits the sensitivity 
of the assay. 
The effect of complex formation (conjugation) dramatically affected the 
spectroscopic properties of naphthofluorescein. A wavelength shift to ca. 650 
nm (excitation) and 685 nm (emission) was obtained when BSA was 
conjugated to naphthofluorescein succinimidyl ester (Figure 7.4). Similar 
effect but lower shifts were observed with NF-a-casein and NF-ovalbumin 
conjugates (Table 7.4). The excitation wavelength shift of NF-BSA is 
particularly useful in matching the characteristics of the fluorophore to those of 
the 650 nm diode laser available at low cost. 
Following standard chemistries AP , PK and CT were successfully immobilised 
onto controlled pore glass (CPG) as demonstrated by the subsequent 
proteolytic cleavage of dye-bound proteins, generating fluorescent signals in a 
flow system. The system was optimised with respect to pH, buffer 
composition, temperature, incubation time and volume of protease reactors 
(7.2.7-7.2.10). Using the optimal conditions Calibration graphs for cNF-BSA 
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were constructed with AP, PK and CT (Figure 7.11). The limit of detection for 
the substrate (>lg/ml) are given in Table 7.5. These results indicate that cNF-
BSA can ideally be used as a substrate for a variety of proteolyic enzymes. 
Based on these studies, a model assay for AP and PK was developed to 
demonstrate the dual simultaneous assay concept (7.212) . 
The suitability of cNF-BSA as a substrate in enzyme inhibition assays has also 
been demonstrated. The inhibition of AP with protease inhibitor cocktail and 
EDTA at ng/ml and >lg/ml levels was achieved respectively. 3-
aminophenylboronic (APBA) inhibited PK at >lg/ml range and the inhibition of 
CT by 4-(2-aminoethyl) benzenesulfonyl fluoride (AEBSF) at >lg/ml level was 
obtained. 
Based on the preliminary investigations, an assay for measuring the inhibitory 
effect of APBA on AP and PK columns was studied. As can be seen in Figure 
7.23 PK selectively inhibit APBA. This approach offers the potential to 
determine the concentration of two or more analytes in a single sample which 
could be used for the simultaneous detection of drugs using anti-drug 
antibodies. In addition, it may be possible to extend this concept to the 
development of more rapid simultaneous homogenous-enzyme-linked assays. 
In conclusion, the application of cNF-BSA in an FIA system is a rapid, simple 
(does not require any process such as separation, precipitation or 
centrifugation) and sensitive method for the assay of protease inhibitors, 
essential requirements for a routine assay. It is easily automatable and would 
be well suited for high throughput screening. 
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Chapter 8 
Conclusions 
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8.1 Conclusions 
Enzymes are being used to an over-increasing extent in automated assays in 
analytical chemistry and biochemistry. This is clearly indicated by the 
dramatic increase in the number of papers being published in this area and by 
the large range of commercial instrumentation that has become available in 
recent years. 
The main advantage of enzymes as reagents in analytical chemistry is their 
specificity and extreme sensitivity. Disadvantages are their high cost 
especially when continuous flow, automated systems are employed and 
relative instability 
These general limitations on enzymes as catalysts have been minimised to a 
great extent by the technique of immobilisation. 
Spectrofluorimetry in the long wavelength region (600-1000 nm) is a recent 
development of photoluminescence spectroscopy and has many advantages 
compared with more conventional measurements made in ultraviolet and 
visible regions [36). These include: 
I. Lower background scattering- Raman and Rayleigh 
11. Less photodecomposition 
Ill. Fewer bright fluorophores hence less background fluorescence 
IV. Availability of compact bright light sources 
v. Good solid state detectors 
Fluorigenic substrates are widely used to detect and quantify phosphatases, 
esterases, glycosidases and proteases [32-34, 123] . Such compounds offer 
advantages over radioisotope-based assays, including ease of use and safety 
in handling. In addition, the sensitivity of fluorigenic substrates is superior to 
that of chromogenic substrates [30, 32-33]. A disadvantage associated with 
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most of these substrates, however, is that the excitation and emission 
wavelengths of their reaction products are especially unsuitable for work with 
biological samples. The biological samples possess a high level of proteins 
and other natural polymers which cause intense light scattering signals, and 
they commonly contain numerous fluorophores whose broad spectra wholly or 
partly overlap those of the target fluorophores in the commonly used excitation 
and emission wavelength ranges of 300-400 nm and 400-500 nm respectively. 
Recent studies have shown that many of these problems can be successfully 
tackled by using fluorophores which absorb and emit at higher than those 
given above. The dye families with long wavelength emission are xanthenes, 
phenoxazines, polymethine cyanines and phthalocyanines. To develop a 
range of assays it is only necessary to synthesise or modify fluorophores to 
provide suitable reactive groups. Fluorophores with moderate molar 
absorptivities and quantum yields may give excellent limits of detection 
because of low background. 
When the project was established a number of aims were set out, these were: 
1. To synthesise and characterise nonfluorescent derivatives of 
long wavelength xanthine and phenoxazine dyes. 
2. To evaluate their use as substrates for numerous enzymes. 
3. To develop the possibility of flow injection assays and inhibition-
based assays using immobilised enzymes. 
4. To establish dual/multi-enzyme and multi-analyte assays. 
5. To develop assays based on the selective inhibition of enzymes 
that could be used in high throughput screening. 
To a large extent the aims of the project have been successfully fulfilled with 
the use of naphthofluorescein derivatives. 
Naphthofluorescein is a xanthene dye whose spectroscopic characteristics 
include an excitation wavelength of 595 nm and emission wavelength of 660 
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nm. Similarly UV-vis absorption spectrometry shows that it has a strong 
absorption band near 600 nm (figure 3.5) . 
One of the most interesting developments in the present investigation was to 
study the effects of a range of shift reagents (cyclodextrins and surfactants) on 
the spectroscopic properties of naphthofluorescein (table 3.1). The inclusion 
of cyclodextrins is influenced by the hydrophobicity and shape of the guest 
molecule. Addition of U-, ~- and A-cyclodextrins (5 % w/v) had relatively little 
effect on the absorption wavelengths, whilst methyl-~-cyclodextrin and 2-
hydroxypropyl-p-cyclodextrin at the same concentration produced shifts to 609 
and 615 nm respectively. The most dramatic wavelength shifts were obtained 
with CHAPS (a zwitterionic surfactant), which produced shifts to ca. 635 nm 
(excitation) and 680 nm (fluorescence) when present at 2 .5 % level. Lower 
levels of this reagent produced slightly less significant shifts while 3% CHAPS 
produced a small further shift in excitation wavelength, but had little effect on 
the fluorescence emission. 
The work that was conducted to synthesise derivatives of naphthofluorescein 
(3.2), NFDP, NFMP (3.3) and NFDA (5A)) was successful. NFMP and NFDP 
were produced in good yields, with high purity and they were stable over a 
period of twelve months at 4 ac. In contrast, NFDA, although stable for twelve 
months when dried and frozen, deteriorated over a period of 2 hours in 
solution. As a result, the NFDA solution was freshly prepared before use. 
Preliminary studies showed that the rate of hydrolysis of naphthofluorescein 
phosphate by alkaline phosphatase was dependent on enzyme concentration 
(3.3.1.3). The kinetic parameters of NFMP were compared with equivalent 
characteristics of 4-MUP a conventional fluorigenic substrate for alkaline 
phosphatase (3.3.1 A). It was found that there is a great potential for the use 
of NFMP as a long wavelength substrate for ALP. 
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The phosphate derivatives of NF are particularly suitable for alkaline 
phosphatase. As an enzymatic product, NF absorbs and fluoresces maximally 
at an alkaline pH at which the enzyme assays are performed. 
The findings of combined effects of the wavelength shift in excitation and 
intensity enhancement led to the idea that it would be possible to measure 
naphthofluorescein produced by the enzymatic hydrolysis of NFMP and NFDP 
with the detector system recently developed in our laboratory. This was 
demonstrated by the determination of the anti-asthmatic drug theophylline by 
using its inhibitory effect on ALP in the flow injection microreactor system. The 
solid state fluorescence instrument could detect NF at levels of ca. 10-9 M. 
Acetylcholinesterase (AChE) is a hydrolase enzyme with rather narrow 
substrate specificity for acetylcholine and related compounds. It exhibits 
maximum specificity at alkaline pH. Therefore, naphthofluorescein di-acetate 
was used as a substrate for this particular enzyme. Flow injection carried out 
with immobilised AChE permitted rapid enzyme measurements. It was 
observed that immobilised AchE efficiently catalysed NFDA. A calibration 
graph obtained for NFDA showed good linearity in the range (2.5-12.5 x 10-6 
M) (figure 5.10). AChE is an active neurotransmitter its inhibitors include 
organophosphorus and carbamate pesticides and therapeutic drugs regulating 
Alzheimer's disease. An assay was also developed for one of its inhibitors, 
metrifonate, which is used as a pesticide as well as a drug. The method 
allows continuous reuse of immobilised enzyme without loss of the enzyme 
activity. The proposed method is sensitive (0.5 x 10-7-6 X 10-6 M), rapid 
(allowing 30 measurements per hour) and economic. The lack of interference 
by the compounds normally found in blood may make the system attractive for 
clinical studies. This type of system is applicable to other inhibitors of AchE, 
and to inhibitors of other enzymes. 
The investigation of ~-galactosidase is particularly important because several 
genetic diseases have been reported to be caused by its deficiency [228). The 
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enzyme was assayed successfully under continuous flow conditions. 
Naphthofluorescein ~-D-galactopyranoside was used as a fluorigenic 
substrate. The relative inhibition of ~-galactosidase by p-
hydroxymercuribenzoic acid and phenylethyl ~-D-thiogalactoside was also 
determined at l!M level by varying the inhibitor concentration with constant 
substrate concentration and constant volume of the enzyme reactor. The 
approach of immobilised enzyme assays allowed automated studies to be 
completed with significant time saving and reduction of reagent consumption. 
Detection of protease activity is important for biochemical applications such as 
quantifying protease activity in cell or tissue extracts, during enzyme 
purification, in protease inhibition particularly in high throughput screeing and 
for quality control testing. Assays for proteases were developed using a fairly 
new approach which uses proteins labeled with such a number of dyes that 
their fluorescence is highly quenched. The release of fragments by proteolytic 
enzymes generates an increase in fluorescence that correlates with the 
enzymatic activity present in the assay. Proteins (bovine serum albumin 
(BSA), a-casein and ovalbumin) were labeled with various concentrations of 5-
(and-6)-carboxynaphthofluoresceinsuccinimidyl ester. The efficiency of these 
conjugates was investigated with alkaline protease (AP), proteinase K (PK) 
and a-chymotrypsin (figure 7.5). The NF-BSA conjugate was found to be 
more promissing, was therefore selected for further studies. 
Another interesting feature of this study was that the absorption peak shifted to 
longer wavelengths by complex formation with protein . This implies that NF is 
bound to protein and that its spectral properties are changed by complex 
formation. 
Protease inhibition assays using a variety of inhibitors such as EDTA, 
protease inhibitor cocktail (including aprotinin), 3-aminophenylboronic acid and 
AEBSF for AP, PK and a-chymotrypsin were also developed successfully. A 
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dual enzyme assay and an assay based on the selective inhibition of 
proteinase K was also demonstrated. 
In conclusion , it was found that BSA labeled with multiple NF dyes are efficient 
protease substrates useful for the sensitive detection of a variety of proteolytic 
enzymes. These fluorigenic substrates provide a simple assay that is easily 
automated with good sensitivity and broad responsive range for detection of a 
variety of enzymes and their inhibitors. 
The work presented in this thesis has been an investigation designed to 
demonstrate the use of long wavelength substrates for enzyme assays and 
inhibition based assays. The technique has the benefits of the sensitivity and 
specificity of fluorescence as well as all the advantages of measurement in the 
long wavelength region. While the objectives has been successfully achieved, 
additional work has to be carried out to further improve the performance of the 
system e.g. optimise the chemistry of immobilisation process to increase the 
degree of immobilisation of the enzyme, use of other stationary phases of 
higher immobilisation capacity, use of other long wavelength fluorophores, 
increase sensitivity, lower detection limit, reduce assay time and increase 
reproducibility of the assay. In addition, to further enhance the operation, the 
manually operated operation and switching valves can be replaced by 
computer controlled valves thereby providing a semi-automated assay system. 
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